WO2001030266A1 - Filter apparatus for ostium of left atrial appendage - Google Patents

Filter apparatus for ostium of left atrial appendage Download PDF

Info

Publication number
WO2001030266A1
WO2001030266A1 PCT/US2000/029489 US0029489W WO0130266A1 WO 2001030266 A1 WO2001030266 A1 WO 2001030266A1 US 0029489 W US0029489 W US 0029489W WO 0130266 A1 WO0130266 A1 WO 0130266A1
Authority
WO
WIPO (PCT)
Prior art keywords
atrial appendage
filtering membrane
left atrial
ostium
support structure
Prior art date
Application number
PCT/US2000/029489
Other languages
French (fr)
Other versions
WO2001030266A9 (en
Inventor
Robert A. Van Tassel
Robert G. Hauser
Robert Schwartz
David Holmes
Gregg S. Sutton
Thomas E. Borillo
Jeffrey Welch
Original Assignee
Atritech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/428,008 external-priority patent/US6551303B1/en
Priority to IL14913200A priority Critical patent/IL149132A0/en
Priority to DE2000613880 priority patent/DE60013880T2/en
Priority to EP00973875A priority patent/EP1227770B1/en
Priority to ES00973875T priority patent/ES2223602T3/en
Priority to CA 2388600 priority patent/CA2388600C/en
Application filed by Atritech, Inc. filed Critical Atritech, Inc.
Priority to AU12327/01A priority patent/AU779358B2/en
Priority to AT00973875T priority patent/ATE275886T1/en
Priority to JP2001532689A priority patent/JP4630513B2/en
Publication of WO2001030266A1 publication Critical patent/WO2001030266A1/en
Priority to IL149132A priority patent/IL149132A/en
Publication of WO2001030266A9 publication Critical patent/WO2001030266A9/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12122Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder within the heart
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12136Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12159Solid plugs; being solid before insertion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/0105Open ended, i.e. legs gathered only at one side
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00597Implements comprising a membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00619Locking means for locking the implement in expanded state
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00632Occluding a cavity, i.e. closing a blind opening
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/0103With centering means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2002/018Filters implantable into blood vessels made from tubes or sheets of material, e.g. by etching or laser-cutting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0006Rounded shapes, e.g. with rounded corners circular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/005Rosette-shaped, e.g. star-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0067Three-dimensional shapes conical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0069Three-dimensional shapes cylindrical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/0076Quadric-shaped ellipsoidal or ovoid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/0078Quadric-shaped hyperboloidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/008Quadric-shaped paraboloidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0093Umbrella-shaped, e.g. mushroom-shaped

Definitions

  • the invention relates to a membrane structure applied to or across the ostium of an atrial appendage for filtering blood between an atrium of the heart and the associated atrial appendage or appendages to prevent a thrombus from leaving the atrial appendage while allowing blood flow through the membrane.
  • Atrial fibrillation may result in pooling of blood in the left atrial appendage. Blood pooling may also be spontaneous.
  • blood clots can form and accumulate therein, build upon themselves, and propagate out from the atrial appendage into the atrium. These blood clots can then enter the systemic or pulmonary circulations and cause serious problems if they migrate from the atrial appendage and become free in the blood stream and embolize distally into the arterial system.
  • Patent 5,865,791 relates to the reduction of regions of blood stasis and ultimately thrombus formation in such regions, particularly in the atrial appendages of patients with atrial fibrillation. More specifically, the 791 patent relates to procedures and devices for affixing the atrial appendages in an orientation that prevents subsequent formation of thrombus. In the A91 patent, the appendage is removed from the atrium by pulling on it and by putting a loop around it to form a sack of the atrial appendage and then cutting it off from the rest of the heart.
  • U.S. Patent 5,306,234 relates to a method for surgically closing the passage between the atrium and the atrial appendage or severing the atrial appendage.
  • Other methods of treatment include surgically removing the atrial appendages to prevent blood stasis in the atrial appendages.
  • the invention provides a filtering membrane that allows blood to pass therethrough while substantially preventing blood clots formed in the atrial appendages from exiting therefrom. Such clots may cause heart attacks, strokes and other embolic events if allowed to leave the atrial appendage and enter the bloodstream.
  • the filtering membrane is permanently positioned across the ostium of the atrial appendage by a support structure attached to the filtering membrane.
  • the filtering membrane filters blood flowing between the atrium and the left atrial appendage and effectively isolates blood clots from leaving the atrial appendage and entering the atrium. It may be larger than the ostium of the appendage, and extend over an area larger than the appendage ostium. It is percutaneously delivered to the ostium of the atrial appendage by a catheter and then may be expanded for positioning across or over the ostium and has a means to secure the filtering membrane across or over the ostium.
  • the filtering membrane itself is permeable to permit blood flow across the membrane. By allowing the such blood flow across the membrane, the porous structure minimizes any pressure gradient between the atrial appendage and the atrium in a controlled manner.
  • the porous filtering membrane may eventually become infiltrated with cells.
  • the permeable filtering membrane allows such tissue growth which may begin along the outer periphery of the structure. Such tissue growth minimizes uncontrolled leakage about the periphery of the filtering membrane and may assist in attachment of the filtering membrane to the ostium or surrounding tissue.
  • the support structure for the filtering membrane may have a means for self-centering the filtering membrane over the appendage ostium.
  • the filtering membrane may be glued to the wall of the atrial appendage adjacent the ostium, or the support structure may have wires, barbs, prongs or other methods of fixation which pass through the ostium and extend into or through the atrial appendage and which permanently engage an interior wall thereof.
  • an anchor in the wall of the atrial appendage may be tethered to the filtering membrane for holding the filtering membrane in place. Springs may also extend between the anchor and the filtering membrane to hold the filtering membrane against the ostium.
  • the filtering membrane may also be connected to a tether, elastic tether or spring and placed through the atrial appendage wall for holding the filtering membrane against the ostium and may pull on the atrial appendage such that its volume is reduced or eliminated, trapping and isolating blood clots therein.
  • Part of the device may involve a suction apparatus to remove clots that are already in place.
  • the filtering membrane placement may require closure of an atrial septal defect created by the placement of this filter device about the appendage.
  • the filtering membrane may be held in place by a coiled spring which engages the interior wall of the atrial appendage.
  • the filtering membrane itself is permeable.
  • the permeability of the filtering membrane allows blood to flow across, while inhibiting blood clots within the atrial appendage from exiting the atrial appendage into the bloodstream.
  • a permeable filtering membrane it may eventually become infiltrated with cells so that it may become a "living" structure, and can develop an endothelial/endocardial lining to enable it in turn to become a non-thrombogenic surface. It thus can develop an endothelium and with time become highly biocompatible .
  • an anticoagulant or other compounds such as, for example, heparin, or it may be treated to prevent thrombus from forming on the filtering membrane surface, to extend its patency or until it is infiltrated with cells and/or develops an endothelial covering.
  • the device when implanted in the atrial appendage, may also have the ability to perform electrical monitoring of the heart. This may include two or more electrical contacts placed apart on the device, and connected to signal conditioning circuitry for determination of cardiac features such as rhythm of the atria or ventricles. Another sensor on the device could measure pressure of the atria, atrial appendage, or ventricular end diastolic pressures (left or right) through the open mitral or tricuspid valves. A suitable telemetry system would be used to telemeter this important electrical and hemodynamic information non-invasively outside the patient. Also, memory could be present on the device in order to record the information for later recovery via noninvasive telemetry. Objects of the Invention
  • FIG. 1 is a partial cross sectional view of a heart showing a catheter entering the left atrial appendage using a retrograde procedure from the aorta in accordance with the invention.
  • FIG. 2 is a partial cross sectional view of a heart showing a catheter entering the left atrial appendage using a transeptal procedure from the femoral vein or superior vena cava in accordance with the invention.
  • FIG. 3 is a partial cross sectional view of a heart showing a catheter entering the right atrial appendage from the jugular vein or optionally from the femoral vein in accordance with the invention.
  • FIG. 4 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage.
  • FIG. 5 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage with a permeable filtering membrane having flexible wire prongs with atraumatic bulbs to hold the filtering membrane in place and electronics built into the filtering membrane in accordance with the invention.
  • FIG. 6 is similar to FIG. 5 with the atraumatic bulbs removed so that the flexible wire prongs may puncture the atrium wall and secure the filtering membrane to the atrial appendage and a centering rim added to the filtering membrane in accordance with the invention.
  • FIG. 7 is a partial cross sectional view of a portion of a heart as in FIG. 5 with a support portion between the filtering membrane and the prongs in accordance with the invention.
  • FIG. 8 is similar to FIG. 7 with the atraumatic bulbs removed so that the flexible wire prongs may puncture the atrium wall and secure the filtering membrane to the atrial appendage in accordance with the invention.
  • FIG. 9 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage with a permeable filtering membrane having a large expandable support portion to hold the filtering membrane in place in accordance with the invention.
  • FIG. 10 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage having an anchor and a tether to hold the filtering membrane in place in accordance with the invention.
  • FIG. 11 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage having an anchor and a spring to hold the filtering membrane in place, a centering rim on the filtering membrane and a centering cable in accordance with the invention.
  • FIG. 12 is the same as FIG. 11 with the spring filling the atrium to help hold the filtering membrane in place in accordance with the invention.
  • FIG. 13 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage with the filtering membrane adhesively being held in place in accordance with the invention.
  • FIG. 14 is a partial cross sectional view of a delivery catheter having a disk, a spring and filtering membrane therein in accordance with the invention.
  • FIG. 15 is a schematic view of a disk, spring and filtering membrane after being expanded out of the delivery catheter of FIG. 11 in accordance with the invention.
  • FIG. 16 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage having a disk, a filtering membrane and a spring therebetween in accordance with the invention.
  • FIG. 17 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage shown in a collapsed position in accordance with the invention.
  • FIG. 18 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage having a disk, a spring, a filtering membrane and vacuum in the catheter in accordance with the invention.
  • FIG. 19 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage showing an umbrella folded for entering the atrial appendage in accordance with the invention.
  • FIG. 20 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage showing the umbrella opened in the atrial appendage to secure the umbrella into the wall of the atrial appendage in accordance with the invention.
  • FIG. 21 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage showing the umbrella and filtering membrane positioned across the ostium of the atrial appendage in accordance with the invention.
  • FIG. 22 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage showing a support portion having a filtering membrane positioned across the ostium of the atrial appendage in accordance with the invention.
  • FIG. 23 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage showing the atrial appendage reduced to a minimum volume by a disk and spring squeezing the appendage against a filtering membrane in accordance with the invention.
  • FIG. 24 is a perspective view of another embodiment of a filtering membrane and apparatus for installing the filtering membrane in accordance with the invention.
  • FIG. 25 is a sectional view of the filtering membrane and apparatus illustrated in FIG. 24, in accordance with the invention.
  • FIG. 26 is an enlarged view of a portion of the apparatus of FIG. 25 in accordance with the invention.
  • FIG. 27 is a partial cross-sectional view illustrating an early stage in the installation of the apparatus of FIG. 24, in accordance with the invention.
  • FIG. 28 is a partial cross-sectional view similar to FIG. 27, illustrating a later stage in the procedure in accordance with the invention.
  • FIG. 29 illustrates another embodiment of the filtering membrane and apparatus for installing the filtering membrane in accordance with the invention.
  • FIG. 30 is an enlarged view of the filtering membrane and apparatus illustrated in FIG. 29 in accordance with the invention.
  • FIG. 31 is a planar development of the apparatus for attaching the filtering membrane illustrated in FIGS. 29-30 in accordance with the invention.
  • FIG. 32 is a planar development of the apparatus depicted in FIG. 31 in an expanded configuration, in accordance with the invention.
  • FIG. 33 is a perspective view of the filtering membrane and apparatus for attaching the filtering membrane of FIG. 30, illustrated in an expanded configuration in accordance with the invention.
  • FIG. 34 is an elevational view of an embodiment of the filtering membrane in accordance with the invention.
  • FIG. 35 is an elevational view of another embodiment of the filtering membrane in accordance with the invention.
  • FIG. 36 is an elevational view of yet another embodiment of the filtering membrane in accordance with the invention.
  • FIG. 37 is an elevational view of a further embodiment of the filtering membrane in accordance with the invention.
  • FIG. 38 is a partial cross-sectional view illustrating an early stage in the procedure of installing of the filtering membrane of FIGS. 29-37 in accordance with the invention.
  • FIG. 39 is a partial cross-sectional view similar to FIG. 39 illustrating a later stage in the procedure in accordance with the invention.
  • FIG. 40 is a partial cross-sectional view similar to FIG. 39 illustrating a still later stage in the procedure in accordance with the invention.
  • FIG. 41 is a view similar to FIG. 38 illustrating an alternative embodiment of the apparatus illustrated in FIGS. 29-32.
  • FIG. 42 is a partial cross-sectional view similar to FIG. 41 illustrating a later stage in the procedure in accordance with the invention.
  • FIG. 43 is a partial cross-sectional view similar to FIG. 42 illustrating a still later stage in the procedure in accordance with the invention.
  • FIG. 44(a) illustrates an alternative embodiment of the apparatus illustrated in FIG. 30 in accordance with the invention.
  • FIG. 44(b) illustrates the apparatus illustrated in FIG. 44(a) in an expanded configuration in accordance with the invention.
  • FIG. 45 is a view similar to FIG. 44 illustrating another embodiment in accordance with the invention.
  • FIG. 46 illustrates yet another embodiment of the filtering membrane and apparatus for attaching the filtering membrane in accordance with the invention.
  • FIG. 47 is an elevational view taken from direction 47 of FIG. 41 in accordance with the invention.
  • FIG. 48 is elevational view taken from direction 48 of FIG. 41 in accordance with the invention.
  • FIG. 49 is a sectional view illustrating the apparatus of FIG. 46 along with additional apparatus in accordance with the invention.
  • FIG. 50 is a partial cross-sectional view illustrating a first installed configuration of the apparatus of FIG. 46 in accordance with the invention.
  • FIG. 51 is a partial cross-sectional view similar to FIG. 50 illustrating a second installed configuration of the apparatus of FIG. 46 in accordance with the invention.
  • FIG. 52 is a partial cross-sectional view illustrating another embodiment of the apparatus in accordance with the invention.
  • FIG. 53 illustrates yet another embodiment of the apparatus in accordance with the invention.
  • FIG. 54 is an end view of the apparatus of FIG. 53 in accordance with the invention.
  • FIG. 55 illustrates additional apparatus for installing the apparatus of FIG. 53 in accordance with the invention.
  • FIG. 56 is an enlarged sectional view of the apparatus of FIG. 53 and FIG. 55 in a compacted configuration, in accordance with the invention.
  • FIG. 52 is a partial cross-sectional view of the apparatus of FIG. 56 illustrating an early stage in the procedure in accordance with the invention.
  • FIG. 58 is a partial cross-sectional view similar to FIG. 52 illustrating a later stage in the procedure in accordance with the invention.
  • FIG. 54 illustrates a further embodiment of the apparatus in accordance with the invention.
  • FIG. 60 is an end view of the apparatus of FIG. 54 in accordance with the invention.
  • FIG. 61 illustrates a still further embodiment of the apparatus in accordance with the invention.
  • FIG. 62 illustrates additional apparatus for use with the apparatus of FIGS 54-61 in accordance with the invention.
  • FIG. 63 is an enlarged sectional view of the apparatus of FIG. 62 in accordance with the invention.
  • FIG. 59 is a partial cross-sectional view of the apparatus of FIG. 54 illustrating an early stage in the procedure in accordance with the invention.
  • FIG. 65. is a partial cross-sectional view similar to FIG. 59 illustrating a later stage in the procedure in accordance with the invention.
  • FIG. 66 illustrates yet another embodiment of the apparatus in accordance with the invention.
  • FIG. 67 is an end view of the apparatus of FIG. 66 in accordance with the invention.
  • FIG. 68 illustrates additional apparatus for use with the apparatus of FIGS. 66-67 in accordance with the invention.
  • FIG. 69 is an enlarged sectional view of the apparatus of FIGS. 66 and 68 in accordance with the invention.
  • FIG. 70 is a partial cross-sectional view of the apparatus of FIG. 66 illustrating an early stage in the procedure in accordance with the invention.
  • FIG. 71 is a partial cross-sectional view similar to FIG. 70 illustrating a later stage in the procedure in accordance with the invention.
  • FIG. 72 illustrates another embodiment of the apparatus in accordance with the invention.
  • FIG. 73 illustrates yet another embodiment of the apparatus in accordance with the invention.
  • FIG. 74 is a partial cross-sectional view of the apparatus of FIG. 72 illustrating an early stage in the procedure in accordance with the invention.
  • FIG. 75 is a partial cross-sectional view similar to FIG. 74 illustrating a later stage in the procedure in accordance with the invention.
  • FIG. 76 illustrates yet another embodiment of the apparatus in accordance with the invention.
  • FIG. 77 is a distal end view of the apparatus of FIG. 76 in accordance with the invention.
  • FIG. 78 is an enlarged sectional view of additional apparatus for use with the apparatus of FIGS. 76-77 in accordance with the invention.
  • FIG. 79 is a partial cross-sectional view of the apparatus of FIGS. 76-77 illustrating an early stage in the procedure in accordance with the invention.
  • FIG. 80 is a partial cross-sectional view similar to FIG. 79 illustrating a later stage in the procedure in accordance with the invention.
  • FIG. 81 illustrates a further embodiment of the apparatus in accordance with the invention.
  • FIG. 82 is a distal end view of the apparatus of FIG. 81 in accordance with the invention.
  • FIG. 83 is an enlarged sectional view of additional apparatus for use with the apparatus of FIGS. 81-82 in accordance with the invention.
  • FIG. 84 is a partial cross-sectional view of the apparatus of FIGS. 81-82 illustrating an early stage in the procedure in accordance with the invention.
  • FIG. 85 is a partial cross-sectional view similar to FIG. 84 illustrating a later stage in the procedure in accordance with the invention.
  • FIG. 86 is a partial cross-sectional view similar to FIG. 85 illustrating a still later stage in the procedure in accordance with the invention.
  • FIG. 87 is a sectional view of a proximal portion of another embodiment in accordance with the invention.
  • FIG. 88 is an enlarged sectional view of a distal portion of the embodiment illustrated in FIG. 87 in accordance with the invention.
  • FIG. 89 is a perspective view of the embodiment illustrated in FIG. 88(b) in accordance with the invention.
  • FIG. 90 is a sectional view of an early stage of a procedure in accordance with the invention.
  • FIG. 91 is a sectional view similar to FIG. 90, illustrating a further stage in a procedure in accordance with the invention.
  • FIG. 92 is a sectional view similar to FIG. 91, illustrating a later stage in a procedure in accordance with the invention.
  • FIG. 93 is a sectional view similar to FIG. 92 at reduced scale, illustrating a later stage in a procedure in accordance with the invention.
  • FIG. 94 is a sectional view similar to FIG.
  • FIG. 95 is a sectional view similar to FIG. 93, illustrating yet another embodiment in accordance with the invention.
  • FIG. 96 is a sectional view similar to FIG. 93, illustrating still another embodiment in accordance with the invention.
  • FIG. 97 is a sectional view similar to FIG. 93, illustrating a further embodiment in accordance with the invention.
  • FIG. 98 is a sectional view similar to FIG. 88(b), illustrating another embodiment in accordance with the invention.
  • FIG. 99 is a sectional view similar to FIG.
  • FIG. 100 is a sectional view similar to FIG. 99, illustrating a still later stage in a procedure in accordance with the invention.
  • the invention may also be used on the right atrial appendage and in general for placement across any aperture in the body in which blood is permitted to flow therethrough or therefrom but in which blood clots are substantially prevented from escaping from the atrial appendage and entering into the bloodstream.
  • a thrombus, blood clot, or emboli 30 may occur from pooling of blood in the left atrial appendage 13 due to poor circulation of blood therein when the patient experiences atrial fibrillation.
  • thrombus 30 When blood pools in the left atrial appendage 13, thrombus 30 can accumulate therein, build upon itself, and propagate out from the left atrial appendage 13 into the left atrium 11, thus leaving the heart and entering the blood stream. Once in the bloodstream, such thrombus can block blood flow to the heart, brain, other organs, or peripheral vessels if it becomes lodged in the arteries thereof. Heart attack, a stroke, or ischemia may result.
  • a filtering membrane 40 is permanently placed across the ostium 20 of the atrial appendage 13.
  • the filtering membrane 40 can be made of bicompatible materials, such as, for example, ePFTE (e.g., Gortex ® ) , polyester (e.g., Dacron ® ) , PTFE (e.g., Teflon ® ), silicone, urethane, metal fibers, or other biocompatible polymers .
  • the filtering membrane 40 is a permeable filtering membrane, having pore sizes ranging from about 50 to about 400 microns. It is also contemplated that the pores may also be larger or smaller as indicated by the circumstances, provided such pores substantially inhibit thrombus from passing therethrough.
  • the open area of the filtering membrane is preferably at least 20% of the overall surface area, although a range of about 25-60% may be preferred.
  • the structure of the filtering membrane is preferably a two-dimensional screen, a cellular matrix, a woven or non-woven mesh, or the like.
  • the filtering membrane may also be a permeable metal or a metal mesh of fine fibers.
  • the filtering membrane may be coated or covered with an anticoagulant, such as heparin, or another compound, or treated to provide antithromogenic properties .
  • the porosity of the filtering membrane allows blood to flow therethrough while blocking or inhibiting the passage of thrombus, clots, or emboli formed within the atrial appendage from entering the atrium of the heart and, eventually, the patient's bloodstream.
  • the characteristic of allowing the flow of blood through the filtering membrane provides several advantages. For example, the left atrial appendage inherently contracts during normal cardiac function to force blood through the heart. These contractions result in blood flow through the ostium of the left atrial appendage. Allowing blood flow through the filtering membrane substantially reduces any pressure gradient that may exist between the appendage and the atrium.
  • the reduction of the pressure gradient may be helpful to the patient during recovery from the implantation of the filtering membrane structure in the atrial appendage. More particularly, the heart is able to more gradually adapt to the presence of the filtering membrane when blood is permitted to flow through the membrane, and consequently through the ostium of the left atrial appendage.
  • the filtering function also reduces the risk of leakage about the periphery of the filtering membrane, or of dislodgement of the filtering membrane that may result from the exertion of pressure against the surface of the filtering membrane. Allowing the blood flow across the filtering membrane may relieve this pressure, sufficiently and in a controlled manner, to reduce such leakage or dislodgement.
  • Tissue ingrowth may provide additional securement of the filtering membrane to the ostium. More particularly, the growth of tissue may occur along the outer periphery of the filtering membrane or supporting structure adjacent the ostium. This tissue growth, in cooperation with the pressure relief provided by the permeable structure, may provide additional means of reducing leakage about the periphery of the filtering membrane. Tissue growth may eventually cover additional surface area of the filtering membrane.
  • the filtering membrane 40 placed across or over the ostium 20 should be antithrombotic .
  • heparin or other anticoagulants or antiplatelet agents may be used on the filtering membrane 40.
  • permeable filtering membranes 40 When permeable filtering membranes 40 are used, an ingrowth of cells may eventually cover the filtering membrane with endothelial cells.
  • the endothelial cells present a smooth cellular wall covering the filtering membrane which prevents thrombosis from occurring at the filtering membrane.
  • the permeable filtering membrane 40 is permanently implanted across the ostium and retained in position by a support structure attached to the filtering membrane.
  • a support structure attached to the filtering membrane.
  • such permanent placement is achieved by aspects of the support structure which, for example, may engage and/or pierce the wall of the atrial appendage.
  • such permanent placement may be achieved by the support structure which expands to engage either the ostium and/or the interior wall of the atrial appendage.
  • FIGS. 1 and 2 show a cross section of a human heart showing a thrombus 30 in the left atrial appendage 13.
  • the figures also show the atrial appendage ostium 20 which is to have a filtering membrane 40 placed over it to prevent the thrombus 30 from escaping out of the atrial appendage 13 into the left atrium 11 and thus into the blood stream, which could cause a stroke, a heart attack or ischemia.
  • FIG. 3 shows a cross section of a human heart showing a thrombus 30 in the right atrial appendage 23.
  • the right atrial appendage 23 can be treated in the same manner as the left atrial appendage 13.
  • FIG. 4 shows a cross section of the left atrium 11, the ostium 20 and the left atrial appendage 13 having a thrombus 30 therein.
  • FIG. 5 shows a first embodiment of the invention having the permeable filtering membrane 40 and a plurality of flexible prongs 50 which may be made from a shape memory alloy, such as Nitinol ® , for retaining a predisposed shape.
  • the prongs 50 may be atraumatic so that they do not perforate the left atrial appendage 13.
  • the prongs 50 may have atraumatic bulbs 55 on their tips so that the tips of the prongs 50 will not perforate the left atrial appendage 13.
  • Nitinol ® has the property of being able to be placed in a catheter in a compact configuration and then expanded when released from the catheter to a predetermined memory shape.
  • the shape selected may be for the prongs 50 to curve around the lip of the ostium 20 and then hug the sides of the left atrial appendage 13. In this manner the filtering membrane 40 allows blood to flow through the ostium 20 but which blocks or substantially inhibits thrombus 30, clots or emboli from leaving the left atrial appendage 13 and entering the atrium, and eventually, the bloodstream of the patient.
  • the filtering membrane 40 is self centering across or over the ostium 20 of the left atrial appendage 13, by placing the prongs 50 in a circle around the filtering membrane 40 such that the prongs 50 fit against the wall of the left atrial appendage 13 of or within the lumen of the ostium 20 to center the filtering membrane 40 across or over the ostium 20.
  • the filtering membrane 40 may also be centered by a centering rim 65 (see FIG. 6) attached to the back (appendage) side of the filtering membrane 40 that protrudes into the ostium 20 for centering.
  • the centering rim 65 has a diameter of less than the diameter of the filtering membrane 40.
  • the centering means may also consist of a series of centering cables 66 (see FIG. 11) which attach to a spring 90 or tether 85 from the centering rim 65 or the filtering membrane 40, to assure that centering occurs with placement.
  • Optionally electronics such as sensors 300 and chips 310, built into the filtering membrane may be used to provide data about hemodynamic pressure, flow rates, temperature, heart rates, and electrical signals in the heart.
  • the sensors 300 may measure pressures in the atria or atrial appendage.
  • the sensors may also measure ventricular end diastolic pressures through the open mitral or cuspid valves.
  • Other information about the heart may be gathered such as noise from accelerometers to detect leakage, valve efficiency, activity levels of the patient and other noise related data.
  • the sensors 300 may also be blood oxygen sensors.
  • the chip 310 may use telemetry to transmit the information gathered by the sensors 300 and processed or stored by the chip 310 to receiving devices to aid in the treatment of the patient.
  • the protective bulbs 55 are removed from the flexible prongs 50 of FIG. 5 such that flexible prongs 50 puncture the walls of the left atrial appendage 13 and secure the filtering membrane 40 in place.
  • the flexible prongs 50 may penetrate into the atrial appendage wall or extend through the atrial appendage wall.
  • the prongs may have barbed ends 51 to prevent the prongs from withdrawing from the atrial appendage wall.
  • filtering membrane 40 has a permeable structure which allows blood to flow therethrough but which blocks or substantially inhibits thrombus, clots or emboli from entering the atrium, and eventually, the bloodstream of the patient.
  • the filtering membrane 40 has centering rim 65 attached for centering the filtering membrane in the ostium 20 and marker 320 in the filtering membrane 40 for observing the position of the filtering membrane while it is being inserted.
  • the marker may be used for x-ray or ultrasound observation.
  • Nitinol ® was cited above as a type of shape memory alloy prong material which can be used, any type memory alloy may be used. Such alloys tend to have a temperature induced phase change which will cause the material to have a preferred configuration when heated above a certain transition temperature.
  • Other metals which may be used as prongs include corrosion resistant spring metals such as Elgiloy ® or spring tempered steel.
  • FIG. 7 Another embodiment of the invention is shown in FIG. 7. It is similar to the embodiment shown in FIG. 5.
  • the embodiment in FIG. 7 has a support structure 60 attached to the filtering membrane 40 for expanding in the ostium 20 helping to secure the filtering membrane 40 thereto.
  • the prongs 50 operate in the same manner as in FIG. 5 hugging the inner walls of the left atrial membrane 13 to secure the filtering membrane 40 across the ostium 20.
  • filtering membrane 40 has a permeable structure which allows blood to flow therethrough but which blocks or substantially inhibits thrombus, clots or emboli from entering the atrium, and eventually, the bloodstream of the patient.
  • the support structure 60 may also be made from Nitinol ® , Elgiloy ® or another expandable spring loaded or balloon expandable material.
  • the filtering membrane 40 may be self centering across or over the ostium 20 of the left 13 atrial appendage, by placing the support structure 50 into the ostium wherein the support structure plugs the ostium with the filtering membrane 40 centered in the support structure. Further the prongs 50 fit against the wall of the left atrial appendage 13 of or within the lumen of the ostium 20 to center the filtering membrane 40 across or over the ostium 20.
  • FIG. 7a -7d illustrate an alternative embodiment for securing membrane 40 across the ostium 20 of the left atrial appendage 30.
  • Securing structure 510 has a substantially cylindrical anchor structure 512 and an expandable structure, such as balloon structure 514 for expanding anchor structure 512.
  • FIG. 7a illustrates anchor structure in a compacted configuration about balloon structure 514.
  • FIG. 8 the protective bulbs 55 are removed from the flexible prongs 50 of FIG. 7 such that flexible prongs 50 puncture the walls of the left atrial appendage 13 and secure the filtering membrane 40 in place.
  • the flexible prongs 50 may penetrate into the atrial appendage wall or extend through the atrial appendage wall.
  • the prongs may have barbed ends 51 to prevent the prongs from withdrawing from the atrial appendage wall.
  • filtering membrane 40 has a permeable structure which allows blood to flow therethrough but which blocks or substantially inhibits thrombus, clots or emboli from entering the atrium, and eventually, the bloodstream of the patient.
  • a larger expandable support structure 70 is used to both engage the sides of the ostium 20 and hug the inside walls of the left atrial appendage 13.
  • the support structure may be made of Nitinol ® , Elgiloy ® or other material which may be delivered in a catheter and expanded to the proper size and shape to securely hold the filtering membrane 40 across or over the ostium 20 which allows blood to flow through filtering membrane 40 but which blocks or substantially inhibits thrombus 30, clots or emboli from entering the atrium, and eventually, the bloodstream of the patient.
  • FIG. 10 shows another embodiment of the invention wherein the filtering membrane 40 is secured across the ostium 20 by means of an anchor 80 which is driven into or through the wall of the left atrial appendage 13 and secured therein by the surface area of the anchor so that it will not pull out of or through the wall of the left atrial appendage 13 or cause embolism from the left atrial appendage 13.
  • a tether 85 is attached to the anchor 80 and to the filtering membrane 40 to secure the filtering membrane 40 snuggly against the ostium 20.
  • Filtering membrane 40 has a permeable structure which permits unclotted blood to flow through the filtering membrane.
  • a contrast medium 270 such as radiographic contrast or a similar substance, may be introduced into the left atrial appendage 13 by injection through a catheter after the filtering membrane 40 is in place.
  • the device delivery catheter itself may have a port for this injection.
  • the port may also be used to inject the contrast medium 270 that can be immediately visualized, and examined for diagnostic purposes.
  • the introduction of the contrast medium 270 into the left atrial appendage 30 may increase the volume of fluid within the appendage and, consequently, the hemodynamic pressure exerted against the walls of the atrial appendage and against any membrane or structure that may be used to occlude the atrial appendage.
  • the filtering membrane 40 allows blood and contrast medium 270 to flow therethrough, and therefore may equalize hemodynamic pressure between the atrium and the left atrial appendage 30 in a controlled manner.
  • the contrast medium may be used with any of the embodiments of the invention.
  • FIG. 11 shows another embodiment of the invention wherein filtering membrane 40 has a spiral spring 90 in addition to the anchor 80.
  • the spiral spring 90 can be used in conjunction with or separately from the tether 85 to pull the filtering membrane 40 against the ostium 20.
  • a spiral spring 90 has been shown in FIG. 11 the shape used may be oval, cylindrical, oblong, or other shape to connect the anchor 80 to the filtering membrane 40.
  • the spiral spring 90 may fill the volume of the left atrial appendage 13 securing the filtering membrane 40 to the ostium 20.
  • the spiral spring 90 filling the left atrial appendage 13 may also have an anchor 80 and tether 85 to help secure the filtering membrane 40 to the ostium 20.
  • centering rim 65 may be used as shown in FIG. 11 to center the filtering membrane 40 over ostium 20 of left atrial appendage 13.
  • Centering cables 66 connected to spring 90 and either filtering membrane 40 or centering rim 65 may also be used to center the filtering membrane 40 across or over the ostium 20.
  • FIG. 13 shows yet another means of securing the filtering membrane 40 across or over the ostium 20.
  • filtering membrane 40 is directly attached to the ostium 20 by an adhesive 100.
  • FIG. 14 shows a delivery catheter 125 containing a collapsed permeable filtering membrane 40 and a collapsed disk 130 connected to the permeable filtering membrane 40 by a spring 90 on catheter 21.
  • the disk 130 may be made of a flexible woven metal or a flexible woven metal with a thin permeable polymer sandwiched inside. Disk 130 may also be a polymer weave.
  • the disk 130 is flexible and compresses or folds so it fits into the delivery catheter 125 and expands to its desired shape after release from the delivery catheter 125.
  • filtering membrane- 40 compresses or folds to fit into the delivery catheter 125 and expands to its desired shape after release.
  • FIG. 15 shows the permeable filtering membrane 40, disk 130 and spring 90 from FIG. 14 in an expanded configuration outside of the delivery catheter 125.
  • FIG. 15 shows the spring 90 connecting the permeable filtering membrane 40 and the disk 130 for urging them together.
  • an elastic tether or a tether with teeth and a pawl on the permeable filtering membrane 40 to form a ratchet can also be used to pull the permeable filtering membrane 40 and the disk 130 together.
  • FIG. 16 shows the device of FIGS. 15 applied to the left atrial appendage 13 having thrombus 30.
  • the spring 90 pulls the disk 130 toward the permeable filtering membrane 40, collapsing the left atrial appendage 13 and trapping the thrombus 30 therein as shown in FIG. 17.
  • FIG. 18 shows an alternate embodiment of the device in FIGS. 16 and 17 wherein the catheter 21 is equipped with a vacuum 140 for sucking out blood and thrombosis 30 found in the left atrial appendage 13.
  • the vacuum 140 will help collapse the left atrial appendage 13 such that spring 90 need not be as large as in FIG. 16.
  • FIGS. 19-21 show another embodiment of the invention using an umbrella principle for securing the filtering membrane 40 against the ostium 20.
  • FIG. 19 shows closed umbrella struts 160 entering the ostium 20 of left atrial appendage 13.
  • the filtering membrane 40 is some distance back from the umbrella struts 160 at the bottom of the range of teeth 195 on pole 170.
  • FIG. 19 shows closed umbrella struts 160 entering the ostium 20 of left atrial appendage 13.
  • the filtering membrane 40 is some distance back from the umbrella struts 160 at the bottom of the range of teeth 195 on pole 170.
  • FIG. 20 shows the umbrella struts inside of the left atrial appendage 13 with the struts 160 open.
  • Umbrella opening structure 175 on pole 170 pushes the struts out to the umbrella open position.
  • the umbrella opening structure 175 can be pushed to the open position or have a spring loaded mechanism to push the struts 160 to the open position.
  • the ends of the umbrella struts 160 engage the left atrial appendage wall around the ostium 20 and prevent the umbrella from being withdrawn from the left atrial appendage 13.
  • the ends of the umbrella struts 160 that engage the atrial appendage wall may be blunted or have bulbs on the tips or have padding so as not to puncture the left atrial appendage 13.
  • FIG. 21 shows the filtering membrane 40 drawn up against the ostium 20 by ratcheting the filtering membrane along pole 170.
  • the pawl mechanism 200 engages teeth 195 on pole 170 and is moved forward to snugly position the filtering membrane 40 across the ostium 20.
  • FIG. 22 shows a support structure 260 applied to the ostium 20 of left atrial appendage 13.
  • the support structure 260 expands after leaving a delivery catheter such that the wall of the support structure secures the support structure by pressure to the ostium 20.
  • Filtering membrane 240 folds or is compressed into the delivery catheter and expands as the support structure 260 expands and lodges in the ostium 20 of the left atrial appendage 13.
  • FIG. 23 shows the left atrial appendage 13 compressed such that the volume of the atrial appendage is reduced to almost nothing. With the volume reduced the atrial appendage will not have a large volume of blood which can produce a thrombus.
  • disk 130 and spring 90 pull the left atrial appendage 13 toward filtering membrane 40.
  • FIG. 23 shows the use of a disk 130 and spring 90 to act on the left appendage, any method to reduce the volume of the atrial appendage as much as possible may be used.
  • the filtering membrane 40 is much larger than the ostium 20.
  • the oversized filtering membrane 40 may alternatively be used in all embodiments to ensure that the ostium 20 is completely covered.
  • the filtering membrane 40 has a permeable structure which allows blood to flow therethrough, but which blocks or substantially inhibits thrombus, clots or emboli from entering the atrium, and eventually, the bloodstream of the patient.
  • FIGS. 24-28 show another embodiment of the invention wherein the filtering membrane 40 is retained in position across the ostium 20 by an expandable structure, such as balloon structure 402.
  • balloon structure 402 may be manufactured from polymeric materials or similar materials known in the art.
  • Tube 404 communicates with the internal cavity of balloon structure 402 for introducing saline or other appropriate fluid into the balloon structure 402.
  • Filtering membrane 40 is attached to tube 404 in any appropriate manner, such as adhesive, sutures, or other means, and is provided with an aperture 406 which permits access to an end portion of tube 404, which acts as a balloon introduction port 408 to allow the introduction of fluid into the balloon structure 402.
  • FIG. 24 also illustrates a structure for introducing fluid into the balloon structure 402, such as catheter apparatus 410.
  • Catheter apparatus 410 includes an outlet port 412 at its distal end portion for ejecting fluid from the catheter apparatus 410.
  • Outlet port 412 may be connected to the balloon introduction port 408, which in turn communicates with the internal lumen of tube 404 and the interior of balloon structure 402.
  • FIG. 25 illustrates the filtering membrane 40, the balloon structure 402, the tube 404, together with the catheter 410 attached to the tube 404, in a compacted configuration within a delivery tube 422. More particularly, balloon structure 402 is in its collapsed state and filtering membrane 40 is flexible and compressed or folded to fit into the delivery tube 422. Filtering membrane 40 is designed to expand into a disc-like shape after release from tube 422.
  • FIG. 26 illustrates the certain structures pertinent to the interconnection of catheter 410 with tube 404. More particularly, outlet port 412 of catheter 410 may be provided with narrow tube 424 which is received within balloon introduction port 408 and maintains a valve 426 in an open position when outlet port 412 is connected to inlet port 408. When outlet port 412 is removed from balloon introduction port 408, valve 426 may close to prevent fluid from leaving balloon structure 402, as shown in FIG. 26.
  • Delivery tube 422 may be introduced into the venous or arterial system at an appropriate location, and advanced to into the atrium of the heart with appropriate steering and visualization apparatus (not shown) .
  • FIG. 27 illustrates a later stage in the installation procedure wherein the filtering membrane 40, the balloon structure 402, the tube 404, and the catheter 410 have been advanced from the delivery tube 422 (not shown in FIG. 27) .
  • the balloon structure 402 is positioned within the left atrial appendage 13 such that the filtering membrane 40 is positioned about the ostium 20. Fluid is subsequently introduced into the catheter 410 which passes through tube 404 to expand the balloon structure 402, as illustrated in FIG. 28.
  • the balloon structure 402 expands within the atrial appendage 13 and secures the filtering membrane 40 in position.
  • the valve mechanism 426 (not shown in FIG.
  • FIGS. 29-40 illustrate yet another embodiment for attaching the filtering membrane across the ostium 20 of the left atrial appendage 13.
  • FIG. 29 illustrates the filtering membrane 40, the attachment apparatus 440 for securing the filtering membrane 40 across the ostium 20 of the atrial appendage 13, and catheter apparatus 442 for installing the attachment apparatus 440 and filtering membrane 40.
  • attachment apparatus 440 and filtering membrane 40 may be initially in a compacted configuration.
  • Attachment apparatus 440 is preferably an expandable tubular apparatus having an initial diameter 444 of about 1-3 mm and an initial length 446 of about 0.5-6 cm.
  • Attachment apparatus is preferably manufactured from a flexible material such as stainless steel, nitinol, nylon, polyester, PET, or polyethylene.
  • Filtering membrane 40 is attached to attachment apparatus 440 at the proximal end thereof, in a loosely fitted, somewhat conical configuration and defines a central opening 448, which allows the catheter 450 of catheter apparatus 442 to pass through membrane 40, as will be described in greater detail herein.
  • filtering membrane 40 may also cover a greater portion of the length 446 of the attachment apparatus 440, or filtering membrane 40 may cover the entire attachment apparatus 440 in a substantially sock-like fashion.
  • Filtering membrane 40 may be fabricated from a material that also has elastic characteristics which may expand from a first size to a second size.
  • Catheter 450 supplies expansion fluid, such as saline or contrast medium, into expandable structure, such as balloon structure 452, which is positioned within the interior lumen of attachment apparatus 440 in order to radially expand attachment apparatus 440 when it is positioned within the atrial appendage 13.
  • Expandable structure 452 may include a distal, atraumatic tip portion 454, e.g., a flexible helical coil or soft plastic tip.
  • FIGS. 31 and 32 illustrate planar developments of attachment apparatus 440.
  • the structure of attachment apparatus 440 preferably allows the length 446 of the apparatus in its initial configuration (FIG. 31) to remain substantially constant with respect to the length 456 in its expanded configuration (FIG. 32) .
  • attachment apparatus 440 is provided with a configuration having several serpentine segments 458, 460, and 462. Adjacent serpentine segments are interconnected by a plurality of longitudinal struts, e.g., rings 457 and 460 are interconnected by struts 464 and rings 460 and 462 are interconnected by struts 466.
  • a plurality of U-shaped members 470 at the distal end portion of apparatus 440 provide an attachment point for the filtering membrane 40.
  • FIG. 33 illustrates attachment member 440 in an expanded configuration, wherein length 456 remains substantially constant with respect to the length 446 of the configuration illustrated in FIG. 30.
  • Diameter 472 is substantially larger than diameter 444 (FIG. 30) in order to secure filtering membrane 40 with the atrial appendage 13, as will be described herein.
  • FIGS. 34-37 illustrate several embodiments of the filtering membrane 40.
  • catheter 450 passes through opening 458 in filtering membrane 40 in order to supply expansion fluid to expandable balloon structure 452.
  • FIGS. 34-37 may facilitate the passage of balloon structure 452, or other interventional devices therethrough.
  • FIG. 34 illustrates filtering membrane 40a having a composite construction comprising filtering section 474a and elastic section 476a.
  • the filtering section 474a is fabricated from a filtering material that provides the function of filtering the blood to allow the blood to pass therethrough while blocking or substantially inhibiting the passage of clots, thrombus or emboli therethrough, as described above.
  • the elastic section 476a is fabricated from an elastic material, e.g., silicone, urethane or other similar material, that stretches to enlarge opening 458a to allow the balloon structure 452 or other intervention devices, such as, e.g., wires, catheters or the like, to pass therethrough and to subsequently return to its initial size.
  • the initial size of aperture 458a provides similar characteristic to inhibit clots, thrombus or emboli from passing through 458a as filtering material of filtering section 474a.
  • elastic material 476a extends substantially across the entire diameter 472a of the filtering membrane 40a.
  • Filtering membrane 40b (FIG. 35) is constructed with a filtering section 474b (i.e., the same material as filtering section 474a) and an elastic section 476b (i.e., the same elastic material as elastic section 476a) .
  • the filtering section 474b substantially concentrically surrounds the elastic section 476b.
  • the elastic section 476b is provided with an opening 458b that expands to allow the balloon structure 452 or other interventional devices to pass therethrough and to return to initial size in order to provide substantially the same characteristic of inhibiting the passage of thrombus, clots and emboli from passing therethrough as the filtering material of the filtering section 474b.
  • Filtering membrane 40c (FIG. 36) is constructed with a filtering section 474c (i.e., the same material as filtering section 474a) and an elastic section 476c (i.e., the same elastic material as elastic section 476a) .
  • the filtering section 474c substantially concentrically surrounds an elastic section, such as substantially elliptical section 476c.
  • the elastic section 476c is provided with an aperture, such as a slit 458c that expands to allow the balloon structure 452 or other interventional devices to pass therethrough and to return to initial size to provide substantially the same characteristic of inhibiting the passage of thrombus, clots and emboli from passing therethrough as the filtering material of the faltering section 474b.
  • an aperture such as a slit 458c that expands to allow the balloon structure 452 or other interventional devices to pass therethrough and to return to initial size to provide substantially the same characteristic of inhibiting the passage of thrombus, clots and emboli from passing therethrough as the filtering material of the faltering section 474b.
  • Filtering membrane 40d may be fabricated from the same material as filtering section 474a, above, in several sections, such as sections 475d and 477d, which overlap at region 479d to form an opening therethrough for balloon structure 452 or other interventional devices. It is further contemplated that three or more sections of filtering material may be used in an overlapping configuration, in a manner similar to, for example, the "aperture" configuration of an optical device. The balloon structure 452 may be passed through the opening between sections 475d and 477d.
  • FIGS. 38-40 illustrate the procedure for installing attachment apparatus 440 and filtering membrane 40 in the atrial appendage 13.
  • balloon structure 452 along with attachment apparatus 440 are inserted into the atrial appendage 13 in its initial, compact configuration.
  • expansion fluid is passed through catheter 450 and exits through port 453 to fill the interior of balloon structure 452.
  • Balloon structure 452 expands, thereby radially enlarging attachment apparatus 440, as described with respect to FIGS.
  • attachment apparatus engages the interior of the atrial appendage 13, thereby securing filtering membrane 40 in position across the ostium 20.
  • Balloon structure 452 may be removed from the atrial appendage 13 by returning the balloon structure 452 to its initial compact configuration (e.g., by draining the expansion fluid therefrom) and withdrawing the balloon structure proximally through opening 458.
  • the filtering membrane may be fabricated with an elastic portion which expands to permit the withdrawal of the balloon structure therethrough, and which subsequently reduces in size to inhibit the passage of thrombi, clots and emboli therethrough into the atrium.
  • the catheter structure 442 may be subsequently removed from the patient.
  • the balloon structure 452 may remain within the atrial appendage 13 following expansion of attachment apparatus 440 and subsequent return of the balloon structure 452 to its initial compact configuration.
  • catheter 450 may be detachable from balloon structure 452 in a manner similar to the configuration of catheter 410 and tube 404 (FIG. 26) .
  • FIGS. 41-43 illustrate another embodiment of the invention. Attachment apparatus 460 and balloon apparatus 462 are substantially the same as attachment apparatus 440 and balloon apparatus 452, described hereinabove, with the differences noted below.
  • Attachment apparatus 460 may be provided with a plurality of engagement members 464, such as prongs, hooks, or the like, in order to engage and/or pierce the wall of the atrial appendage to provide additional securement of the attachment apparatus 460.
  • Balloon structure 452 may be used in connection with attachment apparatus 460.
  • balloon structure 462 may be provided having a distal end portion which is configured to expand to a greater extent than the proximal portion thereof (FIG. 42) . This greater expansion of the balloon structure 462 provides additional force in the area of the engagement members 464 to drive them into the wall of the atrial appendage 13 (FIG. 43) .
  • FIGS. 44-45 illustrate additional embodiments of expandable structures for radially enlarging the attachment apparatus 440 (or 460) within the atrial appendage.
  • mechanical expansion structures may be particularly useful.
  • FIGS. 44 (a) - (b) illustrate a mechanical expansion structure 472 which may be used to radially expand attachment apparatus 440.
  • mechanical expansion structure 472 may have a compact configuration wherein a plurality of contact members 474 define a diameter 476 that enables the structure to be inserted within the attachment apparatus 440.
  • FIG. 44(a) mechanical expansion structure 472 may have a compact configuration wherein a plurality of contact members 474 define a diameter 476 that enables the structure to be inserted within the attachment apparatus 440.
  • mechanical expansion structure 472 also has an expanded configuration, wherein contact members 474 are further spaced apart to define a larger diameter 477 which radially enlarges the attachment apparatus to the configuration illustrated in FIGS. 32-33 and 39-40.
  • a linkage configuration may include linkage members 478 and sleeve 479.
  • Sleeve 479 is provided with internal threading (not shown) which engages external threading 480 on a portion of drive screw 481.
  • Angular rotation of drive screw 481 (as indicated by the arrow) provides longitudinal movement of sleeve 479 which cooperates with linkage members 478 to controllably move the contact members 474 between the compact and expanded configurations .
  • FIG. 45 illustrates mechanical expansion structure 482, which is substantially identical to mechanical expansion structure 472.
  • Sleeve 489 interacts with linkage members 478 to controllably move contact members 474, as described above with respect to sleeve 479.
  • Sleeve 489 is longitudinally slidable with respect to elongated member 491.
  • a locking structure (not shown) may also be provided to fix the position of sleeve 489 (and thus contact members 474) with respect to elongated member 491.
  • Mechanical expansion structures 472 and 482 may remain in the atrial appendage 13 following the expansion of attachment apparatus 440 (or 460) .
  • a portion of the drive screw 481 or elongated member 491 may be detachable from the expansion structures 472 or 482, respectively (not shown) .
  • apparatus substantially similar to mechanical expansion structures 472/482 may be useful as supporting structures for filtering membrane 40.
  • filtering membrane 40 may be attached to an end portion of structure 472/482, e.g., by attaching filtering membrane 40 to end portions of contact members 474 or by substantially enclosing contact members 474 and linkage members 478.
  • the structure 472/482 may be positioned in the atrial appendage 13 and expanded as described above, such that filtering membrane 40 extends across the ostium 20 to allow blood to pass therethrough while inhibiting the passage of thrombus through the filtering membrane 40.
  • Drive screw 481 or elongated member 491 may be subsequently detached from the apparatus 472/482.
  • FIGS. 46-48 illustrate another embodiment of the invention.
  • Filtering membrane 40 may be installed in the atrial appendage 13 and held therein by attachment apparatus 500, which preferably consists of a pair of flexible wire portions 502a and 502b, which are preferably constructed of a material such as nitinol or Elgiloy or stainless steel and having a wire diameter of approximately .005 to .020 inch.
  • Each wire portion 502a/502b may include a curved portion 504a/504b, a pair of support members 506a/506b and a plurality of engagement members 508.
  • the curved portions 504a/504b define a substantially closed portion for mounting the filtering membrane 40.
  • the filtering membrane 40 is attached with sutures, adhesive, or other appropriate means.
  • the engagement members 508 are configured to engage the interior of the atrial appendage 13 to secure the filtering membrane 40 in position across the ostium 20, as will be described herein.
  • the engagement members 508 may be provided with atraumatic end portions 510.
  • FIG. 49 illustrates attachment apparatus 500 and filtering membrane 40 in a compacted configuration for installation in the atrial appendage 13.
  • a delivery catheter apparatus 520 is used to introduce the attachment apparatus 500 and filtering membrane 40 to the atrial appendage.
  • the curved portions 504a/504b are deflected proximally toward parallelism with the longitudinal axis of the catheter 520, and the engagement members 508 are deflected distally toward parallelism with the longitudinal axis.
  • An inner member 522 is slidably received within the interior of catheter 520 and may be moved relatively longitudinally with respect to catheter apparatus 520 in order to deploy and install the attachment apparatus 500 and filtering membrane 40.
  • FIGS. 50-52 illustrated several options for installing the filtering membrane across the ostium 20.
  • the curved portions 504a/504b are positioned within the walls of the ostium 20 itself.
  • the engagement members 508 provide additional support by engaging the interior of the atrial appendage.
  • the curved portions 504a/504b are positioned outside the ostium within the atrium.
  • Engagement members 508 retain the filtering membrane 40 in position.
  • engagement member 508 are provided with sharpened barb end portions 512 which engage and/or pierce the wall of the atrial appendage to secure the filtering membrane in position (FIG. 52).
  • FIGS. 53-54 illustrate another embodiment of the invention.
  • Attachment apparatus 600 provides a plurality of strut wires 620, e.g., six to 12 strut wires, that extend radially outward from a support ring 604.
  • the strut wires 602 may be constructed from an alloy, such as nitinol, having shape memory characteristics.
  • the support ring 604 maintains the strut wires 602 in the proper configuration and may be made of radiopaque materials, such as, e.g., platinum to provide fluoroscopic imaging of the device position.
  • the support ring 604 is adjacent the proximal end portion 606 of the apparatus 600, and the strut wires 602 extend distally therefrom toward the distal end portion 608.
  • the strut wires may be provided with barbs 610 or other methods for attachment to the interior of the atrial appendage.
  • the proximal portion of the struts 602 provide a bulb shape to conform to the ostium and/or the internal wall of the atrial appendage .
  • the filtering membrane 40 is attached to strut wires 602 adjacent the proximal portion 606 and provides the characteristics described above, wherein blood is allowed to pass through the filtering membrane 40, but thrombi, clots, and emboli are inhibited from passing therethrough.
  • the filtering membrane 40 may be connected to the strut wires 602 using adhesive, sutures, encapsulation or other means.
  • FIGS. 55-56 illustrate apparatus for delivering and installing the attachment apparatus 600 and filtering membrane 40.
  • the catheter apparatus 620 includes an outer sheath 622 and an inner member 624 slidably received within the interior of outer sheath 622.
  • the outer sheath 622 and inner member 624 may be fabricated from materials, such as polymers, that are sufficiently flexible to negotiate the anatomy, yet sufficiently rigid for relative longitudinal movement to deploy and position the attachment apparatus 600.
  • Inner member 624 may have a distal end portion 626 and a shoulder portion 638.
  • Support ring 604 is sized to provide a slide fit over the distal portion 626, and is engaged by the shoulder portion 608. The aperture in support ring 604 is sufficiently small to inhibit clots from passing through.
  • the aperture in support ring is provided with an elastic material such as elastic section 476b illustrated in FIG. 35 to prevent the passage of clots therethrough.
  • strut wires 602 When positioned about distal end portion 626, strut wires 602 are deflected distally toward parallelism with the longitudinal axis of the catheter device 622 and retained in the deflected configuration by the outer sheath 622.
  • the outer sheath 622 is moved longitudinally relative to the inner member 626.
  • the shoulder portion 628 retains the attachment apparatus 600 in position.
  • the shape memory characteristics of the strut wires 602 causes the apparatus to return to a shape approximating that of FIG. 53.
  • 57-58 illustrate the installation of attachment apparatus 600 and filtering membrane 40 in greater detail.
  • the catheter device 620 is advanced partially within the atrial appendage 13.
  • the outer sheath 622 may be retracted proximally, which permits the strut wires 602 to extend radially outwardly.
  • the physician may use the radiopaque characteristics of the ring 604 in order to properly position the ring 604 within the ostium 20. Further proximal retraction of the outer sheath 622 allows the strut wires 602 to extend further radially outward to engage the interior of the atrial appendage 13 (FIG. 58) .
  • the barbs 610 may engage and/or pierce the wall of the atrial appendage to provide increased stability of the attachment apparatus 600.
  • the filtering membrane 40 is consequently positioned across the ostium 20 in order to allow blood to pass through the filtering membrane, while substantially inhibiting thrombi, clots, and emboli from exiting the atrial appendage 13.
  • FIGS. 59-60 illustrate another embodiment of the invention.
  • Attachment apparatus 650 provides a first plurality of strut wires 652 that extend distally and radially outward from a support ring 654 toward the distal end portion 656 of the attachment apparatus 650, and a second plurality of strut wires 658 that extend proximally and radially outward from support ring 654 toward the proximal end portion 660.
  • the strut wires 652/658 may be constructed from an alloy, similar to material used for strut wires 602, above.
  • the support ring 654 maintains the strut wires 652/658 in the proper configuration and is substantially similar to support ring 604, above.
  • the strut wires 652 may be provided with barbs 662 or other methods for attachment to the interior of the atrial appendage.
  • the struts 652/658 are configured to engage the walls of the ostium on the inner and outside sides thereof, respectively.
  • the strut wires 658 may serve as a membrane mounting structure.
  • the filtering membrane 40 is attached to strut wires 658 and provides the characteristics described above, wherein blood is allowed to pass through the filtering membrane 40, but thrombi, clots, and emboli are inhibited from passing therethrough.
  • the filtering membrane 40 may be connected to the strut wires 602 using adhesive, sutures, encapsulation or other means.
  • Attachment apparatus 670 is constructed of braided or woven mesh material rather than the strut wires 652/658 described with respect to FIGS. 59-60.
  • the distal portion 672 is configured to engage the wall of the atrial appendage adjacent the inner portion of the ostium, and the proximal portion 676 is configured to engage the outer portion of the ostium, and the neck portion 674 is disposed therebetween.
  • the braided or woven self-expanded mesh material of attachment apparatus 670 has similar filtering characteristics as filtering membrane 40, or alternatively, a filtering membrane is attached to the mesh material to provide those characteristics.
  • FIG. 62-63 illustrate apparatus for delivering and installing the attachment apparatus 650 and filtering membrane 40 and/or attachment apparatus 670.
  • the catheter apparatus 620 is described above with respect to FIG. 55.
  • Strut wires 652 of apparatus 650 (or distal portions 672 of apparatus 670) are deflected distally toward parallelism with the longitudinal axis of the catheter device 620 and retained in the deflected configuration by the outer sheath 622.
  • strut wires 658 (or proximal portions 676) are deflected proximally toward parallelism with the longitudinal axis and retained in this configuration by the outer sheath 622.
  • the outer sheath 622 is moved longitudinally relative to the inner member 626.
  • FIGS. 64-65 illustrate the installation of attachment apparatus 650/670 and filtering membrane 40 in greater detail. As illustrated in FIG. 64, the catheter device 622 is advanced partially within the atrial appendage 13. The outer sheath 622 may be retracted proximally, which permits the strut wires 652 to extend radially outwardly.
  • the physician may use the radiopaque characteristics of the ring 654 in order to properly position the ring 654 within the ostium 20. Further proximal retraction of the outer sheath 622 allows the distal strut wires 652 and the proximal strut wires 658 to extend radially outward and engage the interior of the atrial appendage 13 (FIG: 65) . The barbs 662 may engage and/or pierce the wall of the atrial appendage to provide increased stability of the attachment apparatus 600.
  • the filtering membrane 40 is consequently positioned across the ostium 20 in order to allow blood to pass through the filtering membrane, while substantially inhibiting thrombi, clots, and emboli from exiting the atrial appendage 13. FIGS.
  • Attachment apparatus 700 provides a plurality of strut wires 702 that extend radially outward from a support ring 704. A first portion 706 of each strut wire 702 extends towards the proximal end portion 708 of the attachment apparatus 700, and a second portion 710 of each strut wire 702 extends towards the distal end portion 712. The distal portion 710 of each strut wire 702 may be provided with a sharpened barb tip 714 or other methods for attachment to the interior of the atrial appendage.
  • the strut wires 702 are constructed from an alloy, similar to material used for strut wires 602, above.
  • the support ring 704 maintains the strut wires 702 in the proper configuration and is substantially similar to support ring 604, above.
  • the proximal portions 706 and distal portions 710 of strut wires 702 are configured to engage the walls of the ostium on the outer and inner sides thereof, respectively.
  • the filtering membrane 40 is attached to proximal portions 706 of strut wires 702 and provides the characteristic described above, wherein blood is allowed to pass through the filtering membrane 40, but thrombi, clots, and emboli are inhibited from passing therethrough.
  • the filtering membrane 40 may be connected to the strut wires 702 using adhesive, sutures, encapsulation or other means.
  • FIGS. 68-69 illustrate apparatus for delivering and installing the attachment apparatus 700 and filtering membrane 40.
  • the catheter apparatus 620 is described above with respect to FIG. 55.
  • Strut wires 702 are deflected towards parallelism with the longitudinal axis of the catheter device 620 and retained in the deflected configuration by the outer sheath 622.
  • the outer sheath 622 is moved longitudinally relative to the inner member 626.
  • the shoulder portion 628 retains the attachment apparatus 700 in position.
  • the shape memory characteristics of the strut wires 702 causes the apparatus to resume the shape approximating that of FIG. 66.
  • FIGS. 70-71 illustrate the installation of attachment apparatus 700 and filtering membrane 40 in greater detail.
  • the catheter device 622 is advanced partially within the atrial appendage 13.
  • the outer sheath 622 may be retracted proximally, which permits the distal portions 710 of strut wires 702 to extend radially outwardly. Further proximal retraction of the outer sheath 622 allows the distal portions 710 to engage the interior of the atrial appendage 13 and the proximal portions 706 to engage the outer portion of the ostium 20 (FIG. 71) .
  • the barbs 714 may engage and/or pierce the wall of the atrial appendage to provide increased stability of the attachment apparatus 700.
  • the filtering membrane 40 is consequently positioned across the ostium 20 in order to allow blood to pass through the filtering membrane, while substantially inhibiting thrombi, clots, and emboli from exiting the atrial appendage 13.
  • FIGS. 72-73 illustrate additional embodiments of the invention.
  • Attachment apparatus 750 includes a plurality of strut wires 752 that extend radially outward and distally from a support member 754 towards the distal end portion 756.
  • Each strut wire 752 may be provided with a sharpened barb tip 758 or other methods for attachment to the interior of the atrial appendage.
  • the strut wires 702 are constructed from an alloy, similar to the material used for strut wires 602, above.
  • the support member 754 maintains the strut wires 752 in the desired configuration.
  • the proximal end portion of support member 754 supports a curved membrane mounting structure 760 that defines a substantially closed curve.
  • the filtering membrane 40 is attached to membrane mounting structure 760 and provides the characteristic described above, wherein blood is allowed to pass through the filtering membrane 40, but thrombi, clots, and emboli are inhibited from passing therethrough.
  • the filtering membrane 40 may be connected to the membrane mounting structure 760 using adhesive, sutures, encapsulation or other means.
  • the attachment apparatus 770 illustrated in FIG. 73 is substantially identical to attachment apparatus 750, with the differences noted herein.
  • the proximal end portion of support member 754 supports a membrane mounting structure 772 having a spiral configuration.
  • the filtering membrane 40 is attached to spiral mounting structure 772 substantially as described above with respect to membrane mounting structure 760, above.
  • the spiral configuration may, e.g., assist in reducing the mounting structure to a compacted configuration during installation.
  • FIGS. 74-75 illustrate the installation of attachment apparatus 750 (or 770) and filtering membrane 40 in the atrial appendage 13.
  • Catheter apparatus 780 is provided for delivering and installing the attachment apparatus 750 and filtering membrane 40.
  • the catheter apparatus 780 is similar to catheter apparatus 620 described above with respect to FIG. 55.
  • Catheter apparatus 780 includes an outer sheath 782 and an inner member 784.
  • Inner member 784 preferably has an engagement surface 785 on a distal end portion thereof.
  • strut wires 752 are deflected towards parallelism with the longitudinal axis of the catheter device 780 and retained in the deflected configuration by the outer sheath 782 (not shown in FIG. 74) .
  • the membrane mounting portion 760 (or 772) is folded, rolled or otherwise compacted inside outer sheath 782 as illustrated in FIG. 74.
  • the catheter device 780 is advanced partially within the atrial appendage 13.
  • the outer sheath 782 may be retracted proximally, which permits the strut wires 752 to extend radially outwardly due to its shape memory characteristics, as shown.
  • the inner member 784 retains the attachment apparatus 750 in position.
  • proximal retraction of the outer sheath 782 allows the strut wires 752 to extend radially outward and engage the interior of the atrial appendage.
  • the barbs 758 may engage and/or pierce the wall of the atrial appendage to provide increased stability of the attachment apparatus 700.
  • the membrane mounting structure 760 (or 772) is likewise permitted to return to its disc-like configuration, such that filtering membrane 40 is positioned across the ostium 20 in order to allow blood to pass through the filtering membrane, while substantially inhibiting thrombi, clots, and emboli from exiting the atrial appendage 13.
  • FIGS. 76-80 illustrate another embodiment of the invention.
  • Attachment apparatus 800 has a braided or woven mesh portion 802 and a plurality of engagement members 804.
  • Woven portion 802 defines a proximal portion 806 and distal portion 810.
  • Woven portion 802 is fabricated from a material having shape memory characteristics, such as nitinol or an elastic polymeric material.
  • Woven portion 802 is fabricated such that proximal portions 806 and distal portions 810 are normally biased to extend radially outward from support rings 812 and 814, respectively.
  • the configuration of the woven portion 802 illustrated in FIGS. 76-77 is intended to conform to the ostium of the atrial appendage.
  • the braided or woven self-expanding mesh material of woven portion 802 also has similar filtering characteristics as filtering membrane 40, which allows blood to pass therethrough while substantially inhibiting the passage of thrombus.
  • a filtering membrane is attached to the woven material to provide these characteristics.
  • a plurality of engagement members 804 extend distally from support ring 814.
  • the end portions of engagement members 804 may be provided with a barbed configuration to engage and/or pierce the wall of the atrial appendage and retain the engagement member in the wall.
  • Engagement members 804 are similarly constructed from material having shape memory characteristics, such as nitinol.
  • FIG. 78 illustrates apparatus for delivering and installing the attachment apparatus 800 and filtering membrane 40.
  • the catheter apparatus 820 is similar to that described above with respect to catheter apparatus 520 (FIG. 55) .
  • Inner member 825 may include a guide wire 824 and shoulder portion 826.
  • Guide wire 824 may extend through support rings 812 and 814.
  • woven portion 802 is deflected towards parallelism with the longitudinal axis of the catheter device 820 and retained in the deflected configuration by the outer sheath 822.
  • the engagement members 804 are deflected towards parallelism and retained in such position by the outer sheath 822.
  • the outer sheath 822 is moved longitudinally relative to the inner member 626, while the shoulder portion 826 retains the attachment apparatus 800 in position.
  • the shape memory characteristics of the woven portion 802 cause the apparatus to return to the shape approximating that of FIG. 78.
  • attachment apparatus 800 is partially inserted into the atrial appendage 13.
  • Guide member 824 may be used to assist in the placement of attachment apparatus 800 with the atrial appendage by providing visual or tactile indication to the physician.
  • Outer sheath 822 may be retracted proximally, which allows engagement members 804 to deflect radially outwardly, thereby engaging the interior wall of the atrial appendage.
  • the barbs 805 may engage and/or pierce the wall of the atrial appendage to provide increased stability of the attachment apparatus 800.
  • Outer sheath 822 may be further retracted proximally, thereby exposing woven portion 802, which expands radially outwardly to conform to the ostium 20 of the atrial appendage.
  • the filtering membrane 40 (or the woven portion 802 having such filtering characteristics) is consequently positioned across the ostium 20 in order to allow blood to pass through the filtering membrane, while substantially inhibiting thrombi, clots, and emboli from exiting the atrial appendage 13.
  • FIGS. 81-86 illustrate another embodiment of the invention.
  • Attachment apparatus 850 has a support structure including a plurality of struts 852 and an anchor structure 854.
  • Struts 852 each define a proximal portion 856 and a distal portion 858.
  • Struts 852 are fabricated from a material having shape memory characteristics, such as nitinol or an elastic polymeric material. Struts are fabricated such that proximal portions 856 and distal portions 858 are normally biased to extend radially outwardly.
  • the configuration of the struts 852 illustrated in FIG. 78 conforms to the ostium of the atrial appendage when installed, as described herein.
  • Filtering membrane 40 substantially covers struts 802, and provides the filtering characteristics described above, which allows blood to pass therethrough but substantially inhibits the passage of clots, thrombus, or emboli.
  • Anchor structure 854 extends distally from struts 802 and includes a stylet tip 860 and two or more barbs 862.
  • FIG. 83 illustrates apparatus for delivering and installing the attachment apparatus 850 and filtering membrane 40.
  • the catheter apparatus 880 is similar to that described above with respect to catheter apparatus 780 (FIG. 74) .
  • An outer sheath 882 and inner member 884 having an engagement surface 888 are provided.
  • Struts 852 are deflected towards parallelism with the longitudinal axis of the catheter device 880 and retained in the deflected configuration by the outer sheath 882.
  • Barbs 862 of the anchor portion are deflected towards parallelism by the distal nose portion 883 of the outer sheath 882.
  • the inner member 884 is moved longitudinally relative to the outer sheath 882.
  • the engagement surface 888 of the inner member 884 urges the attachment apparatus 850 out of the outer sheath 882.
  • the shape memory characteristics of the material causes the apparatus to return to the shape approximating that of FIG. 81.
  • attachment apparatus 800 is partially inserted into the atrial appendage 13.
  • the stylet tip 860 is exposed from outer sheath 882 and pierces the wall of the atrial appendage.
  • the distal nose portion 883 of the outer sheath 882 retains the barbs 862 towards parallelism with the longitudinal axis, thereby enabling these barbs 862 to pass through the wall of the atrial appendage.
  • the barbs 862 may deflect radially outwardly, thereby preventing the anchor structure from being withdrawn proximally back through the wall (FIG. 85) .
  • FIG. 85 As illustrated in FIG.
  • outer sheath 882 may be retracted proximally, thereby exposing struts 852, which expand radially outwardly to conform to the ostium 20 of the atrial appendage.
  • the filtering membrane 40 (or the woven portion 802 having such filtering characteristics) is consequently positioned across the ostium 20 in order to allow blood to pass through the filtering membrane, while substantially inhibiting thrombi, clots, and emboli from exiting the atrial appendage 13.
  • FIGS. 86 and 88 Another embodiment is illustrated in FIGS. 86 and 88 and is denoted generally by reference number 900.
  • This embodiment may comprise a deployment apparatus 910 for installing attachment apparatus 912, thereby securing the filtering membrane 40 across the ostium 20 of the atrial appendage 13.
  • Deployment apparatus 910 has a proximal handle portion 914 and an elongated shaft portion 916.
  • Elongated shaft portion 916 is preferably flexible for introducing the apparatus in the patient' s vascular system and advancing the attachment apparatus into the atrium of the heart and adjacent the atrial appendage 13.
  • Proximal handle portion 910 may comprise a body portion 918, which supports the elongated shaft portion 916 (consisting of a drive tube 926 and an outer tube 936) .
  • Body portion 918 also supports a rotation knob 920 and a longitudinal slide 922.
  • the rotation knob 920 is configured to rotate angularly about the longitudinal axis of the body portion 918 (as indicated by arrow 924) .
  • Drive tube 926 is connected to rotation knob 920, such that rotation of the rotation knob 920 also rotates drive tube 926 about the longitudinal axis of (as indicated by arrow 928) .
  • Drive tube 926 may be provided with an internal lumen 930 to permit a guide wire (not shown) to be used in connection with this procedure.
  • Longitudinal slide control 922 may be slidable within a slot 932 in the body portion 918 (as indicated by arrow 934) .
  • Slide control 922 is connected to outer tube 936, and is longitudinally slidable therewith (as indicated by arrow 938) .
  • attachment apparatus 912 is configured for attachment to the distal end of elongated shaft portion 910. Attachment apparatus 912 is initially in the compacted configuration shown in FIGS. 88 and 89.
  • attachment apparatus 912 may comprise an outer portion 941 having an initially cylindrical configuration with a diameter 940 of about 2.0 mm and an initial length 942 of about 2.5 cm.
  • Outer portion 941 is preferably manufactured from a flexible material such as stainless steel, nitinol, or Elgiloy ® . Outer portion 941 has a plurality of longitudinal struts 946 defined elongated slots 944. Longitudinal struts 946 are configured to enlarge radially outwardly to engage the ostium of the left atrial appendage, as will be described herein.
  • Filtering membrane 40 is attached to outer portion 941 preferably about the proximal portions of the longitudinal struts 946 and has an initially cylindrical configuration. Filtering membrane 40 may be fabricated in a tapered configured and folded about the outer portion 941. Alternatively, membrane 40 may be fabricated from a material that has elastic characteristics which allow expansion from the initial cylindrical configuration to a substantially tapered configuration (see, FIG. 90) .
  • attachment apparatus 912 may also comprise a male threaded member 948 defining outer threads 950, and a female threaded member 952 defining inner threads 953 cooperating with outer threads 950.
  • Male threaded member 948 is longitudinally fixed adjacent the proximal portion of outer portion 941
  • female threaded member 952 is longitudinally fixed adjacent the distal portion of outer portion 914.
  • the medial portion of the longitudinal struts 946 deflect radially outwardly in a toggle-like fashion (as illustrated in FIG. 90) .
  • a plurality of locking tabs 954 are provided adjacent the proximal portion of attachment apparatus 912, as will described herein.
  • proximal end portion of elongated shaft portion 910 is configured for attachment to, and subsequent removal from, the attachment apparatus 912. More particularly, a collet 956 is attached to the distal end of outer tube 936. Collet 956 may be provided with a plurality of apertures 959, which receive locking tabs 954 therein.
  • Driver 958 may be attached to the distal end of drive tube 926.
  • Driver 958 preferably has a locking arrangement with respect to a longitudinal bore 960 in male threaded member 948,
  • driver 958 may have a faceted outer surface defining six planar surfaces which is received in bore 960 defining a complementary faceted surface that allows relative longitudinal movement between driver 958 and male threaded member 948, while inhibiting relative angular rotation therebetween.
  • Attachment apparatus 912 is positioned at least partially within the atrial appendage 13 in the compacted configuration as illustrated in FIGS. 88 and 89.
  • FIG. 90 A next stage in the procedure for installing the attachment apparatus 912 and filtering membrane 40 is illustrated in FIG. 90.
  • the rotation knob 920 may be rotated in the direction indicated by arrow 924 (see, FIG. 88. Rotation of rotation knob 920 causes drive tube 926, along with driver 958, to also rotate angularly.
  • the cooperating relationship of driver 958 within male threaded member 948 causes male threaded member 948 to rotate angularly (as indicated by arrow 962) .
  • the outer threads 950 and inner threads 953 are configured such that rotation of male threaded member 948 causes longitudinal motion of female threaded member 952 (i.e., in the direction indicated by arrow 964).
  • the male threaded member 948 is rotated to cause the female threaded member 952 to move proximally, thereby deflecting the longitudinal struts 946 radially outwardly (as indicated by arrow 966) . Further rotation of the male threaded member 948 deflects the longitudinal struts 946 radially outwardly until they engage the ostium 20 or the interior wall of the atrial appendage 13.
  • the deployment apparatus 910 may be detached from the attachment apparatus 912. More particularly, collet 956 is moved proximally longitudinally by moving longitudinal slider 922 proximally with respect to handle body portion 918 (as indicated by arrow 970) .
  • attachment apparatus 912 secures the filtering membrane 40 across the ostium 20 of the atrial appendage 13. Filtering membrane 40 provides the filtering characteristics described above, which allows blood to pass therethrough but substantially inhibits the passage of clots, thrombus, or emboli.
  • FIGS. 94-97 illustrate several additional embodiments of the attachment apparatus described herein with respect to FIGS. 88-93.
  • FIG. 94 illustrates attachment apparatus 981, substantially similar to attachment apparatus 912, having one or more barbs 980 provided on longitudinal struts 946 in order to engage the ostium 20 or the interior wall of the atrial appendage 13.
  • FIG. 95 illustrates attachment apparatus 983, substantially similar to attachment apparatus 912, wherein each of the longitudinal struts 946 has a substantially straight longitudinal section 984, which may provide improved conformity to the ostium 20 of the atrial appendage 13.
  • FIG. 96 illustrates attachment member 985, substantially similar to attachment apparatus 912, wherein the longitudinal struts 946 have unequal length sections 987 and 990, which may provide additional stability and conformity to the ostium 20.
  • FIG. 97 illustrates attachment apparatus 992, substantially similar to attachment apparatus 912, wherein the longitudinal struts 946 are configured to engage the ostium 20 or the interior wall of the atrial appendage 13 at a plurality of longitudinal locations, e.g., locations 993 and 994. This configuration may be achieved by attaching a portion of the longitudinal struts 946 to a slidable collar 995.
  • the longitudinal struts 946 may be provided with barbs 996, which are configured to engage the ostium 20 and the interior wall of the atrial appendage 13 at a plurality of locations.
  • FIGS. 98-100 Yet another embodiment is illustrated in FIGS. 98-100, and is denoted by reference number 1000.
  • Apparatus 1000 is substantially similar to the apparatus 900 described above, with the differences noted herein.
  • Attachment apparatus 1012 is substantially similar to attachment apparatus 912.
  • filtering membrane 40 may be annularly attached to the outer portion 941 adjacent the proximal end portion thereof.
  • filtering membrane 40 may be separately expandable from longitudinal struts 946.
  • filtering membrane 40 is attached to an expandable membrane support frame 1040 which is preferably fabricated from a material having shape-memory characteristics, such as nitinol, and is self-expanding to radially outwardly disposed configuration.
  • Deployment apparatus 1010 is substantially similar to deployment apparatus 910.
  • deployment apparatus 1010 may also comprise sheath 1030 which is sized to fit coaxially about the membrane 40 and the outer tube 936.
  • Sheath 1030 retains the membrane support frame 1040 in a compacted configuration substantially parallel with the longitudinal axis of the apparatus. Sheath 1030 may be withdrawn proximally in order to permit the membrane support frame to expand radially outwardly.
  • FIG. 98 illustrates the attachment apparatus
  • Sheath 1030 is coaxially disposed about the filtering membrane 40 to retain the membrane support frame 1040 substantially parallel with the longitudinal axis.
  • the cooperating threaded portions 952 and 948 are relatively positioned such that longitudinal struts 946 are also in the compacted, substantially cylindrical configuration. This configuration is useful for inserting and positioning the attachment apparatus 1012 adjacent the ostium 20 of the atrial appendage 13.
  • FIG. 99 illustrates a next step in the deployment of attachment apparatus 1012.
  • the sheath 1030 may be withdrawn proximally (as indicated by arrow 1031) . Withdrawal of sheath 1030 permits membrane support frame 1040 to expand radially outwardly (as indicated by arrows 1041), thereby outwardly expanding filtering membrane 40 therewith.
  • FIG. 100 illustrates a further step in the deployment of attachment apparatus.
  • Filtering membrane 40 is positioned by the physician over the ostium 20 of the atrial appendage 13.
  • the filtering membrane may define an outer periphery which is larger than the size of the ostium 20.
  • Filtering membrane 40 is secured in position by expanding longitudinal struts 946 to engage the interior of the atrial appendage 13 and/or the ostium 20. Expansion of the longitudinal struts 946 is effected by rotation of the male threaded member 948 with respect to the female threaded member 952 by driver 958 (as described above with respect to FIG. 90) .
  • the deployment apparatus 1010 may be detached from the attachment apparatus 1012, substantially as described above with respect to FIGS. 91-92.
  • the filtering membrane 40 is secured in position by the attachment apparatus 1012 across the ostium 20. More particularly, the outer periphery of the filtering membrane 40 may be secured in direct engagement with the atrial wall surrounding the ostium 20.
  • the devices described above may be percutaneously delivered to the left and right atrial appendages 13, 23 respectively.
  • the devices may have materials in them which enhance visualization or imaging by ultrasound, x-ray or other means making it easier for the device to be implanted and accurately centered with respect to the ostium 20 of the atrial appendage 13.
  • catheter 21 is seen entering the heart by way of the aorta 12 to the left ventricle 16 passing through the mitral valve 17 and then entering the left atrial appendage 13 to apply the permeable filtering membrane 40 in one of the embodiments as disclosed above.
  • the catheter 21 enters the heart from the femoral vein, passes through the inferior vena cava 18 to the right atrium and then passes through the fossa ovalis 19 or through the septum 29 into the left atrium 11 and then approaches the left atrial appendage 13 to apply the permeable filtering membrane 40 thereto.
  • FIG. 3 shows the catheter 21 being applied to the right atrial appendage 23.
  • Catheter 21 may enter the heart through the jugular vein 28 or the femoral vein to the inferior vena cava 18.
  • the invention may be practiced with numerous means of attaching the filtering membrane 40 across the ostium 20 of the atrial appendages 13 and 23. All of the above embodiments shown and discussed for the left atrial appendage 13 are also useable on the right atrial appendage 23. Any combination of the attachment means with adhesives, prongs, cylindrical structures, anchors, disks, tethers or springs may be used.
  • the filtering membrane may also be inside of the atrial appendages 13 and 23, or may penetrate the atrial appendage and provide a means to securely lock the filtering membrane device into place. Other means of providing a filtering membrane for allowing blood flow therethrough and substantially inhibiting blood clots from exiting out of the atrial appendages not listed herein may also be used.

Abstract

Apparatus for permanent placement across an ostium of a left atrial appendage in a patient, which includes a filtering membrane configured to extend across the ostium of the left atrial appendage. The filtering membrane has a permeable structure which allows blood to flow through but substantially inhibits thrombus from passing therethrough. The apparatus also includes a support structure attached to the filtering membrane which retains the filtering membrane in position across the ostium of the left atrial appendage by permanently engaging a portion of the interior wall of the left atrial appendage. The support structure may be radially expandable from a first configuration to a second configuration which engages the ostium or the interior wall of the left atrial appendage. The filtering membrane may define an opening therethrough that is configured to expand from a first size which inhibits the passage of thrombus therethrough to a second size which allows an interventional device, e.g., an expansion balloon, to pass therethrough, and wherein the opening is resiliently biased towards the first size.

Description

FILTER APPARATUS FOR OSTIUM OF LEFT ATRIAL APPENDAGE
Background of the Invention
Field of the Invention The invention relates to a membrane structure applied to or across the ostium of an atrial appendage for filtering blood between an atrium of the heart and the associated atrial appendage or appendages to prevent a thrombus from leaving the atrial appendage while allowing blood flow through the membrane.
Description of the Related Art
There are a number of heart diseases (e.g., coronary artery disease, mitral valve disease) that have various adverse effects on the heart. An adverse effect of certain cardiac diseases, such as mitral valve disease, is atrial (or auricular) fibrillation. Atrial fibrillation may result in pooling of blood in the left atrial appendage. Blood pooling may also be spontaneous. When blood pools in the atrial appendage, blood clots can form and accumulate therein, build upon themselves, and propagate out from the atrial appendage into the atrium. These blood clots can then enter the systemic or pulmonary circulations and cause serious problems if they migrate from the atrial appendage and become free in the blood stream and embolize distally into the arterial system. Similar problems also occur when a blood clot extending from an atrial appendage into an atrium breaks off and enters the blood supply. Since blood from the left atrium and ventricle supply the heart and brain, blood clots from the atrial appendages can obstruct blood flow therein causing heart attacks, strokes or other organ ischemia. It is therefore necessary to find a means of preventing blood clots from forming in the atrial appendages and to prevent these blood clots, once formed, from leaving the atrial appendages to the heart, lungs, brain or other circulations of the patient which can cause heart attacks or strokes or other organ ischemia. U.S. Patent 5,865,791 relates to the reduction of regions of blood stasis and ultimately thrombus formation in such regions, particularly in the atrial appendages of patients with atrial fibrillation. More specifically, the 791 patent relates to procedures and devices for affixing the atrial appendages in an orientation that prevents subsequent formation of thrombus. In the A91 patent, the appendage is removed from the atrium by pulling on it and by putting a loop around it to form a sack of the atrial appendage and then cutting it off from the rest of the heart.
U.S. Patent 5,306,234 relates to a method for surgically closing the passage between the atrium and the atrial appendage or severing the atrial appendage. Other methods of treatment include surgically removing the atrial appendages to prevent blood stasis in the atrial appendages. Summary of the Invention
The invention provides a filtering membrane that allows blood to pass therethrough while substantially preventing blood clots formed in the atrial appendages from exiting therefrom. Such clots may cause heart attacks, strokes and other embolic events if allowed to leave the atrial appendage and enter the bloodstream.
The filtering membrane is permanently positioned across the ostium of the atrial appendage by a support structure attached to the filtering membrane. The filtering membrane filters blood flowing between the atrium and the left atrial appendage and effectively isolates blood clots from leaving the atrial appendage and entering the atrium. It may be larger than the ostium of the appendage, and extend over an area larger than the appendage ostium. It is percutaneously delivered to the ostium of the atrial appendage by a catheter and then may be expanded for positioning across or over the ostium and has a means to secure the filtering membrane across or over the ostium.
The filtering membrane itself is permeable to permit blood flow across the membrane. By allowing the such blood flow across the membrane, the porous structure minimizes any pressure gradient between the atrial appendage and the atrium in a controlled manner. The porous filtering membrane may eventually become infiltrated with cells. The permeable filtering membrane allows such tissue growth which may begin along the outer periphery of the structure. Such tissue growth minimizes uncontrolled leakage about the periphery of the filtering membrane and may assist in attachment of the filtering membrane to the ostium or surrounding tissue.
There are many means for fixing the filtering membrane in position across the ostium of the atrial appendage. The support structure for the filtering membrane may have a means for self-centering the filtering membrane over the appendage ostium. The filtering membrane may be glued to the wall of the atrial appendage adjacent the ostium, or the support structure may have wires, barbs, prongs or other methods of fixation which pass through the ostium and extend into or through the atrial appendage and which permanently engage an interior wall thereof. Alternatively, an anchor in the wall of the atrial appendage may be tethered to the filtering membrane for holding the filtering membrane in place. Springs may also extend between the anchor and the filtering membrane to hold the filtering membrane against the ostium. The filtering membrane may also be connected to a tether, elastic tether or spring and placed through the atrial appendage wall for holding the filtering membrane against the ostium and may pull on the atrial appendage such that its volume is reduced or eliminated, trapping and isolating blood clots therein. Part of the device may involve a suction apparatus to remove clots that are already in place. The filtering membrane placement may require closure of an atrial septal defect created by the placement of this filter device about the appendage. Alternatively, the filtering membrane may be held in place by a coiled spring which engages the interior wall of the atrial appendage.
The filtering membrane itself is permeable. The permeability of the filtering membrane allows blood to flow across, while inhibiting blood clots within the atrial appendage from exiting the atrial appendage into the bloodstream. In the case of a permeable filtering membrane, it may eventually become infiltrated with cells so that it may become a "living" structure, and can develop an endothelial/endocardial lining to enable it in turn to become a non-thrombogenic surface. It thus can develop an endothelium and with time become highly biocompatible . It may be coated or covered with an anticoagulant or other compounds, such as, for example, heparin, or it may be treated to prevent thrombus from forming on the filtering membrane surface, to extend its patency or until it is infiltrated with cells and/or develops an endothelial covering.
The device, when implanted in the atrial appendage, may also have the ability to perform electrical monitoring of the heart. This may include two or more electrical contacts placed apart on the device, and connected to signal conditioning circuitry for determination of cardiac features such as rhythm of the atria or ventricles. Another sensor on the device could measure pressure of the atria, atrial appendage, or ventricular end diastolic pressures (left or right) through the open mitral or tricuspid valves. A suitable telemetry system would be used to telemeter this important electrical and hemodynamic information non-invasively outside the patient. Also, memory could be present on the device in order to record the information for later recovery via noninvasive telemetry. Objects of the Invention
It is an object of the invention to provide a filter between the atrium and atrial appendage to prevent blood clots from flowing therebetween. It is an object of the invention to provide a filter between the atrium and atrial appendage to allow blood flow across the filter, e.g., to reduce any hemodynamic pressure differential therebetween.
It is an object of the invention to provide a filter which is permanently implanted between the atrium and the atrial appendage by a support structure which substantially conforms to the contours of the ostium and the interior wall of the atrial appendage.
It is an object of the invention to reduce the volume of an atrial appendage to reduce the size of the region for potential blood stasis formation, and consequently the effective volume of the affected atrium.
It is an object of the invention to reduce the region of static blood in the atrial appendages and hence the thrombogenicity of the atrium.
It is an object of the invention to measure hemodynamics pressure (or flow) , or electrical signals in the heart and telemeter them outside the body for diagnosis or monitoring.
It is an object of the invention to prevent blood clots from forming in the atrial appendages.
It is an object of the invention to position across the ostium of the atrial appendage a non- thrombogenic, biocompatible surface that prevents blood clots from forming.
It is an object of the invention to provide a permeable filtering membrane surface which may eventually become lined with endothelial or endocardial cells .
It is an object of the invention to isolate the atrial appendage from the atrium proper with respect to the passage of thrombus with a filtering membrane, while allowing communication through which blood may flow.
It is an object of the invention to minimally invasively prevent blood clots from forming in the atrial appendages and escaping therefrom.
It is an object of the invention to remove thrombi from the atrium via suction or other means.
It is an object of the invention to prevent thrombus by use of heparin, other antithrombogenic substances, or other compounds on or eluted from the filtering membrane.
It is an object of the invention to ensure the filtering membrane is centered across or over the ostium of the atrial appendage. It is an object of the invention to accurately place the filtering membrane across or over the ostium of the atrial appendage.
Other objects, advantages and novel features of the present invention will become apparent from the following detailed description of the invention when considered in conjunction with the accompanying drawings .
Brief Description of the Drawings
FIG. 1 is a partial cross sectional view of a heart showing a catheter entering the left atrial appendage using a retrograde procedure from the aorta in accordance with the invention. FIG. 2 is a partial cross sectional view of a heart showing a catheter entering the left atrial appendage using a transeptal procedure from the femoral vein or superior vena cava in accordance with the invention.
FIG. 3 is a partial cross sectional view of a heart showing a catheter entering the right atrial appendage from the jugular vein or optionally from the femoral vein in accordance with the invention. FIG. 4 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage.
FIG. 5 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage with a permeable filtering membrane having flexible wire prongs with atraumatic bulbs to hold the filtering membrane in place and electronics built into the filtering membrane in accordance with the invention. FIG. 6 is similar to FIG. 5 with the atraumatic bulbs removed so that the flexible wire prongs may puncture the atrium wall and secure the filtering membrane to the atrial appendage and a centering rim added to the filtering membrane in accordance with the invention.
FIG. 7 is a partial cross sectional view of a portion of a heart as in FIG. 5 with a support portion between the filtering membrane and the prongs in accordance with the invention. FIG. 8 is similar to FIG. 7 with the atraumatic bulbs removed so that the flexible wire prongs may puncture the atrium wall and secure the filtering membrane to the atrial appendage in accordance with the invention. FIG. 9 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage with a permeable filtering membrane having a large expandable support portion to hold the filtering membrane in place in accordance with the invention.
FIG. 10 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage having an anchor and a tether to hold the filtering membrane in place in accordance with the invention.
FIG. 11 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage having an anchor and a spring to hold the filtering membrane in place, a centering rim on the filtering membrane and a centering cable in accordance with the invention.
FIG. 12 is the same as FIG. 11 with the spring filling the atrium to help hold the filtering membrane in place in accordance with the invention.
FIG. 13 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage with the filtering membrane adhesively being held in place in accordance with the invention.
FIG. 14 is a partial cross sectional view of a delivery catheter having a disk, a spring and filtering membrane therein in accordance with the invention. FIG. 15 is a schematic view of a disk, spring and filtering membrane after being expanded out of the delivery catheter of FIG. 11 in accordance with the invention. FIG. 16 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage having a disk, a filtering membrane and a spring therebetween in accordance with the invention.
FIG. 17 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage shown in a collapsed position in accordance with the invention. FIG. 18 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage having a disk, a spring, a filtering membrane and vacuum in the catheter in accordance with the invention. FIG. 19 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage showing an umbrella folded for entering the atrial appendage in accordance with the invention. FIG. 20 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage showing the umbrella opened in the atrial appendage to secure the umbrella into the wall of the atrial appendage in accordance with the invention.
FIG. 21 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage showing the umbrella and filtering membrane positioned across the ostium of the atrial appendage in accordance with the invention.
FIG. 22 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage showing a support portion having a filtering membrane positioned across the ostium of the atrial appendage in accordance with the invention.
FIG. 23 is a partial cross sectional view of a portion of a heart showing an atrium and its associated atrial appendage showing the atrial appendage reduced to a minimum volume by a disk and spring squeezing the appendage against a filtering membrane in accordance with the invention.
FIG. 24 is a perspective view of another embodiment of a filtering membrane and apparatus for installing the filtering membrane in accordance with the invention.
FIG. 25 is a sectional view of the filtering membrane and apparatus illustrated in FIG. 24, in accordance with the invention.
FIG. 26 is an enlarged view of a portion of the apparatus of FIG. 25 in accordance with the invention.
FIG. 27 is a partial cross-sectional view illustrating an early stage in the installation of the apparatus of FIG. 24, in accordance with the invention.
FIG. 28 is a partial cross-sectional view similar to FIG. 27, illustrating a later stage in the procedure in accordance with the invention. FIG. 29 illustrates another embodiment of the filtering membrane and apparatus for installing the filtering membrane in accordance with the invention.
FIG. 30 is an enlarged view of the filtering membrane and apparatus illustrated in FIG. 29 in accordance with the invention.
FIG. 31 is a planar development of the apparatus for attaching the filtering membrane illustrated in FIGS. 29-30 in accordance with the invention. FIG. 32 is a planar development of the apparatus depicted in FIG. 31 in an expanded configuration, in accordance with the invention.
FIG. 33 is a perspective view of the filtering membrane and apparatus for attaching the filtering membrane of FIG. 30, illustrated in an expanded configuration in accordance with the invention.
FIG. 34 is an elevational view of an embodiment of the filtering membrane in accordance with the invention.
FIG. 35 is an elevational view of another embodiment of the filtering membrane in accordance with the invention. FIG. 36 is an elevational view of yet another embodiment of the filtering membrane in accordance with the invention.
FIG. 37 is an elevational view of a further embodiment of the filtering membrane in accordance with the invention.
FIG. 38 is a partial cross-sectional view illustrating an early stage in the procedure of installing of the filtering membrane of FIGS. 29-37 in accordance with the invention. FIG. 39 is a partial cross-sectional view similar to FIG. 39 illustrating a later stage in the procedure in accordance with the invention.
FIG. 40 is a partial cross-sectional view similar to FIG. 39 illustrating a still later stage in the procedure in accordance with the invention.
FIG. 41 is a view similar to FIG. 38 illustrating an alternative embodiment of the apparatus illustrated in FIGS. 29-32. FIG. 42 is a partial cross-sectional view similar to FIG. 41 illustrating a later stage in the procedure in accordance with the invention.
FIG. 43 is a partial cross-sectional view similar to FIG. 42 illustrating a still later stage in the procedure in accordance with the invention. FIG. 44(a) illustrates an alternative embodiment of the apparatus illustrated in FIG. 30 in accordance with the invention. FIG. 44(b) illustrates the apparatus illustrated in FIG. 44(a) in an expanded configuration in accordance with the invention.
FIG. 45 is a view similar to FIG. 44 illustrating another embodiment in accordance with the invention
FIG. 46 illustrates yet another embodiment of the filtering membrane and apparatus for attaching the filtering membrane in accordance with the invention. FIG. 47 is an elevational view taken from direction 47 of FIG. 41 in accordance with the invention.
FIG. 48 is elevational view taken from direction 48 of FIG. 41 in accordance with the invention. FIG. 49 is a sectional view illustrating the apparatus of FIG. 46 along with additional apparatus in accordance with the invention.
FIG. 50 is a partial cross-sectional view illustrating a first installed configuration of the apparatus of FIG. 46 in accordance with the invention. FIG. 51 is a partial cross-sectional view similar to FIG. 50 illustrating a second installed configuration of the apparatus of FIG. 46 in accordance with the invention. FIG. 52 is a partial cross-sectional view illustrating another embodiment of the apparatus in accordance with the invention.
FIG. 53 illustrates yet another embodiment of the apparatus in accordance with the invention.
FIG. 54 is an end view of the apparatus of FIG. 53 in accordance with the invention.
FIG. 55 illustrates additional apparatus for installing the apparatus of FIG. 53 in accordance with the invention.
FIG. 56 is an enlarged sectional view of the apparatus of FIG. 53 and FIG. 55 in a compacted configuration, in accordance with the invention.
FIG. 52 is a partial cross-sectional view of the apparatus of FIG. 56 illustrating an early stage in the procedure in accordance with the invention.
FIG. 58 is a partial cross-sectional view similar to FIG. 52 illustrating a later stage in the procedure in accordance with the invention. FIG. 54 illustrates a further embodiment of the apparatus in accordance with the invention.
FIG. 60 is an end view of the apparatus of FIG. 54 in accordance with the invention.
FIG. 61 illustrates a still further embodiment of the apparatus in accordance with the invention.
FIG. 62 illustrates additional apparatus for use with the apparatus of FIGS 54-61 in accordance with the invention. FIG. 63 is an enlarged sectional view of the apparatus of FIG. 62 in accordance with the invention.
FIG. 59 is a partial cross-sectional view of the apparatus of FIG. 54 illustrating an early stage in the procedure in accordance with the invention. FIG. 65.is a partial cross-sectional view similar to FIG. 59 illustrating a later stage in the procedure in accordance with the invention.
FIG. 66 illustrates yet another embodiment of the apparatus in accordance with the invention.
FIG. 67 is an end view of the apparatus of FIG. 66 in accordance with the invention.
FIG. 68 illustrates additional apparatus for use with the apparatus of FIGS. 66-67 in accordance with the invention.
FIG. 69 is an enlarged sectional view of the apparatus of FIGS. 66 and 68 in accordance with the invention.
FIG. 70 is a partial cross-sectional view of the apparatus of FIG. 66 illustrating an early stage in the procedure in accordance with the invention.
FIG. 71 is a partial cross-sectional view similar to FIG. 70 illustrating a later stage in the procedure in accordance with the invention. FIG. 72 illustrates another embodiment of the apparatus in accordance with the invention.
FIG. 73 illustrates yet another embodiment of the apparatus in accordance with the invention.
FIG. 74 is a partial cross-sectional view of the apparatus of FIG. 72 illustrating an early stage in the procedure in accordance with the invention.
FIG. 75 is a partial cross-sectional view similar to FIG. 74 illustrating a later stage in the procedure in accordance with the invention. FIG. 76 illustrates yet another embodiment of the apparatus in accordance with the invention.
FIG. 77 is a distal end view of the apparatus of FIG. 76 in accordance with the invention. FIG. 78 is an enlarged sectional view of additional apparatus for use with the apparatus of FIGS. 76-77 in accordance with the invention.
FIG. 79 is a partial cross-sectional view of the apparatus of FIGS. 76-77 illustrating an early stage in the procedure in accordance with the invention.
FIG. 80 is a partial cross-sectional view similar to FIG. 79 illustrating a later stage in the procedure in accordance with the invention.
FIG. 81 illustrates a further embodiment of the apparatus in accordance with the invention.
FIG. 82 is a distal end view of the apparatus of FIG. 81 in accordance with the invention. FIG. 83 is an enlarged sectional view of additional apparatus for use with the apparatus of FIGS. 81-82 in accordance with the invention.
FIG. 84 is a partial cross-sectional view of the apparatus of FIGS. 81-82 illustrating an early stage in the procedure in accordance with the invention.
FIG. 85 is a partial cross-sectional view similar to FIG. 84 illustrating a later stage in the procedure in accordance with the invention. FIG. 86 is a partial cross-sectional view similar to FIG. 85 illustrating a still later stage in the procedure in accordance with the invention.
FIG. 87 is a sectional view of a proximal portion of another embodiment in accordance with the invention.
FIG. 88 is an enlarged sectional view of a distal portion of the embodiment illustrated in FIG. 87 in accordance with the invention. FIG. 89 is a perspective view of the embodiment illustrated in FIG. 88(b) in accordance with the invention.
FIG. 90 is a sectional view of an early stage of a procedure in accordance with the invention.
FIG. 91 is a sectional view similar to FIG. 90, illustrating a further stage in a procedure in accordance with the invention.
FIG. 92 is a sectional view similar to FIG. 91, illustrating a later stage in a procedure in accordance with the invention.
FIG. 93 is a sectional view similar to FIG. 92 at reduced scale, illustrating a later stage in a procedure in accordance with the invention. FIG. 94 is a sectional view similar to FIG.
93, illustrating another embodiment in accordance with the invention.
FIG. 95 is a sectional view similar to FIG. 93, illustrating yet another embodiment in accordance with the invention.
FIG. 96 is a sectional view similar to FIG. 93, illustrating still another embodiment in accordance with the invention.
FIG. 97 is a sectional view similar to FIG. 93, illustrating a further embodiment in accordance with the invention.
FIG. 98 is a sectional view similar to FIG. 88(b), illustrating another embodiment in accordance with the invention. FIG. 99 is a sectional view similar to FIG.
98, illustrating a later stage in a procedure in accordance with the invention. - I I
FIG. 100 is a sectional view similar to FIG. 99, illustrating a still later stage in a procedure in accordance with the invention.
Description of the Preferred Embodiments Although atrial fibrillation may result in the pooling of blood in the left atrial appendage and the majority of use of the invention is anticipated to be for the left atrial appendage, the invention may also be used on the right atrial appendage and in general for placement across any aperture in the body in which blood is permitted to flow therethrough or therefrom but in which blood clots are substantially prevented from escaping from the atrial appendage and entering into the bloodstream. As shown in FIG. 4, a thrombus, blood clot, or emboli 30 (collectively referred to as a thrombus) may occur from pooling of blood in the left atrial appendage 13 due to poor circulation of blood therein when the patient experiences atrial fibrillation. When blood pools in the left atrial appendage 13, thrombus 30 can accumulate therein, build upon itself, and propagate out from the left atrial appendage 13 into the left atrium 11, thus leaving the heart and entering the blood stream. Once in the bloodstream, such thrombus can block blood flow to the heart, brain, other organs, or peripheral vessels if it becomes lodged in the arteries thereof. Heart attack, a stroke, or ischemia may result.
To prevent thrombus 30 from forming in the left atrial appendage 13, or to prevent thrombus formed therein from leaving and entering the blood stream which may cause a heart attack, a stroke or ischemia, a filtering membrane 40 is permanently placed across the ostium 20 of the atrial appendage 13. The filtering membrane 40 can be made of bicompatible materials, such as, for example, ePFTE (e.g., Gortex®) , polyester (e.g., Dacron®) , PTFE (e.g., Teflon®), silicone, urethane, metal fibers, or other biocompatible polymers .
The filtering membrane 40 is a permeable filtering membrane, having pore sizes ranging from about 50 to about 400 microns. It is also contemplated that the pores may also be larger or smaller as indicated by the circumstances, provided such pores substantially inhibit thrombus from passing therethrough. The open area of the filtering membrane is preferably at least 20% of the overall surface area, although a range of about 25-60% may be preferred. The structure of the filtering membrane is preferably a two-dimensional screen, a cellular matrix, a woven or non-woven mesh, or the like. The filtering membrane may also be a permeable metal or a metal mesh of fine fibers. The filtering membrane may be coated or covered with an anticoagulant, such as heparin, or another compound, or treated to provide antithromogenic properties .
The porosity of the filtering membrane, described above, allows blood to flow therethrough while blocking or inhibiting the passage of thrombus, clots, or emboli formed within the atrial appendage from entering the atrium of the heart and, eventually, the patient's bloodstream. The characteristic of allowing the flow of blood through the filtering membrane provides several advantages. For example, the left atrial appendage inherently contracts during normal cardiac function to force blood through the heart. These contractions result in blood flow through the ostium of the left atrial appendage. Allowing blood flow through the filtering membrane substantially reduces any pressure gradient that may exist between the appendage and the atrium.
The reduction of the pressure gradient may be helpful to the patient during recovery from the implantation of the filtering membrane structure in the atrial appendage. More particularly, the heart is able to more gradually adapt to the presence of the filtering membrane when blood is permitted to flow through the membrane, and consequently through the ostium of the left atrial appendage.
The filtering function also reduces the risk of leakage about the periphery of the filtering membrane, or of dislodgement of the filtering membrane that may result from the exertion of pressure against the surface of the filtering membrane. Allowing the blood flow across the filtering membrane may relieve this pressure, sufficiently and in a controlled manner, to reduce such leakage or dislodgement.
Tissue ingrowth may provide additional securement of the filtering membrane to the ostium. More particularly, the growth of tissue may occur along the outer periphery of the filtering membrane or supporting structure adjacent the ostium. This tissue growth, in cooperation with the pressure relief provided by the permeable structure, may provide additional means of reducing leakage about the periphery of the filtering membrane. Tissue growth may eventually cover additional surface area of the filtering membrane.
The filtering membrane 40 placed across or over the ostium 20 should be antithrombotic . In order to make the filtering membrane antithrombotic, heparin or other anticoagulants or antiplatelet agents may be used on the filtering membrane 40.
When permeable filtering membranes 40 are used, an ingrowth of cells may eventually cover the filtering membrane with endothelial cells. The endothelial cells present a smooth cellular wall covering the filtering membrane which prevents thrombosis from occurring at the filtering membrane. The permeable filtering membrane 40 is permanently implanted across the ostium and retained in position by a support structure attached to the filtering membrane. As will be described herein, such permanent placement is achieved by aspects of the support structure which, for example, may engage and/or pierce the wall of the atrial appendage. Alternatively, such permanent placement may be achieved by the support structure which expands to engage either the ostium and/or the interior wall of the atrial appendage. Furthermore, the support structure may be configured to conform to the unique configuration of the ostium and/or the interior wall of the atrial appendage, and the filtering membrane held in position by the support structure to conform to the ostium. FIGS. 1 and 2 show a cross section of a human heart showing a thrombus 30 in the left atrial appendage 13. The figures also show the atrial appendage ostium 20 which is to have a filtering membrane 40 placed over it to prevent the thrombus 30 from escaping out of the atrial appendage 13 into the left atrium 11 and thus into the blood stream, which could cause a stroke, a heart attack or ischemia.
FIG. 3 shows a cross section of a human heart showing a thrombus 30 in the right atrial appendage 23. The right atrial appendage 23 can be treated in the same manner as the left atrial appendage 13.
FIG. 4 shows a cross section of the left atrium 11, the ostium 20 and the left atrial appendage 13 having a thrombus 30 therein.
FIG. 5 shows a first embodiment of the invention having the permeable filtering membrane 40 and a plurality of flexible prongs 50 which may be made from a shape memory alloy, such as Nitinol®, for retaining a predisposed shape. The prongs 50 may be atraumatic so that they do not perforate the left atrial appendage 13. The prongs 50 may have atraumatic bulbs 55 on their tips so that the tips of the prongs 50 will not perforate the left atrial appendage 13. Nitinol® has the property of being able to be placed in a catheter in a compact configuration and then expanded when released from the catheter to a predetermined memory shape. The shape selected may be for the prongs 50 to curve around the lip of the ostium 20 and then hug the sides of the left atrial appendage 13. In this manner the filtering membrane 40 allows blood to flow through the ostium 20 but which blocks or substantially inhibits thrombus 30, clots or emboli from leaving the left atrial appendage 13 and entering the atrium, and eventually, the bloodstream of the patient.
The filtering membrane 40 is self centering across or over the ostium 20 of the left atrial appendage 13, by placing the prongs 50 in a circle around the filtering membrane 40 such that the prongs 50 fit against the wall of the left atrial appendage 13 of or within the lumen of the ostium 20 to center the filtering membrane 40 across or over the ostium 20. The filtering membrane 40 may also be centered by a centering rim 65 (see FIG. 6) attached to the back (appendage) side of the filtering membrane 40 that protrudes into the ostium 20 for centering. The centering rim 65 has a diameter of less than the diameter of the filtering membrane 40. The centering means may also consist of a series of centering cables 66 (see FIG. 11) which attach to a spring 90 or tether 85 from the centering rim 65 or the filtering membrane 40, to assure that centering occurs with placement.
Optionally electronics, such as sensors 300 and chips 310, built into the filtering membrane may be used to provide data about hemodynamic pressure, flow rates, temperature, heart rates, and electrical signals in the heart. When the filtering membrane is placed in the left atrial appendage 13 the sensors 300 may measure pressures in the atria or atrial appendage. The sensors may also measure ventricular end diastolic pressures through the open mitral or cuspid valves. Other information about the heart may be gathered such as noise from accelerometers to detect leakage, valve efficiency, activity levels of the patient and other noise related data. The sensors 300 may also be blood oxygen sensors. The chip 310 may use telemetry to transmit the information gathered by the sensors 300 and processed or stored by the chip 310 to receiving devices to aid in the treatment of the patient.
In FIG. 6 the protective bulbs 55 are removed from the flexible prongs 50 of FIG. 5 such that flexible prongs 50 puncture the walls of the left atrial appendage 13 and secure the filtering membrane 40 in place. The flexible prongs 50 may penetrate into the atrial appendage wall or extend through the atrial appendage wall. The prongs may have barbed ends 51 to prevent the prongs from withdrawing from the atrial appendage wall.
As described above, filtering membrane 40 has a permeable structure which allows blood to flow therethrough but which blocks or substantially inhibits thrombus, clots or emboli from entering the atrium, and eventually, the bloodstream of the patient. The filtering membrane 40 has centering rim 65 attached for centering the filtering membrane in the ostium 20 and marker 320 in the filtering membrane 40 for observing the position of the filtering membrane while it is being inserted. The marker may be used for x-ray or ultrasound observation.
Although Nitinol® was cited above as a type of shape memory alloy prong material which can be used, any type memory alloy may be used. Such alloys tend to have a temperature induced phase change which will cause the material to have a preferred configuration when heated above a certain transition temperature. Other metals which may be used as prongs include corrosion resistant spring metals such as Elgiloy ® or spring tempered steel.
Another embodiment of the invention is shown in FIG. 7. It is similar to the embodiment shown in FIG. 5. The embodiment in FIG. 7 has a support structure 60 attached to the filtering membrane 40 for expanding in the ostium 20 helping to secure the filtering membrane 40 thereto. The prongs 50 operate in the same manner as in FIG. 5 hugging the inner walls of the left atrial membrane 13 to secure the filtering membrane 40 across the ostium 20. As described above, filtering membrane 40 has a permeable structure which allows blood to flow therethrough but which blocks or substantially inhibits thrombus, clots or emboli from entering the atrium, and eventually, the bloodstream of the patient. The support structure 60 may also be made from Nitinol®, Elgiloy® or another expandable spring loaded or balloon expandable material. The filtering membrane 40 may be self centering across or over the ostium 20 of the left 13 atrial appendage, by placing the support structure 50 into the ostium wherein the support structure plugs the ostium with the filtering membrane 40 centered in the support structure. Further the prongs 50 fit against the wall of the left atrial appendage 13 of or within the lumen of the ostium 20 to center the filtering membrane 40 across or over the ostium 20.
FIG. 7a -7d illustrate an alternative embodiment for securing membrane 40 across the ostium 20 of the left atrial appendage 30. Securing structure 510 has a substantially cylindrical anchor structure 512 and an expandable structure, such as balloon structure 514 for expanding anchor structure 512.
FIG. 7a illustrates anchor structure in a compacted configuration about balloon structure 514.
In FIG. 8 the protective bulbs 55 are removed from the flexible prongs 50 of FIG. 7 such that flexible prongs 50 puncture the walls of the left atrial appendage 13 and secure the filtering membrane 40 in place. The flexible prongs 50 may penetrate into the atrial appendage wall or extend through the atrial appendage wall. The prongs may have barbed ends 51 to prevent the prongs from withdrawing from the atrial appendage wall. As described above, filtering membrane 40 has a permeable structure which allows blood to flow therethrough but which blocks or substantially inhibits thrombus, clots or emboli from entering the atrium, and eventually, the bloodstream of the patient.
In the embodiment shown in FIG. 9 a larger expandable support structure 70 is used to both engage the sides of the ostium 20 and hug the inside walls of the left atrial appendage 13. Again the support structure may be made of Nitinol®, Elgiloy® or other material which may be delivered in a catheter and expanded to the proper size and shape to securely hold the filtering membrane 40 across or over the ostium 20 which allows blood to flow through filtering membrane 40 but which blocks or substantially inhibits thrombus 30, clots or emboli from entering the atrium, and eventually, the bloodstream of the patient. FIG. 10 shows another embodiment of the invention wherein the filtering membrane 40 is secured across the ostium 20 by means of an anchor 80 which is driven into or through the wall of the left atrial appendage 13 and secured therein by the surface area of the anchor so that it will not pull out of or through the wall of the left atrial appendage 13 or cause embolism from the left atrial appendage 13. A tether 85 is attached to the anchor 80 and to the filtering membrane 40 to secure the filtering membrane 40 snuggly against the ostium 20. Filtering membrane 40 has a permeable structure which permits unclotted blood to flow through the filtering membrane.
A contrast medium 270, such as radiographic contrast or a similar substance, may be introduced into the left atrial appendage 13 by injection through a catheter after the filtering membrane 40 is in place. The device delivery catheter itself may have a port for this injection. The port may also be used to inject the contrast medium 270 that can be immediately visualized, and examined for diagnostic purposes. In prior art devices, the introduction of the contrast medium 270 into the left atrial appendage 30 may increase the volume of fluid within the appendage and, consequently, the hemodynamic pressure exerted against the walls of the atrial appendage and against any membrane or structure that may be used to occlude the atrial appendage. The filtering membrane 40 allows blood and contrast medium 270 to flow therethrough, and therefore may equalize hemodynamic pressure between the atrium and the left atrial appendage 30 in a controlled manner. The contrast medium may be used with any of the embodiments of the invention.
FIG. 11 shows another embodiment of the invention wherein filtering membrane 40 has a spiral spring 90 in addition to the anchor 80. The spiral spring 90 can be used in conjunction with or separately from the tether 85 to pull the filtering membrane 40 against the ostium 20. Although a spiral spring 90 has been shown in FIG. 11 the shape used may be oval, cylindrical, oblong, or other shape to connect the anchor 80 to the filtering membrane 40. In another embodiment shown in FIG. 12 the spiral spring 90 may fill the volume of the left atrial appendage 13 securing the filtering membrane 40 to the ostium 20. The spiral spring 90 filling the left atrial appendage 13 may also have an anchor 80 and tether 85 to help secure the filtering membrane 40 to the ostium 20. Alternatively centering rim 65 may be used as shown in FIG. 11 to center the filtering membrane 40 over ostium 20 of left atrial appendage 13. Centering cables 66 connected to spring 90 and either filtering membrane 40 or centering rim 65 may also be used to center the filtering membrane 40 across or over the ostium 20.
FIG. 13 shows yet another means of securing the filtering membrane 40 across or over the ostium 20. In this embodiment filtering membrane 40 is directly attached to the ostium 20 by an adhesive 100.
FIG. 14 shows a delivery catheter 125 containing a collapsed permeable filtering membrane 40 and a collapsed disk 130 connected to the permeable filtering membrane 40 by a spring 90 on catheter 21.
The disk 130 may be made of a flexible woven metal or a flexible woven metal with a thin permeable polymer sandwiched inside. Disk 130 may also be a polymer weave. The disk 130 is flexible and compresses or folds so it fits into the delivery catheter 125 and expands to its desired shape after release from the delivery catheter 125. Similarly, filtering membrane- 40 compresses or folds to fit into the delivery catheter 125 and expands to its desired shape after release. FIG. 15 shows the permeable filtering membrane 40, disk 130 and spring 90 from FIG. 14 in an expanded configuration outside of the delivery catheter 125.
FIG. 15 shows the spring 90 connecting the permeable filtering membrane 40 and the disk 130 for urging them together. In other embodiments an elastic tether or a tether with teeth and a pawl on the permeable filtering membrane 40 to form a ratchet can also be used to pull the permeable filtering membrane 40 and the disk 130 together.
FIG. 16 shows the device of FIGS. 15 applied to the left atrial appendage 13 having thrombus 30. After the device is applied, the spring 90 pulls the disk 130 toward the permeable filtering membrane 40, collapsing the left atrial appendage 13 and trapping the thrombus 30 therein as shown in FIG. 17.
FIG. 18 shows an alternate embodiment of the device in FIGS. 16 and 17 wherein the catheter 21 is equipped with a vacuum 140 for sucking out blood and thrombosis 30 found in the left atrial appendage 13. The vacuum 140 will help collapse the left atrial appendage 13 such that spring 90 need not be as large as in FIG. 16. FIGS. 19-21 show another embodiment of the invention using an umbrella principle for securing the filtering membrane 40 against the ostium 20. FIG. 19 shows closed umbrella struts 160 entering the ostium 20 of left atrial appendage 13. The filtering membrane 40 is some distance back from the umbrella struts 160 at the bottom of the range of teeth 195 on pole 170. FIG. 20 shows the umbrella struts inside of the left atrial appendage 13 with the struts 160 open. Umbrella opening structure 175 on pole 170 pushes the struts out to the umbrella open position. The umbrella opening structure 175 can be pushed to the open position or have a spring loaded mechanism to push the struts 160 to the open position. The ends of the umbrella struts 160 engage the left atrial appendage wall around the ostium 20 and prevent the umbrella from being withdrawn from the left atrial appendage 13. The ends of the umbrella struts 160 that engage the atrial appendage wall may be blunted or have bulbs on the tips or have padding so as not to puncture the left atrial appendage 13. FIG. 21 shows the filtering membrane 40 drawn up against the ostium 20 by ratcheting the filtering membrane along pole 170. The pawl mechanism 200 engages teeth 195 on pole 170 and is moved forward to snugly position the filtering membrane 40 across the ostium 20.
FIG. 22 shows a support structure 260 applied to the ostium 20 of left atrial appendage 13. The support structure 260 expands after leaving a delivery catheter such that the wall of the support structure secures the support structure by pressure to the ostium 20. Filtering membrane 240 folds or is compressed into the delivery catheter and expands as the support structure 260 expands and lodges in the ostium 20 of the left atrial appendage 13.
FIG. 23 shows the left atrial appendage 13 compressed such that the volume of the atrial appendage is reduced to almost nothing. With the volume reduced the atrial appendage will not have a large volume of blood which can produce a thrombus. In the embodiment shown disk 130 and spring 90 pull the left atrial appendage 13 toward filtering membrane 40. Although FIG. 23 shows the use of a disk 130 and spring 90 to act on the left appendage, any method to reduce the volume of the atrial appendage as much as possible may be used.
As shown in FIG. 23 the filtering membrane 40 is much larger than the ostium 20. The oversized filtering membrane 40 may alternatively be used in all embodiments to ensure that the ostium 20 is completely covered. The filtering membrane 40 has a permeable structure which allows blood to flow therethrough, but which blocks or substantially inhibits thrombus, clots or emboli from entering the atrium, and eventually, the bloodstream of the patient.
FIGS. 24-28 show another embodiment of the invention wherein the filtering membrane 40 is retained in position across the ostium 20 by an expandable structure, such as balloon structure 402. As illustrated in FIG. 25, balloon structure 402 may be manufactured from polymeric materials or similar materials known in the art. Tube 404 communicates with the internal cavity of balloon structure 402 for introducing saline or other appropriate fluid into the balloon structure 402. Filtering membrane 40 is attached to tube 404 in any appropriate manner, such as adhesive, sutures, or other means, and is provided with an aperture 406 which permits access to an end portion of tube 404, which acts as a balloon introduction port 408 to allow the introduction of fluid into the balloon structure 402.
FIG. 24 also illustrates a structure for introducing fluid into the balloon structure 402, such as catheter apparatus 410. Catheter apparatus 410 includes an outlet port 412 at its distal end portion for ejecting fluid from the catheter apparatus 410. Outlet port 412 may be connected to the balloon introduction port 408, which in turn communicates with the internal lumen of tube 404 and the interior of balloon structure 402.
FIG. 25 illustrates the filtering membrane 40, the balloon structure 402, the tube 404, together with the catheter 410 attached to the tube 404, in a compacted configuration within a delivery tube 422. More particularly, balloon structure 402 is in its collapsed state and filtering membrane 40 is flexible and compressed or folded to fit into the delivery tube 422. Filtering membrane 40 is designed to expand into a disc-like shape after release from tube 422. FIG. 26 illustrates the certain structures pertinent to the interconnection of catheter 410 with tube 404. More particularly, outlet port 412 of catheter 410 may be provided with narrow tube 424 which is received within balloon introduction port 408 and maintains a valve 426 in an open position when outlet port 412 is connected to inlet port 408. When outlet port 412 is removed from balloon introduction port 408, valve 426 may close to prevent fluid from leaving balloon structure 402, as shown in FIG. 26.
Delivery tube 422 may be introduced into the venous or arterial system at an appropriate location, and advanced to into the atrium of the heart with appropriate steering and visualization apparatus (not shown) .
FIG. 27 illustrates a later stage in the installation procedure wherein the filtering membrane 40, the balloon structure 402, the tube 404, and the catheter 410 have been advanced from the delivery tube 422 (not shown in FIG. 27) . The balloon structure 402 is positioned within the left atrial appendage 13 such that the filtering membrane 40 is positioned about the ostium 20. Fluid is subsequently introduced into the catheter 410 which passes through tube 404 to expand the balloon structure 402, as illustrated in FIG. 28. The balloon structure 402 expands within the atrial appendage 13 and secures the filtering membrane 40 in position. The valve mechanism 426 (not shown in FIG.
28) of balloon introduction port 408 prevents the fluid from passing out of the balloon structure 402 when the catheter 410 is detached from the balloon port 408 and subsequently removed from the atrium. As described above, filtering membrane 40 has a permeable structure which allows blood to flow therethrough but which blocks or substantially inhibits thrombi, clots or emboli from exiting the atrial appendage 13, and entering the bloodstream of the patient. FIGS. 29-40 illustrate yet another embodiment for attaching the filtering membrane across the ostium 20 of the left atrial appendage 13. FIG. 29 illustrates the filtering membrane 40, the attachment apparatus 440 for securing the filtering membrane 40 across the ostium 20 of the atrial appendage 13, and catheter apparatus 442 for installing the attachment apparatus 440 and filtering membrane 40. As FIG. 30 illustrates, attachment apparatus 440 and filtering membrane 40 may be initially in a compacted configuration. Attachment apparatus 440 is preferably an expandable tubular apparatus having an initial diameter 444 of about 1-3 mm and an initial length 446 of about 0.5-6 cm. Attachment apparatus is preferably manufactured from a flexible material such as stainless steel, nitinol, nylon, polyester, PET, or polyethylene.
Filtering membrane 40 is attached to attachment apparatus 440 at the proximal end thereof, in a loosely fitted, somewhat conical configuration and defines a central opening 448, which allows the catheter 450 of catheter apparatus 442 to pass through membrane 40, as will be described in greater detail herein. Alternatively, filtering membrane 40 may also cover a greater portion of the length 446 of the attachment apparatus 440, or filtering membrane 40 may cover the entire attachment apparatus 440 in a substantially sock-like fashion. Filtering membrane 40 may be fabricated from a material that also has elastic characteristics which may expand from a first size to a second size.
Catheter 450 supplies expansion fluid, such as saline or contrast medium, into expandable structure, such as balloon structure 452, which is positioned within the interior lumen of attachment apparatus 440 in order to radially expand attachment apparatus 440 when it is positioned within the atrial appendage 13. Balloon structure 452 may include a distal, atraumatic tip portion 454, e.g., a flexible helical coil or soft plastic tip.
FIGS. 31 and 32 illustrate planar developments of attachment apparatus 440. The structure of attachment apparatus 440 preferably allows the length 446 of the apparatus in its initial configuration (FIG. 31) to remain substantially constant with respect to the length 456 in its expanded configuration (FIG. 32) . In order to achieve this expansion while maintaining substantially constant length, attachment apparatus 440 is provided with a configuration having several serpentine segments 458, 460, and 462. Adjacent serpentine segments are interconnected by a plurality of longitudinal struts, e.g., rings 457 and 460 are interconnected by struts 464 and rings 460 and 462 are interconnected by struts 466. A plurality of U-shaped members 470 at the distal end portion of apparatus 440 provide an attachment point for the filtering membrane 40.
FIG. 33 illustrates attachment member 440 in an expanded configuration, wherein length 456 remains substantially constant with respect to the length 446 of the configuration illustrated in FIG. 30. Diameter 472 is substantially larger than diameter 444 (FIG. 30) in order to secure filtering membrane 40 with the atrial appendage 13, as will be described herein. FIGS. 34-37 illustrate several embodiments of the filtering membrane 40. As described above, catheter 450 passes through opening 458 in filtering membrane 40 in order to supply expansion fluid to expandable balloon structure 452. After balloon structure 452 has expanded the attachment apparatus 440 to the expanded configuration illustrated in FIG. 33, it may be necessary to remove balloon structure 452 by passing the balloon structure 452 proximally through filtering membrane 40, and more particularly, through opening 458. The embodiments of filtering membrane 40 illustrated in FIGS. 34-37 may facilitate the passage of balloon structure 452, or other interventional devices therethrough. FIG. 34 illustrates filtering membrane 40a having a composite construction comprising filtering section 474a and elastic section 476a. The filtering section 474a is fabricated from a filtering material that provides the function of filtering the blood to allow the blood to pass therethrough while blocking or substantially inhibiting the passage of clots, thrombus or emboli therethrough, as described above. The elastic section 476a is fabricated from an elastic material, e.g., silicone, urethane or other similar material, that stretches to enlarge opening 458a to allow the balloon structure 452 or other intervention devices, such as, e.g., wires, catheters or the like, to pass therethrough and to subsequently return to its initial size. The initial size of aperture 458a provides similar characteristic to inhibit clots, thrombus or emboli from passing through 458a as filtering material of filtering section 474a. In this configuration, elastic material 476a extends substantially across the entire diameter 472a of the filtering membrane 40a.
Filtering membrane 40b (FIG. 35) is constructed with a filtering section 474b (i.e., the same material as filtering section 474a) and an elastic section 476b (i.e., the same elastic material as elastic section 476a) . In filtering membrane 40b, the filtering section 474b substantially concentrically surrounds the elastic section 476b. The elastic section 476b is provided with an opening 458b that expands to allow the balloon structure 452 or other interventional devices to pass therethrough and to return to initial size in order to provide substantially the same characteristic of inhibiting the passage of thrombus, clots and emboli from passing therethrough as the filtering material of the filtering section 474b.
Filtering membrane 40c (FIG. 36) is constructed with a filtering section 474c (i.e., the same material as filtering section 474a) and an elastic section 476c (i.e., the same elastic material as elastic section 476a) . In filtering membrane 40c, the filtering section 474c substantially concentrically surrounds an elastic section, such as substantially elliptical section 476c. The elastic section 476c is provided with an aperture, such as a slit 458c that expands to allow the balloon structure 452 or other interventional devices to pass therethrough and to return to initial size to provide substantially the same characteristic of inhibiting the passage of thrombus, clots and emboli from passing therethrough as the filtering material of the faltering section 474b.
Filtering membrane 40d (FIG. 37) may be fabricated from the same material as filtering section 474a, above, in several sections, such as sections 475d and 477d, which overlap at region 479d to form an opening therethrough for balloon structure 452 or other interventional devices. It is further contemplated that three or more sections of filtering material may be used in an overlapping configuration, in a manner similar to, for example, the "aperture" configuration of an optical device. The balloon structure 452 may be passed through the opening between sections 475d and 477d. After the balloon structure 452 is removed, the overlapping structure substantially closes the opening and provides substantially the same characteristic of inhibiting the passage of thrombus, clots and emboli from passing therethrough as the filtering material of the filtering sections 475d and 477d. FIGS. 38-40 illustrate the procedure for installing attachment apparatus 440 and filtering membrane 40 in the atrial appendage 13. In an initial step (FIG. 38), balloon structure 452, along with attachment apparatus 440 are inserted into the atrial appendage 13 in its initial, compact configuration. In FIG. 39, expansion fluid is passed through catheter 450 and exits through port 453 to fill the interior of balloon structure 452. Balloon structure 452 expands, thereby radially enlarging attachment apparatus 440, as described with respect to FIGS. 31-33, above. As illustrated in FIG. 40, attachment apparatus engages the interior of the atrial appendage 13, thereby securing filtering membrane 40 in position across the ostium 20. Balloon structure 452 may be removed from the atrial appendage 13 by returning the balloon structure 452 to its initial compact configuration (e.g., by draining the expansion fluid therefrom) and withdrawing the balloon structure proximally through opening 458. As described above with respect to FIGS. 34-37, the filtering membrane may be fabricated with an elastic portion which expands to permit the withdrawal of the balloon structure therethrough, and which subsequently reduces in size to inhibit the passage of thrombi, clots and emboli therethrough into the atrium. The catheter structure 442 may be subsequently removed from the patient. Alternatively, the balloon structure 452 may remain within the atrial appendage 13 following expansion of attachment apparatus 440 and subsequent return of the balloon structure 452 to its initial compact configuration. For example, catheter 450 may be detachable from balloon structure 452 in a manner similar to the configuration of catheter 410 and tube 404 (FIG. 26) . FIGS. 41-43 illustrate another embodiment of the invention. Attachment apparatus 460 and balloon apparatus 462 are substantially the same as attachment apparatus 440 and balloon apparatus 452, described hereinabove, with the differences noted below. Attachment apparatus 460 may be provided with a plurality of engagement members 464, such as prongs, hooks, or the like, in order to engage and/or pierce the wall of the atrial appendage to provide additional securement of the attachment apparatus 460. Balloon structure 452 may be used in connection with attachment apparatus 460. Alternatively, balloon structure 462 may be provided having a distal end portion which is configured to expand to a greater extent than the proximal portion thereof (FIG. 42) . This greater expansion of the balloon structure 462 provides additional force in the area of the engagement members 464 to drive them into the wall of the atrial appendage 13 (FIG. 43) .
FIGS. 44-45 illustrate additional embodiments of expandable structures for radially enlarging the attachment apparatus 440 (or 460) within the atrial appendage. Instead of, or in addition to balloon structures (such as balloon structure 452), it is also contemplated that mechanical expansion structures may be particularly useful. FIGS. 44 (a) - (b) illustrate a mechanical expansion structure 472 which may be used to radially expand attachment apparatus 440. As shown in FIG. 44(a), mechanical expansion structure 472 may have a compact configuration wherein a plurality of contact members 474 define a diameter 476 that enables the structure to be inserted within the attachment apparatus 440. As illustrated in FIG. 44(b), mechanical expansion structure 472 also has an expanded configuration, wherein contact members 474 are further spaced apart to define a larger diameter 477 which radially enlarges the attachment apparatus to the configuration illustrated in FIGS. 32-33 and 39-40. A linkage configuration may include linkage members 478 and sleeve 479. Sleeve 479 is provided with internal threading (not shown) which engages external threading 480 on a portion of drive screw 481. Angular rotation of drive screw 481 (as indicated by the arrow) provides longitudinal movement of sleeve 479 which cooperates with linkage members 478 to controllably move the contact members 474 between the compact and expanded configurations .
FIG. 45 illustrates mechanical expansion structure 482, which is substantially identical to mechanical expansion structure 472. Sleeve 489 interacts with linkage members 478 to controllably move contact members 474, as described above with respect to sleeve 479. Sleeve 489 is longitudinally slidable with respect to elongated member 491. A locking structure (not shown) may also be provided to fix the position of sleeve 489 (and thus contact members 474) with respect to elongated member 491.
Mechanical expansion structures 472 and 482 may remain in the atrial appendage 13 following the expansion of attachment apparatus 440 (or 460) . A portion of the drive screw 481 or elongated member 491 may be detachable from the expansion structures 472 or 482, respectively (not shown) . Alternatively, apparatus substantially similar to mechanical expansion structures 472/482 may be useful as supporting structures for filtering membrane 40. According to this embodiment, filtering membrane 40 may be attached to an end portion of structure 472/482, e.g., by attaching filtering membrane 40 to end portions of contact members 474 or by substantially enclosing contact members 474 and linkage members 478. The structure 472/482 may be positioned in the atrial appendage 13 and expanded as described above, such that filtering membrane 40 extends across the ostium 20 to allow blood to pass therethrough while inhibiting the passage of thrombus through the filtering membrane 40. Drive screw 481 or elongated member 491 may be subsequently detached from the apparatus 472/482. FIGS. 46-48 illustrate another embodiment of the invention. Filtering membrane 40 may be installed in the atrial appendage 13 and held therein by attachment apparatus 500, which preferably consists of a pair of flexible wire portions 502a and 502b, which are preferably constructed of a material such as nitinol or Elgiloy or stainless steel and having a wire diameter of approximately .005 to .020 inch. Each wire portion 502a/502b may include a curved portion 504a/504b, a pair of support members 506a/506b and a plurality of engagement members 508. The curved portions 504a/504b define a substantially closed portion for mounting the filtering membrane 40. The filtering membrane 40 is attached with sutures, adhesive, or other appropriate means. The engagement members 508 are configured to engage the interior of the atrial appendage 13 to secure the filtering membrane 40 in position across the ostium 20, as will be described herein. The engagement members 508 may be provided with atraumatic end portions 510.
FIG. 49 illustrates attachment apparatus 500 and filtering membrane 40 in a compacted configuration for installation in the atrial appendage 13. Preferably, a delivery catheter apparatus 520 is used to introduce the attachment apparatus 500 and filtering membrane 40 to the atrial appendage. The curved portions 504a/504b are deflected proximally toward parallelism with the longitudinal axis of the catheter 520, and the engagement members 508 are deflected distally toward parallelism with the longitudinal axis. An inner member 522 is slidably received within the interior of catheter 520 and may be moved relatively longitudinally with respect to catheter apparatus 520 in order to deploy and install the attachment apparatus 500 and filtering membrane 40.
FIGS. 50-52 illustrated several options for installing the filtering membrane across the ostium 20. As illustrated in FIG. 50, the curved portions 504a/504b are positioned within the walls of the ostium 20 itself. The engagement members 508 provide additional support by engaging the interior of the atrial appendage. Alternatively, the curved portions 504a/504b are positioned outside the ostium within the atrium. Engagement members 508 retain the filtering membrane 40 in position. According to yet another alternative embodiment, engagement member 508 are provided with sharpened barb end portions 512 which engage and/or pierce the wall of the atrial appendage to secure the filtering membrane in position (FIG. 52). FIGS. 53-54 illustrate another embodiment of the invention. Attachment apparatus 600 provides a plurality of strut wires 620, e.g., six to 12 strut wires, that extend radially outward from a support ring 604. The strut wires 602 may be constructed from an alloy, such as nitinol, having shape memory characteristics. The support ring 604 maintains the strut wires 602 in the proper configuration and may be made of radiopaque materials, such as, e.g., platinum to provide fluoroscopic imaging of the device position. The support ring 604 is adjacent the proximal end portion 606 of the apparatus 600, and the strut wires 602 extend distally therefrom toward the distal end portion 608. The strut wires may be provided with barbs 610 or other methods for attachment to the interior of the atrial appendage. The proximal portion of the struts 602 provide a bulb shape to conform to the ostium and/or the internal wall of the atrial appendage . The filtering membrane 40 is attached to strut wires 602 adjacent the proximal portion 606 and provides the characteristics described above, wherein blood is allowed to pass through the filtering membrane 40, but thrombi, clots, and emboli are inhibited from passing therethrough. The filtering membrane 40 may be connected to the strut wires 602 using adhesive, sutures, encapsulation or other means.
FIGS. 55-56 illustrate apparatus for delivering and installing the attachment apparatus 600 and filtering membrane 40. The catheter apparatus 620 includes an outer sheath 622 and an inner member 624 slidably received within the interior of outer sheath 622. The outer sheath 622 and inner member 624 may be fabricated from materials, such as polymers, that are sufficiently flexible to negotiate the anatomy, yet sufficiently rigid for relative longitudinal movement to deploy and position the attachment apparatus 600. Inner member 624 may have a distal end portion 626 and a shoulder portion 638. Support ring 604 is sized to provide a slide fit over the distal portion 626, and is engaged by the shoulder portion 608. The aperture in support ring 604 is sufficiently small to inhibit clots from passing through. (Alternatively, the aperture in support ring is provided with an elastic material such as elastic section 476b illustrated in FIG. 35 to prevent the passage of clots therethrough.) When positioned about distal end portion 626, strut wires 602 are deflected distally toward parallelism with the longitudinal axis of the catheter device 622 and retained in the deflected configuration by the outer sheath 622. In order to deploy the attachment apparatus 600, the outer sheath 622 is moved longitudinally relative to the inner member 626. The shoulder portion 628 retains the attachment apparatus 600 in position. Upon retraction of the outer sheath 622, the shape memory characteristics of the strut wires 602 causes the apparatus to return to a shape approximating that of FIG. 53. FIGS. 57-58 illustrate the installation of attachment apparatus 600 and filtering membrane 40 in greater detail. As illustrated in FIG. 57, the catheter device 620 is advanced partially within the atrial appendage 13. The outer sheath 622 may be retracted proximally, which permits the strut wires 602 to extend radially outwardly. The physician may use the radiopaque characteristics of the ring 604 in order to properly position the ring 604 within the ostium 20. Further proximal retraction of the outer sheath 622 allows the strut wires 602 to extend further radially outward to engage the interior of the atrial appendage 13 (FIG. 58) . The barbs 610 may engage and/or pierce the wall of the atrial appendage to provide increased stability of the attachment apparatus 600. The filtering membrane 40 is consequently positioned across the ostium 20 in order to allow blood to pass through the filtering membrane, while substantially inhibiting thrombi, clots, and emboli from exiting the atrial appendage 13.
FIGS. 59-60 illustrate another embodiment of the invention. Attachment apparatus 650 provides a first plurality of strut wires 652 that extend distally and radially outward from a support ring 654 toward the distal end portion 656 of the attachment apparatus 650, and a second plurality of strut wires 658 that extend proximally and radially outward from support ring 654 toward the proximal end portion 660. The strut wires 652/658 may be constructed from an alloy, similar to material used for strut wires 602, above. The support ring 654 maintains the strut wires 652/658 in the proper configuration and is substantially similar to support ring 604, above. The strut wires 652 may be provided with barbs 662 or other methods for attachment to the interior of the atrial appendage. The struts 652/658 are configured to engage the walls of the ostium on the inner and outside sides thereof, respectively.
The strut wires 658 may serve as a membrane mounting structure. The filtering membrane 40 is attached to strut wires 658 and provides the characteristics described above, wherein blood is allowed to pass through the filtering membrane 40, but thrombi, clots, and emboli are inhibited from passing therethrough. The filtering membrane 40 may be connected to the strut wires 602 using adhesive, sutures, encapsulation or other means.
Another embodiment of the invention is illustrated in FIG. 61. Attachment apparatus 670 is constructed of braided or woven mesh material rather than the strut wires 652/658 described with respect to FIGS. 59-60. The distal portion 672 is configured to engage the wall of the atrial appendage adjacent the inner portion of the ostium, and the proximal portion 676 is configured to engage the outer portion of the ostium, and the neck portion 674 is disposed therebetween. The braided or woven self-expanded mesh material of attachment apparatus 670 has similar filtering characteristics as filtering membrane 40, or alternatively, a filtering membrane is attached to the mesh material to provide those characteristics. FIGS. 62-63 illustrate apparatus for delivering and installing the attachment apparatus 650 and filtering membrane 40 and/or attachment apparatus 670. The catheter apparatus 620 is described above with respect to FIG. 55. Strut wires 652 of apparatus 650 (or distal portions 672 of apparatus 670) are deflected distally toward parallelism with the longitudinal axis of the catheter device 620 and retained in the deflected configuration by the outer sheath 622. Similarly, strut wires 658 (or proximal portions 676) are deflected proximally toward parallelism with the longitudinal axis and retained in this configuration by the outer sheath 622. In order to deploy the attachment apparatus 600, the outer sheath 622 is moved longitudinally relative to the inner member 626. The shoulder portion 628 retains the attachment apparatus 650/670 in position. Upon retraction of the outer sheath 622, the shape memory characteristics of the strut wires 652/658 (or portions 672/676) cause the apparatus to return to a shape approximating that of FIG. 59 (or FIG. 61) . FIGS. 64-65 illustrate the installation of attachment apparatus 650/670 and filtering membrane 40 in greater detail. As illustrated in FIG. 64, the catheter device 622 is advanced partially within the atrial appendage 13. The outer sheath 622 may be retracted proximally, which permits the strut wires 652 to extend radially outwardly. The physician may use the radiopaque characteristics of the ring 654 in order to properly position the ring 654 within the ostium 20. Further proximal retraction of the outer sheath 622 allows the distal strut wires 652 and the proximal strut wires 658 to extend radially outward and engage the interior of the atrial appendage 13 (FIG: 65) . The barbs 662 may engage and/or pierce the wall of the atrial appendage to provide increased stability of the attachment apparatus 600. The filtering membrane 40 is consequently positioned across the ostium 20 in order to allow blood to pass through the filtering membrane, while substantially inhibiting thrombi, clots, and emboli from exiting the atrial appendage 13. FIGS. 66-67 illustrate yet another embodiment of the invention. Attachment apparatus 700 provides a plurality of strut wires 702 that extend radially outward from a support ring 704. A first portion 706 of each strut wire 702 extends towards the proximal end portion 708 of the attachment apparatus 700, and a second portion 710 of each strut wire 702 extends towards the distal end portion 712. The distal portion 710 of each strut wire 702 may be provided with a sharpened barb tip 714 or other methods for attachment to the interior of the atrial appendage. The strut wires 702 are constructed from an alloy, similar to material used for strut wires 602, above. The support ring 704 maintains the strut wires 702 in the proper configuration and is substantially similar to support ring 604, above. The proximal portions 706 and distal portions 710 of strut wires 702 are configured to engage the walls of the ostium on the outer and inner sides thereof, respectively. The filtering membrane 40 is attached to proximal portions 706 of strut wires 702 and provides the characteristic described above, wherein blood is allowed to pass through the filtering membrane 40, but thrombi, clots, and emboli are inhibited from passing therethrough. The filtering membrane 40 may be connected to the strut wires 702 using adhesive, sutures, encapsulation or other means.
FIGS. 68-69 illustrate apparatus for delivering and installing the attachment apparatus 700 and filtering membrane 40. The catheter apparatus 620 is described above with respect to FIG. 55. Strut wires 702 are deflected towards parallelism with the longitudinal axis of the catheter device 620 and retained in the deflected configuration by the outer sheath 622. In order to deploy the attachment apparatus 700, the outer sheath 622 is moved longitudinally relative to the inner member 626. The shoulder portion 628 retains the attachment apparatus 700 in position. Upon retraction of the outer sheath 622, the shape memory characteristics of the strut wires 702 causes the apparatus to resume the shape approximating that of FIG. 66.
FIGS. 70-71 illustrate the installation of attachment apparatus 700 and filtering membrane 40 in greater detail. As illustrated in FIG. 70, the catheter device 622 is advanced partially within the atrial appendage 13. The outer sheath 622 may be retracted proximally, which permits the distal portions 710 of strut wires 702 to extend radially outwardly. Further proximal retraction of the outer sheath 622 allows the distal portions 710 to engage the interior of the atrial appendage 13 and the proximal portions 706 to engage the outer portion of the ostium 20 (FIG. 71) . The barbs 714 may engage and/or pierce the wall of the atrial appendage to provide increased stability of the attachment apparatus 700. The filtering membrane 40 is consequently positioned across the ostium 20 in order to allow blood to pass through the filtering membrane, while substantially inhibiting thrombi, clots, and emboli from exiting the atrial appendage 13.
FIGS. 72-73 illustrate additional embodiments of the invention. Attachment apparatus 750 includes a plurality of strut wires 752 that extend radially outward and distally from a support member 754 towards the distal end portion 756. Each strut wire 752 may be provided with a sharpened barb tip 758 or other methods for attachment to the interior of the atrial appendage. The strut wires 702 are constructed from an alloy, similar to the material used for strut wires 602, above. The support member 754 maintains the strut wires 752 in the desired configuration.
The proximal end portion of support member 754 supports a curved membrane mounting structure 760 that defines a substantially closed curve. The filtering membrane 40 is attached to membrane mounting structure 760 and provides the characteristic described above, wherein blood is allowed to pass through the filtering membrane 40, but thrombi, clots, and emboli are inhibited from passing therethrough. The filtering membrane 40 may be connected to the membrane mounting structure 760 using adhesive, sutures, encapsulation or other means.
The attachment apparatus 770, illustrated in FIG. 73 is substantially identical to attachment apparatus 750, with the differences noted herein. For example, the proximal end portion of support member 754 supports a membrane mounting structure 772 having a spiral configuration. The filtering membrane 40 is attached to spiral mounting structure 772 substantially as described above with respect to membrane mounting structure 760, above. The spiral configuration may, e.g., assist in reducing the mounting structure to a compacted configuration during installation.
FIGS. 74-75 illustrate the installation of attachment apparatus 750 (or 770) and filtering membrane 40 in the atrial appendage 13. Catheter apparatus 780 is provided for delivering and installing the attachment apparatus 750 and filtering membrane 40. The catheter apparatus 780 is similar to catheter apparatus 620 described above with respect to FIG. 55. Catheter apparatus 780 includes an outer sheath 782 and an inner member 784. Inner member 784 preferably has an engagement surface 785 on a distal end portion thereof. During installation, strut wires 752 are deflected towards parallelism with the longitudinal axis of the catheter device 780 and retained in the deflected configuration by the outer sheath 782 (not shown in FIG. 74) . Similarly, the membrane mounting portion 760 (or 772) is folded, rolled or otherwise compacted inside outer sheath 782 as illustrated in FIG. 74. In order to deploy the attachment apparatus 750, the catheter device 780 is advanced partially within the atrial appendage 13. The outer sheath 782 may be retracted proximally, which permits the strut wires 752 to extend radially outwardly due to its shape memory characteristics, as shown. The inner member 784 retains the attachment apparatus 750 in position.
As illustrated in FIG. 75, further proximal retraction of the outer sheath 782 allows the strut wires 752 to extend radially outward and engage the interior of the atrial appendage. The barbs 758 may engage and/or pierce the wall of the atrial appendage to provide increased stability of the attachment apparatus 700. The membrane mounting structure 760 (or 772) is likewise permitted to return to its disc-like configuration, such that filtering membrane 40 is positioned across the ostium 20 in order to allow blood to pass through the filtering membrane, while substantially inhibiting thrombi, clots, and emboli from exiting the atrial appendage 13.
FIGS. 76-80 illustrate another embodiment of the invention. Attachment apparatus 800 has a braided or woven mesh portion 802 and a plurality of engagement members 804. Woven portion 802 defines a proximal portion 806 and distal portion 810. Woven portion 802 is fabricated from a material having shape memory characteristics, such as nitinol or an elastic polymeric material. Woven portion 802 is fabricated such that proximal portions 806 and distal portions 810 are normally biased to extend radially outward from support rings 812 and 814, respectively. The configuration of the woven portion 802 illustrated in FIGS. 76-77 is intended to conform to the ostium of the atrial appendage. The braided or woven self-expanding mesh material of woven portion 802 also has similar filtering characteristics as filtering membrane 40, which allows blood to pass therethrough while substantially inhibiting the passage of thrombus. Alternatively, a filtering membrane is attached to the woven material to provide these characteristics.
A plurality of engagement members 804 extend distally from support ring 814. The end portions of engagement members 804 may be provided with a barbed configuration to engage and/or pierce the wall of the atrial appendage and retain the engagement member in the wall. Engagement members 804 are similarly constructed from material having shape memory characteristics, such as nitinol. FIG. 78 illustrates apparatus for delivering and installing the attachment apparatus 800 and filtering membrane 40. The catheter apparatus 820 is similar to that described above with respect to catheter apparatus 520 (FIG. 55) . Inner member 825 may include a guide wire 824 and shoulder portion 826.
Guide wire 824 may extend through support rings 812 and 814. When apparatus 800 is positioned on catheter apparatus 820, woven portion 802 is deflected towards parallelism with the longitudinal axis of the catheter device 820 and retained in the deflected configuration by the outer sheath 822. Similarly, the engagement members 804 are deflected towards parallelism and retained in such position by the outer sheath 822. In order to deploy the attachment apparatus 800, the outer sheath 822 is moved longitudinally relative to the inner member 626, while the shoulder portion 826 retains the attachment apparatus 800 in position. Upon retraction of the outer sheath 822, the shape memory characteristics of the woven portion 802 cause the apparatus to return to the shape approximating that of FIG. 78.
As illustrated in FIG. 79, attachment apparatus 800 is partially inserted into the atrial appendage 13. Guide member 824 may be used to assist in the placement of attachment apparatus 800 with the atrial appendage by providing visual or tactile indication to the physician. Outer sheath 822 may be retracted proximally, which allows engagement members 804 to deflect radially outwardly, thereby engaging the interior wall of the atrial appendage. The barbs 805 may engage and/or pierce the wall of the atrial appendage to provide increased stability of the attachment apparatus 800. Outer sheath 822 may be further retracted proximally, thereby exposing woven portion 802, which expands radially outwardly to conform to the ostium 20 of the atrial appendage. The filtering membrane 40 (or the woven portion 802 having such filtering characteristics) is consequently positioned across the ostium 20 in order to allow blood to pass through the filtering membrane, while substantially inhibiting thrombi, clots, and emboli from exiting the atrial appendage 13.
FIGS. 81-86 illustrate another embodiment of the invention. Attachment apparatus 850 has a support structure including a plurality of struts 852 and an anchor structure 854. Struts 852 each define a proximal portion 856 and a distal portion 858. Struts 852 are fabricated from a material having shape memory characteristics, such as nitinol or an elastic polymeric material. Struts are fabricated such that proximal portions 856 and distal portions 858 are normally biased to extend radially outwardly. The configuration of the struts 852 illustrated in FIG. 78 conforms to the ostium of the atrial appendage when installed, as described herein. Filtering membrane 40 substantially covers struts 802, and provides the filtering characteristics described above, which allows blood to pass therethrough but substantially inhibits the passage of clots, thrombus, or emboli. Anchor structure 854 extends distally from struts 802 and includes a stylet tip 860 and two or more barbs 862.
FIG. 83 illustrates apparatus for delivering and installing the attachment apparatus 850 and filtering membrane 40. The catheter apparatus 880 is similar to that described above with respect to catheter apparatus 780 (FIG. 74) . An outer sheath 882 and inner member 884 having an engagement surface 888 are provided. Struts 852 are deflected towards parallelism with the longitudinal axis of the catheter device 880 and retained in the deflected configuration by the outer sheath 882. Barbs 862 of the anchor portion are deflected towards parallelism by the distal nose portion 883 of the outer sheath 882. In order to deploy the attachment apparatus 850, the inner member 884 is moved longitudinally relative to the outer sheath 882. The engagement surface 888 of the inner member 884 urges the attachment apparatus 850 out of the outer sheath 882. Upon deployment from the outer sheath 882, the shape memory characteristics of the material causes the apparatus to return to the shape approximating that of FIG. 81.
As illustrated in FIG. 84, attachment apparatus 800 is partially inserted into the atrial appendage 13. The stylet tip 860 is exposed from outer sheath 882 and pierces the wall of the atrial appendage. The distal nose portion 883 of the outer sheath 882 retains the barbs 862 towards parallelism with the longitudinal axis, thereby enabling these barbs 862 to pass through the wall of the atrial appendage. Once the barbs 862 have passed through the wall, the barbs 862 may deflect radially outwardly, thereby preventing the anchor structure from being withdrawn proximally back through the wall (FIG. 85) . As illustrated in FIG. 86, outer sheath 882 may be retracted proximally, thereby exposing struts 852, which expand radially outwardly to conform to the ostium 20 of the atrial appendage. The filtering membrane 40 (or the woven portion 802 having such filtering characteristics) is consequently positioned across the ostium 20 in order to allow blood to pass through the filtering membrane, while substantially inhibiting thrombi, clots, and emboli from exiting the atrial appendage 13.
Another embodiment is illustrated in FIGS. 86 and 88 and is denoted generally by reference number 900. This embodiment may comprise a deployment apparatus 910 for installing attachment apparatus 912, thereby securing the filtering membrane 40 across the ostium 20 of the atrial appendage 13.
Deployment apparatus 910 has a proximal handle portion 914 and an elongated shaft portion 916. Elongated shaft portion 916 is preferably flexible for introducing the apparatus in the patient' s vascular system and advancing the attachment apparatus into the atrium of the heart and adjacent the atrial appendage 13. Proximal handle portion 910 may comprise a body portion 918, which supports the elongated shaft portion 916 (consisting of a drive tube 926 and an outer tube 936) . Body portion 918 also supports a rotation knob 920 and a longitudinal slide 922. The rotation knob 920 is configured to rotate angularly about the longitudinal axis of the body portion 918 (as indicated by arrow 924) . Drive tube 926 is connected to rotation knob 920, such that rotation of the rotation knob 920 also rotates drive tube 926 about the longitudinal axis of (as indicated by arrow 928) . Drive tube 926 may be provided with an internal lumen 930 to permit a guide wire (not shown) to be used in connection with this procedure.
Longitudinal slide control 922 may be slidable within a slot 932 in the body portion 918 (as indicated by arrow 934) . Slide control 922 is connected to outer tube 936, and is longitudinally slidable therewith (as indicated by arrow 938) . As FIG. 88 illustrates, attachment apparatus 912 is configured for attachment to the distal end of elongated shaft portion 910. Attachment apparatus 912 is initially in the compacted configuration shown in FIGS. 88 and 89. As FIG. 89 illustrates, attachment apparatus 912 may comprise an outer portion 941 having an initially cylindrical configuration with a diameter 940 of about 2.0 mm and an initial length 942 of about 2.5 cm. Outer portion 941 is preferably manufactured from a flexible material such as stainless steel, nitinol, or Elgiloy ®. Outer portion 941 has a plurality of longitudinal struts 946 defined elongated slots 944. Longitudinal struts 946 are configured to enlarge radially outwardly to engage the ostium of the left atrial appendage, as will be described herein. Filtering membrane 40 is attached to outer portion 941 preferably about the proximal portions of the longitudinal struts 946 and has an initially cylindrical configuration. Filtering membrane 40 may be fabricated in a tapered configured and folded about the outer portion 941. Alternatively, membrane 40 may be fabricated from a material that has elastic characteristics which allow expansion from the initial cylindrical configuration to a substantially tapered configuration (see, FIG. 90) .
With reference to FIG. 88, attachment apparatus 912 may also comprise a male threaded member 948 defining outer threads 950, and a female threaded member 952 defining inner threads 953 cooperating with outer threads 950. Male threaded member 948 is longitudinally fixed adjacent the proximal portion of outer portion 941, and female threaded member 952 is longitudinally fixed adjacent the distal portion of outer portion 914. As male threaded member 948 and female threaded member 952 are longitudinally approximated by relative angular rotation therebetween, the medial portion of the longitudinal struts 946 deflect radially outwardly in a toggle-like fashion (as illustrated in FIG. 90) . The cooperating threaded configuration of members 948 and 952 provides additional resistance against the longitudinal struts 946 returning to the compacted configuration of FIG. 89. A plurality of locking tabs 954 are provided adjacent the proximal portion of attachment apparatus 912, as will described herein.
The proximal end portion of elongated shaft portion 910 is configured for attachment to, and subsequent removal from, the attachment apparatus 912. More particularly, a collet 956 is attached to the distal end of outer tube 936. Collet 956 may be provided with a plurality of apertures 959, which receive locking tabs 954 therein. Driver 958 may be attached to the distal end of drive tube 926. Driver 958 preferably has a locking arrangement with respect to a longitudinal bore 960 in male threaded member 948, For example, driver 958 may have a faceted outer surface defining six planar surfaces which is received in bore 960 defining a complementary faceted surface that allows relative longitudinal movement between driver 958 and male threaded member 948, while inhibiting relative angular rotation therebetween.
Attachment apparatus 912 is positioned at least partially within the atrial appendage 13 in the compacted configuration as illustrated in FIGS. 88 and 89.
A next stage in the procedure for installing the attachment apparatus 912 and filtering membrane 40 is illustrated in FIG. 90. Once the physician has determined that the attachment apparatus 912 is properly positioned, the rotation knob 920 may be rotated in the direction indicated by arrow 924 (see, FIG. 88. Rotation of rotation knob 920 causes drive tube 926, along with driver 958, to also rotate angularly. The cooperating relationship of driver 958 within male threaded member 948 causes male threaded member 948 to rotate angularly (as indicated by arrow 962) . The outer threads 950 and inner threads 953 are configured such that rotation of male threaded member 948 causes longitudinal motion of female threaded member 952 (i.e., in the direction indicated by arrow 964). To deploy the attachment apparatus 912, the male threaded member 948 is rotated to cause the female threaded member 952 to move proximally, thereby deflecting the longitudinal struts 946 radially outwardly (as indicated by arrow 966) . Further rotation of the male threaded member 948 deflects the longitudinal struts 946 radially outwardly until they engage the ostium 20 or the interior wall of the atrial appendage 13. After deployment of the attachment apparatus 912, the deployment apparatus 910 may be detached from the attachment apparatus 912. More particularly, collet 956 is moved proximally longitudinally by moving longitudinal slider 922 proximally with respect to handle body portion 918 (as indicated by arrow 970) . Longitudinal movement of collet 956 disengages locking tabs 954 from within apertures 959 provided on the distal portion of collet 958. As FIG. 92 illustrates, the drive tube 926 and driver 958 may be subsequently detached from the attachment apparatus 912 by proximal movement thereof (as indicated by arrow 970) . It is also contemplated that alternative means may be provided to temporarily attach the shaft portion 910 to the attachment apparatus, such as a friction fit between the various components . As illustrated in FIG. 93, attachment apparatus 912 secures the filtering membrane 40 across the ostium 20 of the atrial appendage 13. Filtering membrane 40 provides the filtering characteristics described above, which allows blood to pass therethrough but substantially inhibits the passage of clots, thrombus, or emboli.
FIGS. 94-97 illustrate several additional embodiments of the attachment apparatus described herein with respect to FIGS. 88-93. FIG. 94 illustrates attachment apparatus 981, substantially similar to attachment apparatus 912, having one or more barbs 980 provided on longitudinal struts 946 in order to engage the ostium 20 or the interior wall of the atrial appendage 13. FIG. 95 illustrates attachment apparatus 983, substantially similar to attachment apparatus 912, wherein each of the longitudinal struts 946 has a substantially straight longitudinal section 984, which may provide improved conformity to the ostium 20 of the atrial appendage 13.
FIG. 96 illustrates attachment member 985, substantially similar to attachment apparatus 912, wherein the longitudinal struts 946 have unequal length sections 987 and 990, which may provide additional stability and conformity to the ostium 20. FIG. 97 illustrates attachment apparatus 992, substantially similar to attachment apparatus 912, wherein the longitudinal struts 946 are configured to engage the ostium 20 or the interior wall of the atrial appendage 13 at a plurality of longitudinal locations, e.g., locations 993 and 994. This configuration may be achieved by attaching a portion of the longitudinal struts 946 to a slidable collar 995. In addition, the longitudinal struts 946 may be provided with barbs 996, which are configured to engage the ostium 20 and the interior wall of the atrial appendage 13 at a plurality of locations.
Yet another embodiment is illustrated in FIGS. 98-100, and is denoted by reference number 1000. Apparatus 1000 is substantially similar to the apparatus 900 described above, with the differences noted herein. Attachment apparatus 1012 is substantially similar to attachment apparatus 912. However, filtering membrane 40 may be annularly attached to the outer portion 941 adjacent the proximal end portion thereof. Moreover, filtering membrane 40 may be separately expandable from longitudinal struts 946. In a preferred embodiment, filtering membrane 40 is attached to an expandable membrane support frame 1040 which is preferably fabricated from a material having shape-memory characteristics, such as nitinol, and is self-expanding to radially outwardly disposed configuration. Deployment apparatus 1010 is substantially similar to deployment apparatus 910. However, deployment apparatus 1010 may also comprise sheath 1030 which is sized to fit coaxially about the membrane 40 and the outer tube 936. Sheath 1030 retains the membrane support frame 1040 in a compacted configuration substantially parallel with the longitudinal axis of the apparatus. Sheath 1030 may be withdrawn proximally in order to permit the membrane support frame to expand radially outwardly. FIG. 98 illustrates the attachment apparatus
1012 in an initial, compacted configuration. Sheath 1030 is coaxially disposed about the filtering membrane 40 to retain the membrane support frame 1040 substantially parallel with the longitudinal axis. Moreover, the cooperating threaded portions 952 and 948 are relatively positioned such that longitudinal struts 946 are also in the compacted, substantially cylindrical configuration. This configuration is useful for inserting and positioning the attachment apparatus 1012 adjacent the ostium 20 of the atrial appendage 13.
FIG. 99 illustrates a next step in the deployment of attachment apparatus 1012. When the attachment apparatus 1012 is positioned adjacent the ostium 20 of the atrial. appendage 13, or partially disposed within the atrial appendage 13, the sheath 1030 may be withdrawn proximally (as indicated by arrow 1031) . Withdrawal of sheath 1030 permits membrane support frame 1040 to expand radially outwardly (as indicated by arrows 1041), thereby outwardly expanding filtering membrane 40 therewith.
FIG. 100 illustrates a further step in the deployment of attachment apparatus. Filtering membrane 40 is positioned by the physician over the ostium 20 of the atrial appendage 13. The filtering membrane may define an outer periphery which is larger than the size of the ostium 20. Filtering membrane 40 is secured in position by expanding longitudinal struts 946 to engage the interior of the atrial appendage 13 and/or the ostium 20. Expansion of the longitudinal struts 946 is effected by rotation of the male threaded member 948 with respect to the female threaded member 952 by driver 958 (as described above with respect to FIG. 90) . When the attachment apparatus 912 is securely positioned within the atrial appendage 13, the deployment apparatus 1010 may be detached from the attachment apparatus 1012, substantially as described above with respect to FIGS. 91-92. The filtering membrane 40 is secured in position by the attachment apparatus 1012 across the ostium 20. More particularly, the outer periphery of the filtering membrane 40 may be secured in direct engagement with the atrial wall surrounding the ostium 20. The devices described above may be percutaneously delivered to the left and right atrial appendages 13, 23 respectively. The devices may have materials in them which enhance visualization or imaging by ultrasound, x-ray or other means making it easier for the device to be implanted and accurately centered with respect to the ostium 20 of the atrial appendage 13. This may consist of small beads placed strategically on the filtering membrane, the connecting elements, or on the anchors. Referring to FIG. 1 catheter 21 is seen entering the heart by way of the aorta 12 to the left ventricle 16 passing through the mitral valve 17 and then entering the left atrial appendage 13 to apply the permeable filtering membrane 40 in one of the embodiments as disclosed above. In FIG. 2 the catheter 21 enters the heart from the femoral vein, passes through the inferior vena cava 18 to the right atrium and then passes through the fossa ovalis 19 or through the septum 29 into the left atrium 11 and then approaches the left atrial appendage 13 to apply the permeable filtering membrane 40 thereto. FIG. 3 shows the catheter 21 being applied to the right atrial appendage 23. Catheter 21 may enter the heart through the jugular vein 28 or the femoral vein to the inferior vena cava 18.
It is understood that the invention may be practiced with numerous means of attaching the filtering membrane 40 across the ostium 20 of the atrial appendages 13 and 23. All of the above embodiments shown and discussed for the left atrial appendage 13 are also useable on the right atrial appendage 23. Any combination of the attachment means with adhesives, prongs, cylindrical structures, anchors, disks, tethers or springs may be used. The filtering membrane may also be inside of the atrial appendages 13 and 23, or may penetrate the atrial appendage and provide a means to securely lock the filtering membrane device into place. Other means of providing a filtering membrane for allowing blood flow therethrough and substantially inhibiting blood clots from exiting out of the atrial appendages not listed herein may also be used.
Obviously, many modifications and variations of the present invention are possible in light of the above teachings. It is therefore to be understood that, within the scope of the appended claims, the invention may be practiced otherwise than as specifically described.

Claims

What Is Claimed Is:
1. Apparatus for permanent placement across an ostium of a left atrial appendage in a patient, comprising: a filtering membrane configured to extend across the ostium of the left atrial appendage and having a permeable structure which allows blood to flow through the filtering membrane but substantially inhibits thrombus from passing therethrough; and a support structure attached to the filtering membrane which retains the filtering membrane in position across the ostium of the left atrial appendage by permanently engaging a portion of the interior wall of the left atrial appendage.
2. The apparatus defined in claim 1, wherein the support structure comprises a plurality of retaining members which engage the portion of the interior wall of the left atrial appendage.
3. The apparatus defined in claim 2, wherein the retaining members are fabricated from a material having shape-memory characteristics.
4. The apparatus defined in claim 3, wherein the retaining members define a first configuration spaced from the interior wall of the left atrial appendage and are resiliently biased towards a second configuration to engage the portion of the interior wall of the left atrial appendage.
5. The apparatus defined in claim 4, further comprising: a sheath configured to maintain the retention members in the first configuration.
6. The apparatus defined in claim 5, wherein the support structure further comprises a support ring to which each of the retention members is attached.
7. The apparatus defined in claim 6, wherein the retention members define a bulb shape in the second configuration to engage the portion of the interior wall of the left atrial appendage.
8. The apparatus defined in claim 6, wherein the retention members define a substantially cylindrical shape in the second configuration to engage the portion of the interior wall of the left atrial appendage .
9. The apparatus defined in claim 2, wherein the retention members comprise end portions configured to penetrate the wall of the left atrial appendage .
10. The apparatus defined in claim 9, wherein the end portions have a barbed structure to secure the retention members in the wall of the left atrial appendage.
11. The apparatus defined in claim 1, wherein the support structure further comprises a membrane attachment structure to which the filtering membrane is attached.
12. The apparatus defined in claim 11, wherein the membrane attachment structure defines a substantially closed curve.
13. The apparatus defined in claim 11, wherein the membrane attachment structure defines a spiral shape.
14. The apparatus defined in claim 11, wherein the membrane attachment structure comprises a plurality of radially extending struts.
15. The apparatus defined in claim 1, wherein the support member comprises an anchor portion configured to penetrate the wall of the left atrial appendage and a tether extending from the anchor portion to the filtering membrane.
16. The apparatus defined in claim 15, wherein the tether is fabricated from an elastic material which provides tension for approximating the filtering membrane and the ostium of the left atrial appendage.
17. The apparatus defined in claim 1, wherein the tether is a coil which provides tension for approximating the filtering membrane and the ostium of the left atrial appendage.
18. The apparatus defined in claim 1, wherein the support structure is an expandable member which is expandable between a first compacted configuration and a second expanded configuration to engage a portion of the interior wall of the left atrial appendage.
19. The apparatus defined in claim 18, wherein the expandable member is a balloon structure.
20. The apparatus defined in claim 18, wherein the filtering membrane defines an aperture in communication with an opening in the balloon structure for introducing an expansion medium into the balloon structure .
21. The apparatus defined in claim 18, wherein the expandable member is a helical coil structure
22. The apparatus defined in claim 1, wherein the support structure defines a substantially cylindrical configuration for engaging the portion of the interior wall of the left atrial appendage.
23. The apparatus defined in claim 22, wherein the filtering membrane is attached about an end portion of the support structure.
24. The apparatus defined in claim 23, wherein the support structure is radially expandable from a first configuration to a second configuration.
25. The apparatus defined in claim 24, further comprising: an expandable structure which radially expands the support structure from the first configuration to the second configuration.
26. The apparatus defined in claim 24, wherein the expandable structure comprises a balloon.
27. The apparatus defined in claim 25, wherein the filtering membrane defines an opening therethrough, and wherein the expandable structure is configured to pass through the opening in the filtering membrane while the expandable structure is in a compacted configuration.
28. The apparatus defined in claim 22, wherein the support structure comprises an engagement member for piercing the wall of the left atrial appendage .
29. The apparatus defined in claim 1, wherein the filtering membrane is flexible.
30. The apparatus defined in claim 1, wherein the filtering membrane defines an opening therethrough that is configured to expand from a first size which inhibits the passage of thrombus therethrough to a second size which allows an interventional device to pass therethrough, and wherein the opening is resiliently biased towards the first size.
31. The apparatus defined in claim 1, wherein a portion of the filtering membrane is fabricated from an elastic material defining an opening therethrough, wherein the opening is configured to expand from a first size which inhibits the passage of thrombus therethrough to a second size which allows an interventional device to pass therethrough, and wherein the opening is resiliently biased towards the first size .
32. The apparatus defined in claim 1, wherein the filtering membrane comprises two overlapping portions which define an opening that allows an interventional device to pass therethrough.
33. The apparatus defined in claim 1, wherein the filtering membrane defines a plurality of pores, wherein each pore has a diameter of between about 50 microns to about 400 microns.
34. The apparatus defined in claim 1, wherein the filtering membrane defines an open area of less than about 60 percent of the surface area thereof.
35. A method of filtering the flow of blood between an atrium and a left atrial appendage of a patient comprising: providing a filtering membrane having a permeable structure which allows blood to flow through the filtering membrane but substantially inhibits thrombus from passing therethrough, and a support structure attached to the filtering membrane configured to permanently engage a portion of an ostium and an interior wall of the left atrial appendage; positioning the filtering membrane across the ostium by permanently engaging the portion of the interior wall of the left atrial appendage with the support structure; and filtering blood flow through the ostium with the filtering membrane such that blood may flow through the filtering membrane while thrombus is substantially inhibited from passing therethrough.
36. The method as defined in claim 35, wherein the support structure comprises a plurality of retaining members, and wherein positioning the filtering membrane further comprises piercing the wall of the left atrial appendage with the retaining members.
37. The method defined in claim 35, wherein the support structure comprises a plurality of retaining members, and wherein positioning the filtering membrane comprises atraumatically engaging the interior wall of the left atrial appendage with the retaining members .
38. The method defined in claim 35, wherein the support structure comprises a centering structure extending from the filtering membrane, and wherein the positioning the filtering membrane comprises centering the filtering membrane over the ostium by passing the centering structure into the ostium.
39. The method as defined in claim 35, wherein the support structure comprises an anchor structure and a tether extending between the anchor structure and the filtering membrane, and wherein positioning the filtering membrane further comprises piercing the wall of the left atrial appendage with the anchor structure.
40. The method as defined in claim 35, wherein the support structure comprises an expandable structure, and wherein the positioning the filtering membrane further comprises expanding the expandable structure to engage an interior wall of the left atrial appendage .
41. The method as defined in claim 35, wherein the support structure comprises a substantially cylindrical configuration, and wherein the positioning the filtering membrane further comprises expanding the support structure to engage the interior wall of the left atrial appendage.
42. The method as defined in claim 41, further comprising: providing an expandable structure which is positioned within the support structure and which radially expands the support structure, and wherein the positioning the filtering membrane further comprises expanding the expandable structure, thereby expanding the support structure.
43. The method as defined in claim 42, wherein the filtering membrane defines an opening therethrough, the method further comprising: after expanding the support structure to engage the interior wall of the left atrial appendage, removing the expandable structure through the opening in the filtering membrane.
44. Apparatus for permanent placement across an ostium of a left atrial appendage in a patient, comprising: a filtering membrane configured to extend across the ostium of the left atrial appendage and having a permeable structure which allows blood to flow through the filtering membrane but substantially inhibits thrombus from passing therethrough; and a support structure comprising a plurality of fingers which are radially outwardly expandable with respect to a longitudinal axis to permanently engage the interior wall of the left atrial appendage, wherein the filtering membrane is attached to the support structure extending across the ostium of the left atrial appendage.
45. Apparatus as defined in claim 44, wherein each finger defines a first end portion, a second end portion, and a medial portion, and wherein the medial portion of each finger is radially outwardly expanded by approximating the first and second end portions .
46. Apparatus as defined in claim 45, wherein the support structure further comprises first and second cooperating threaded members configured for relative angular rotation about the longitudinal axis, wherein each cooperating threaded member is attached to a respective first and second end portion of each finger, and wherein the first and second end portions of said fingers are approximated by said relative angular rotation between the cooperating threaded members .
47. Apparatus as defined in claim 46, further comprising: an actuator configured to expand the plurality of fingers by angularly rotating one of the cooperating threaded members about the longitudinal axis .
48. Apparatus as defined in claim 47, wherein the actuator further comprises an outer tube configured for releasable attachment to the support structure.
49. Apparatus as defined in claim 48, wherein the support member comprises a tab structure and the outer tube defines an aperture at an end portion thereof, and wherein the outer tube is releasably attached to the support member by engagement of the tab structure in the aperture.
50. Apparatus as defined in claim 48, wherein the outer tube is releasably attached to the support member by a frictional fit.
51. Apparatus as defined in claim 44, wherein the fingers are fabricated of stainless steel.
52. Apparatus as defined in claim 44, wherein the fingers are fabricated of nitinol.
53. Apparatus as defined in claim 44, wherein the fingers comprise a barbed portion configured to engage an interior wall of the atrial appendage.
54. Apparatus for permanent placement across an ostium of a left atrial appendage in a patient, comprising: a filtering membrane configured to extend across the ostium of the left atrial appendage and having a permeable structure which allows blood to flow through the filtering membrane but substantially inhibits thrombus from passing therethrough; and a support structure defining a first configuration having a substantially cylindrical shape and a second configuration defining a radially enlarged medial portion to permanently engage the interior wall of the left atrial appendage, wherein the filtering membrane is attached to the support structure extending across the ostium of the left atrial appendage.
55. Apparatus as defined in claim 54, wherein the support structure comprises a plurality of fingers each having a first end portion, a second end portion, and a medial portion, and wherein the medial portion of each finger is radially outwardly expanded in the second configuration.
56. Apparatus as defined in claim 55, wherein the support structure further comprises first and second cooperating threaded members configured for relative angular rotation, wherein each cooperating threaded member is attached to a respective first and second end portion of each finger, and wherein the first and second end portions of said fingers are approximated by said relative angular rotation between the cooperating threaded members.
57. Apparatus as defined in claim 54, further comprising: an actuator configured to expand the plurality of fingers by angularly rotating one of the cooperating threaded members about the longitudinal axis .
58. Apparatus as defined in claim 57, wherein the actuator further comprises an outer tube configured for releasable attachment to the support structure .
59. Apparatus as defined in claim 58, wherein the support member comprises a tab structure and the outer tube defines an aperture at an end portion thereof, and wherein the outer tube is releasably attached to the support member by engagement of the tab structure in the aperture.
60. Apparatus as defined in claim 58, wherein the outer tube is releasably attached to the support member by a frictional fit.
61. Apparatus as defined in claim 55, wherein the fingers are fabricated of stainless steel.
62. Apparatus as defined in claim 55, wherein the fingers are fabricated of nitinol.
63. Apparatus as defined in claim 55, wherein the fingers comprise a barbed portion configured to engage an interior wall of the atrial appendage .
64. Apparatus for permanent placement across an ostium of a left atrial appendage in a patient, comprising: a filtering membrane configured to extend across the ostium of the left atrial appendage and having a permeable structure which allows blood to flow through the filtering membrane but substantially inhibits thrombus from passing therethrough; and a support structure comprising a plurality of fingers which are radially outwardly expandable with respect to a longitudinal axis to permanently engage the interior wall of the left atrial appendage, wherein the filtering membrane is attached to the support structure extending across the ostium of the left atrial appendage; and an actuator configured to remotely radially outwardly expand the support structure.
65. Apparatus as defined in claim 44, wherein each finger defines a first end portion, a second end portion, and a medial portion, and wherein the medial portion of each finger is radially outwardly expanded by approximating the first and second end portions .
66. Apparatus as defined in claim 65, wherein the support structure further comprises first and second cooperating threaded members configured for relative angular rotation about the longitudinal axis, wherein each cooperating threaded member is attached to a respective first and second end portion of each finger, and wherein the first and second end portions of said fingers are approximated by said relative angular rotation between the cooperating threaded members .
67. Apparatus as defined in claim 66, wherein the actuator comprises a drive member configured to expand the plurality of fingers by angularly rotating one of the cooperating threaded members about the longitudinal axis.
68. Apparatus as defined in claim 67, wherein the actuator further comprises an outer tube configured for releasable attachment to the support structure .
69. Apparatus as defined in claim 68, wherein the support member comprises a tab structure and the outer tube defines an aperture at an end portion thereof, and wherein the outer tube is releasably attached to the support member by engagement of the tab structure in the aperture.
70. Apparatus as defined in claim 68, wherein the outer tube is releasably attached to the support member by a frictional fit.
71. Apparatus as defined in claim 64, wherein the fingers are fabricated of stainless steel.
72. Apparatus as defined in claim 64, wherein the fingers are fabricated of nitinol.
73. Apparatus as defined in claim 64, wherein the fingers comprise a barbed portion configured to engage an interior wall of the atrial appendage .
74. Apparatus for permanent placement across an ostium of a left atrial appendage in a patient, comprising: a membrane configured to extend across the ostium of the left atrial appendage and having a structure which substantially inhibits thrombus from passing therethrough; and a support structure comprising a plurality of fingers which are radially outwardly expandable with respect to a longitudinal axis to permanently engage the interior wall of the left atrial appendage, wherein the membrane is attached to the support structure extending across the ostium of the left atrial appendage.
75. Apparatus as defined in claim 74, wherein each finger defines a first end portion, a second end portion, and a medial portion, and wherein the medial portion of each finger is radially outwardly expanded by approximating the first and second end portions .
76. Apparatus as defined in claim 75, wherein the support structure further comprises first and second cooperating threaded members configured for relative angular rotation about the longitudinal axis, wherein each cooperating threaded member is attached to a respective first and second end portion of each finger, and wherein the first and second end portions of said fingers are approximated by said relative angular rotation between the cooperating threaded members .
77. Apparatus as defined in claim 76, further comprising: an actuator configured to expand the plurality of fingers by angularly rotating one of the cooperating threaded members about the longitudinal axis .
78. Apparatus as defined in claim 77, wherein the actuator further comprises an outer tube configured for releasable attachment to the support structure .
79. Apparatus as defined in claim 78, wherein the support member comprises a tab structure and the outer tube defines an aperture at an end portion thereof, and wherein the outer tube is releasably attached to the support member by engagement of the tab structure in the aperture.
80. Apparatus as defined in claim 78, wherein the outer tube is releasably attached to the support member by a frictional fit.
81. Apparatus as defined in claim 74, wherein the fingers are fabricated of stainless steel.
82. Apparatus as defined in claim 74, wherein the fingers are fabricated of nitinol.
83. Apparatus as defined in claim 74, wherein the fingers comprise a barbed portion configured to engage an interior wall of the atrial appendage .
84. Apparatus for permanent placement across an ostium of a left atrial appendage in a patient, comprising: a filtering membrane configured to extend across the ostium of the left atrial appendage and having a permeable structure which allows blood to flow through the filtering membrane but substantially inhibits thrombus from passing therethrough; and a support structure comprising a plurality of fingers which are radially outwardly expandable with respect to a longitudinal axis to permanently engage the interior wall of the left atrial appendage, and a membrane support frame which is radially outwardly expandable to engage the atrial wall surrounding the ostium, wherein the filtering membrane is attached to the membrane support frame to extend over the ostium of the left atrial appendage.
85. Apparatus as defined in claim 84, wherein each finger defines a first end portion, a second end portion, and a medial portion, and wherein the medial portion of each finger is radially outwardly expanded by approximating the first and second end portions .
86. Apparatus as defined in claim 85, wherein the support structure further comprises first and second cooperating threaded members configured for relative angular rotation about the longitudinal axis, wherein each cooperating threaded member is attached to a respective first and second end portion of each 1 1 -
finger, and wherein the first and second end portions of said fingers are approximated by said relative angular rotation between the cooperating threaded members .
87. Apparatus as defined in claim 86, further comprising: an actuator configured to expand the plurality of fingers by angularly rotating one of the cooperating threaded members about the longitudinal axis .
88. Apparatus as defined in claim 87, wherein the actuator further comprises an outer tube configured for releasable attachment to the support structure .
89. Apparatus as defined in claim 88, wherein the support member comprises a tab structure and the outer tube defines an aperture at an end portion thereof, and wherein the outer tube is releasably attached to the support member by engagement of the tab structure in the aperture.
90. Apparatus as defined in claim 88, wherein the outer tube is releasably attached to the support member by a frictional fit.
91. Apparatus as defined in claim 84, whereinAhe fingers are fabricated of stainless steel.
92. Apparatus as defined in claim 84, wherein the fingers are fabricated of nitinol.
.2 -
93. Apparatus as defined in claim 84, wherein the fingers comprise a barbed portion configured to engage an interior wall of the atrial appendage .
94. Apparatus as defined in claim 84, wherein the membrane support frame is fabricated from a material having shape-memory characteristics.
95. Apparatus as defined in claim 84, wherein the membrane support frame is elastically expandable .
PCT/US2000/029489 1999-10-27 2000-10-26 Filter apparatus for ostium of left atrial appendage WO2001030266A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2001532689A JP4630513B2 (en) 1999-10-27 2000-10-26 Filter device for left atrial appendage ostium
DE2000613880 DE60013880T2 (en) 1999-10-27 2000-10-26 FILTER DEVICE FOR THE OSTIUM OF THE LEFT FORWARD ANNEX
EP00973875A EP1227770B1 (en) 1999-10-27 2000-10-26 Filter apparatus for ostium of left atrial appendage
ES00973875T ES2223602T3 (en) 1999-10-27 2000-10-26 FILTER APPARATUS FOR OSTIUM OF A LEFT HEADPHONE APPENDIX.
CA 2388600 CA2388600C (en) 1999-10-27 2000-10-26 Filter apparatus for ostium of left atrial appendage
IL14913200A IL149132A0 (en) 1999-10-27 2000-10-26 Filter apparatus for ostium of left atrial appendage
AU12327/01A AU779358B2 (en) 1999-10-27 2000-10-26 Filter apparatus for ostium of left atrial appendage
AT00973875T ATE275886T1 (en) 1999-10-27 2000-10-26 FILTERING DEVICE FOR THE LEFT ATRIAL OSTIUM
IL149132A IL149132A (en) 1999-10-27 2002-04-15 Filter apparatus for ostium of left atrial appendage

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US09/428,008 US6551303B1 (en) 1999-10-27 1999-10-27 Barrier device for ostium of left atrial appendage
US09/428,008 1999-10-27
US19645400P 2000-04-11 2000-04-11
US60/196,454 2000-04-11
US20696700P 2000-05-25 2000-05-25
US60/206,967 2000-05-25
US20951100P 2000-06-05 2000-06-05
US60/209,511 2000-06-05
US21189600P 2000-06-16 2000-06-16
US60/211,896 2000-06-16
US09/614,091 US6689150B1 (en) 1999-10-27 2000-07-11 Filter apparatus for ostium of left atrial appendage
US09/614,091 2000-07-11

Publications (2)

Publication Number Publication Date
WO2001030266A1 true WO2001030266A1 (en) 2001-05-03
WO2001030266A9 WO2001030266A9 (en) 2002-08-15

Family

ID=30773740

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/029489 WO2001030266A1 (en) 1999-10-27 2000-10-26 Filter apparatus for ostium of left atrial appendage

Country Status (11)

Country Link
US (7) US6689150B1 (en)
EP (2) EP1523957A3 (en)
JP (2) JP4630513B2 (en)
CN (1) CN1399530A (en)
AT (1) ATE275886T1 (en)
AU (1) AU779358B2 (en)
CA (1) CA2388600C (en)
DE (1) DE60013880T2 (en)
ES (1) ES2223602T3 (en)
IL (2) IL149132A0 (en)
WO (1) WO2001030266A1 (en)

Cited By (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024106A2 (en) * 2000-09-21 2002-03-28 Atritech, Inc. Apparatus for implanting devices in atrial appendages
WO2002096295A1 (en) * 2001-05-30 2002-12-05 Scimed Life Systems, Inc. Implantable septal defects closure device
WO2003008030A2 (en) * 2001-07-18 2003-01-30 Atritech, Inc. Implantation catheter with tether system
WO2003032818A2 (en) 2001-10-19 2003-04-24 Ev3 Sunnyvale, Inc. Adjustable left atrial appendage occlusion device
WO2003063732A2 (en) * 2002-01-25 2003-08-07 Atritech, Inc. Atrial appendage blood filtration systems
WO2004012629A1 (en) 1999-08-09 2004-02-12 Cardiokinetix, Inc. A device for improving cardiac function
EP1392394A2 (en) * 2001-06-04 2004-03-03 Albert Einstein Healthcare Network Cardiac stimulating apparatus having a blood clot filter and atrial pacer
WO2004100803A1 (en) * 2003-05-12 2004-11-25 Cardiokinetix, Inc. A system for improving cardiac function
EP1494632A1 (en) * 2002-03-20 2005-01-12 Spiration, Inc. Removable anchored lung volume reduction devices and methods
WO2007035497A1 (en) * 2005-09-16 2007-03-29 Ev3 Endovascular, Inc. Intracardiac cage and method of delivering same
EP1981577A2 (en) * 2005-10-07 2008-10-22 Alex Javois Left atrial appendage occlusion device
EP2083902A2 (en) * 2006-10-18 2009-08-05 Inspiremd Ltd. Filter assemblies
EP2078502A3 (en) * 2001-09-11 2009-08-26 Spiration, Inc. Removable lung reduction devices systems, and methods
EP2163205A1 (en) * 2008-09-11 2010-03-17 Beat Dr. Wicky Device for closing wounds, particularly wounds caused by the insertion of a trocar into the abdominal wall
US7691128B2 (en) 2002-05-06 2010-04-06 St. Jude Medical, Cardiology Division, Inc. PFO closure devices and related methods of use
US7713282B2 (en) 1998-11-06 2010-05-11 Atritech, Inc. Detachable atrial appendage occlusion balloon
US7717937B2 (en) 2001-06-01 2010-05-18 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods and tools, and related methods of use
US7735493B2 (en) 2003-08-15 2010-06-15 Atritech, Inc. System and method for delivering a left atrial appendage containment device
US7806846B2 (en) 2004-03-30 2010-10-05 Nmt Medical, Inc. Restoration of flow in LAA via tubular conduit
US8080032B2 (en) 1998-11-06 2011-12-20 Atritech, Inc. Method and device for left atrial appendage occlusion
US8097015B2 (en) 2003-09-12 2012-01-17 W.L. Gore & Associates, Inc. Device and methods for preventing formation of thrombi in the left atrial appendage
US8372112B2 (en) 2003-04-11 2013-02-12 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods, and related methods of use
US8574264B2 (en) 2003-04-11 2013-11-05 St. Jude Medical, Cardiology Division, Inc. Method for retrieving a closure device
CN104168843A (en) * 2011-11-01 2014-11-26 科赫里克斯医疗股份有限公司 Medical device for modification of left atrial appendage and related systems and methods
US8961586B2 (en) 2005-05-24 2015-02-24 Inspiremd Ltd. Bifurcated stent assemblies
US8979893B2 (en) 2008-09-05 2015-03-17 Pulsar Vascular, Inc. Systems and methods for supporting or occluding a physiological opening or cavity
US9039597B2 (en) 2009-10-26 2015-05-26 Cardiokinetix, Inc. Ventricular volume reduction
US9078660B2 (en) 2000-08-09 2015-07-14 Cardiokinetix, Inc. Devices and methods for delivering an endocardial device
US9119625B2 (en) 2011-10-05 2015-09-01 Pulsar Vascular, Inc. Devices, systems and methods for enclosing an anatomical opening
US9132261B2 (en) 2006-10-18 2015-09-15 Inspiremd, Ltd. In vivo filter assembly
US9259229B2 (en) 2012-05-10 2016-02-16 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening, including coil-tipped aneurysm devices
US9277924B2 (en) 2009-09-04 2016-03-08 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening
US9326873B2 (en) 2007-10-12 2016-05-03 Spiration, Inc. Valve loader method, system, and apparatus
US9474516B2 (en) 2011-11-08 2016-10-25 Boston Scientific Scimed, Inc. Handle assembly for a left atrial appendage occlusion device
US9526644B2 (en) 2006-11-22 2016-12-27 Inspiremd, Ltd. Optimized drug-eluting stent assembly methods
US9592123B2 (en) 2002-08-01 2017-03-14 Cardiokinetix, Inc. Therapeutic methods and devices following myocardial infarction
US9622752B2 (en) 2003-08-08 2017-04-18 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
EP3072461A4 (en) * 2013-11-14 2017-05-31 Lifetech Scientific (Shenzhen) Co., Ltd. Left atrial appendage occluder
US9694121B2 (en) 1999-08-09 2017-07-04 Cardiokinetix, Inc. Systems and methods for improving cardiac function
US9730701B2 (en) 2014-01-16 2017-08-15 Boston Scientific Scimed, Inc. Retrieval wire centering device
US9872767B2 (en) 1999-08-09 2018-01-23 Edwards Lifesciences Corporation Retrievable cardiac devices
US9901350B2 (en) 2005-04-22 2018-02-27 Rex Medical, L.P. Closure device for left atrial appendage
US10004510B2 (en) 2011-06-03 2018-06-26 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening, including shock absorbing aneurysm devices
US10058440B2 (en) 2005-05-24 2018-08-28 Inspiremd, Ltd. Carotid stent apparatus and methods for treatment via body lumens
US10064696B2 (en) 2000-08-09 2018-09-04 Edwards Lifesciences Corporation Devices and methods for delivering an endocardial device
US10076335B2 (en) 2005-12-01 2018-09-18 Atritech, Inc. Apparatus for delivering an implant without bias to a left atrial appendage
US10137015B2 (en) 2006-10-18 2018-11-27 Inspiremd Ltd. Knitted stent jackets
US10307147B2 (en) 1999-08-09 2019-06-04 Edwards Lifesciences Corporation System for improving cardiac function by sealing a partitioning membrane within a ventricle
US10307253B2 (en) 1999-08-09 2019-06-04 Edwards Lifesciences Corporation System for improving cardiac function by sealing a partitioning membrane within a ventricle
AU2017204628B2 (en) * 2002-10-17 2019-07-25 W. L. Gore & Associates, Inc. Embolic filter frame having looped support strut elements
US10368942B2 (en) 2005-09-06 2019-08-06 W. L. Gore & Associates, Inc. Devices and methods for treating cardiac tissue
US10499927B2 (en) 2005-10-19 2019-12-10 Pulsar Vascular, Inc. Methods and systems for endovascularly clipping and repairing lumen and tissue defects
US10624647B2 (en) 2011-06-03 2020-04-21 Pulsar Vascular, Inc. Aneurysm devices with additional anchoring mechanisms and associated systems and methods
US10667896B2 (en) 2015-11-13 2020-06-02 Cardiac Pacemakers, Inc. Bioabsorbable left atrial appendage closure with endothelialization promoting surface
US10751183B2 (en) 2014-09-28 2020-08-25 Edwards Lifesciences Corporation Apparatuses for treating cardiac dysfunction
US10952741B2 (en) 2017-12-18 2021-03-23 Boston Scientific Scimed, Inc. Occlusive device with expandable member
US10993803B2 (en) 2011-04-01 2021-05-04 W. L. Gore & Associates, Inc. Elastomeric leaflet for prosthetic heart valves
WO2021154458A1 (en) * 2020-01-28 2021-08-05 Medtronic, Inc. Modular left atrial appendage closure
US11123079B2 (en) 2018-06-08 2021-09-21 Boston Scientific Scimed, Inc. Occlusive device with actuatable fixation members
US11129622B2 (en) 2015-05-14 2021-09-28 W. L. Gore & Associates, Inc. Devices and methods for occlusion of an atrial appendage
US11154303B2 (en) 2007-10-19 2021-10-26 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US11173023B2 (en) 2017-10-16 2021-11-16 W. L. Gore & Associates, Inc. Medical devices and anchors therefor
US11241239B2 (en) 2018-05-15 2022-02-08 Boston Scientific Scimed, Inc. Occlusive medical device with charged polymer coating
US11253262B2 (en) 2009-06-17 2022-02-22 Coherex Medical, Inc. Delivery device, system, and method thereof
US11331104B2 (en) 2018-05-02 2022-05-17 Boston Scientific Scimed, Inc. Occlusive sealing sensor system
US11369355B2 (en) 2019-06-17 2022-06-28 Coherex Medical, Inc. Medical device and system for occluding a tissue opening and method thereof
US11382635B2 (en) 2018-07-06 2022-07-12 Boston Scientific Scimed, Inc. Occlusive medical device
US11413048B2 (en) 2018-01-19 2022-08-16 Boston Scientific Scimed, Inc. Occlusive medical device with delivery system
US11432809B2 (en) 2017-04-27 2022-09-06 Boston Scientific Scimed, Inc. Occlusive medical device with fabric retention barb
US11457925B2 (en) 2011-09-16 2022-10-04 W. L. Gore & Associates, Inc. Occlusive devices
US11540838B2 (en) 2019-08-30 2023-01-03 Boston Scientific Scimed, Inc. Left atrial appendage implant with sealing disk
US11540837B2 (en) 2009-06-17 2023-01-03 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US11564692B2 (en) 2018-11-01 2023-01-31 Terumo Corporation Occlusion systems
US11596533B2 (en) 2018-08-21 2023-03-07 Boston Scientific Scimed, Inc. Projecting member with barb for cardiovascular devices
US11672541B2 (en) 2018-06-08 2023-06-13 Boston Scientific Scimed, Inc. Medical device with occlusive member
US11812969B2 (en) 2020-12-03 2023-11-14 Coherex Medical, Inc. Medical device and system for occluding a tissue opening and method thereof
US11832824B2 (en) 2013-12-20 2023-12-05 Terumo Corporation Vascular occlusion
US11903589B2 (en) 2020-03-24 2024-02-20 Boston Scientific Scimed, Inc. Medical system for treating a left atrial appendage
US11911258B2 (en) 2013-06-26 2024-02-27 W. L. Gore & Associates, Inc. Space filling devices
US11925356B2 (en) 2021-02-11 2024-03-12 Boston Scientific Scimed, Inc. Occlusive device with expandable member

Families Citing this family (448)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491232B2 (en) 1998-09-18 2009-02-17 Aptus Endosystems, Inc. Catheter-based fastener implantation apparatus and methods with implantation force resolution
US7314477B1 (en) 1998-09-25 2008-01-01 C.R. Bard Inc. Removable embolus blood clot filter and filter delivery unit
US20060229491A1 (en) * 2002-08-01 2006-10-12 Cardiokinetix, Inc. Method for treating myocardial rupture
US7887477B2 (en) * 1999-08-09 2011-02-15 Cardiokinetix, Inc. Method of improving cardiac function using a porous membrane
US7674222B2 (en) * 1999-08-09 2010-03-09 Cardiokinetix, Inc. Cardiac device and methods of use thereof
US6231561B1 (en) 1999-09-20 2001-05-15 Appriva Medical, Inc. Method and apparatus for closing a body lumen
US6551303B1 (en) * 1999-10-27 2003-04-22 Atritech, Inc. Barrier device for ostium of left atrial appendage
US6689150B1 (en) 1999-10-27 2004-02-10 Atritech, Inc. Filter apparatus for ostium of left atrial appendage
US6994092B2 (en) * 1999-11-08 2006-02-07 Ev3 Sunnyvale, Inc. Device for containing embolic material in the LAA having a plurality of tissue retention structures
US8758400B2 (en) 2000-01-05 2014-06-24 Integrated Vascular Systems, Inc. Closure system and methods of use
US6461364B1 (en) 2000-01-05 2002-10-08 Integrated Vascular Systems, Inc. Vascular sheath with bioabsorbable puncture site closure apparatus and methods of use
US9579091B2 (en) 2000-01-05 2017-02-28 Integrated Vascular Systems, Inc. Closure system and methods of use
US7842068B2 (en) 2000-12-07 2010-11-30 Integrated Vascular Systems, Inc. Apparatus and methods for providing tactile feedback while delivering a closure device
US6391048B1 (en) 2000-01-05 2002-05-21 Integrated Vascular Systems, Inc. Integrated vascular device with puncture site closure component and sealant and methods of use
US6942674B2 (en) 2000-01-05 2005-09-13 Integrated Vascular Systems, Inc. Apparatus and methods for delivering a closure device
US20060030881A1 (en) * 2004-08-05 2006-02-09 Cardiokinetix, Inc. Ventricular partitioning device
US9332993B2 (en) 2004-08-05 2016-05-10 Cardiokinetix, Inc. Devices and methods for delivering an endocardial device
US7762943B2 (en) * 2004-03-03 2010-07-27 Cardiokinetix, Inc. Inflatable ventricular partitioning device
US7862500B2 (en) * 2002-08-01 2011-01-04 Cardiokinetix, Inc. Multiple partitioning devices for heart treatment
US8398537B2 (en) 2005-06-10 2013-03-19 Cardiokinetix, Inc. Peripheral seal for a ventricular partitioning device
US9332992B2 (en) 2004-08-05 2016-05-10 Cardiokinetix, Inc. Method for making a laminar ventricular partitioning device
US20020022860A1 (en) * 2000-08-18 2002-02-21 Borillo Thomas E. Expandable implant devices for filtering blood flow from atrial appendages
US6582452B2 (en) 2000-09-08 2003-06-24 James Coleman Surgical stapler
US6626918B1 (en) 2000-10-06 2003-09-30 Medical Technology Group Apparatus and methods for positioning a vascular sheath
US7806904B2 (en) 2000-12-07 2010-10-05 Integrated Vascular Systems, Inc. Closure device
US8690910B2 (en) 2000-12-07 2014-04-08 Integrated Vascular Systems, Inc. Closure device and methods for making and using them
US7905900B2 (en) 2003-01-30 2011-03-15 Integrated Vascular Systems, Inc. Clip applier and methods of use
US6695867B2 (en) 2002-02-21 2004-02-24 Integrated Vascular Systems, Inc. Plunger apparatus and methods for delivering a closure device
US6623510B2 (en) 2000-12-07 2003-09-23 Integrated Vascular Systems, Inc. Closure device and methods for making and using them
US7211101B2 (en) 2000-12-07 2007-05-01 Abbott Vascular Devices Methods for manufacturing a clip and clip
AU2002241628A1 (en) * 2000-12-15 2002-06-24 Mitokor Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
US20020133227A1 (en) * 2001-02-28 2002-09-19 Gregory Murphy Ventricular restoration patch apparatus and method of use
US6702763B2 (en) * 2001-02-28 2004-03-09 Chase Medical, L.P. Sizing apparatus and method for use during ventricular restoration
US20090143808A1 (en) * 2001-04-24 2009-06-04 Houser Russell A Guided Tissue Cutting Device, Method of Use and Kits Therefor
US20080114394A1 (en) * 2001-04-24 2008-05-15 Houser Russell A Arteriotomy Closure Devices and Techniques
US8961541B2 (en) * 2007-12-03 2015-02-24 Cardio Vascular Technologies Inc. Vascular closure devices, systems, and methods of use
US8992567B1 (en) 2001-04-24 2015-03-31 Cardiovascular Technologies Inc. Compressible, deformable, or deflectable tissue closure devices and method of manufacture
JP4255286B2 (en) * 2001-05-17 2009-04-15 ウィルソン−クック メディカル インコーポレイテッド Intragastric device for treating obesity
IES20010547A2 (en) 2001-06-07 2002-12-11 Christy Cummins Surgical Staple
US6592594B2 (en) 2001-10-25 2003-07-15 Spiration, Inc. Bronchial obstruction device deployment system and method
US20050177180A1 (en) * 2001-11-28 2005-08-11 Aptus Endosystems, Inc. Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ
US20110087320A1 (en) * 2001-11-28 2011-04-14 Aptus Endosystems, Inc. Devices, Systems, and Methods for Prosthesis Delivery and Implantation, Including a Prosthesis Assembly
US9320503B2 (en) 2001-11-28 2016-04-26 Medtronic Vascular, Inc. Devices, system, and methods for guiding an operative tool into an interior body region
WO2003045283A1 (en) 2001-11-28 2003-06-05 Aptus Endosystems, Inc. Endovascular aneurysm repair system
US20070073389A1 (en) 2001-11-28 2007-03-29 Aptus Endosystems, Inc. Endovascular aneurysm devices, systems, and methods
US8231639B2 (en) 2001-11-28 2012-07-31 Aptus Endosystems, Inc. Systems and methods for attaching a prosthesis within a body lumen or hollow organ
US20090099650A1 (en) * 2001-11-28 2009-04-16 Lee Bolduc Devices, systems, and methods for endovascular staple and/or prosthesis delivery and implantation
CA2759746C (en) 2001-12-05 2018-05-22 Smt Research And Development Ltd. Endovascular device for entrapment of particulate matter and method for use
US9204956B2 (en) 2002-02-20 2015-12-08 C. R. Bard, Inc. IVC filter with translating hooks
US20030181922A1 (en) 2002-03-20 2003-09-25 Spiration, Inc. Removable anchored lung volume reduction devices and methods
WO2003101310A1 (en) 2002-06-04 2003-12-11 Christy Cummins Blood vessel closure clip and delivery device
US8425549B2 (en) * 2002-07-23 2013-04-23 Reverse Medical Corporation Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US8075585B2 (en) * 2002-08-29 2011-12-13 Stryker Corporation Device and method for treatment of a vascular defect
US8758398B2 (en) 2006-09-08 2014-06-24 Integrated Vascular Systems, Inc. Apparatus and method for delivering a closure element
US8398656B2 (en) 2003-01-30 2013-03-19 Integrated Vascular Systems, Inc. Clip applier and methods of use
US8821534B2 (en) 2010-12-06 2014-09-02 Integrated Vascular Systems, Inc. Clip applier having improved hemostasis and methods of use
US7857828B2 (en) * 2003-01-30 2010-12-28 Integrated Vascular Systems, Inc. Clip applier and methods of use
US8905937B2 (en) 2009-02-26 2014-12-09 Integrated Vascular Systems, Inc. Methods and apparatus for locating a surface of a body lumen
US8202293B2 (en) 2003-01-30 2012-06-19 Integrated Vascular Systems, Inc. Clip applier and methods of use
DE602004018282D1 (en) * 2003-03-17 2009-01-22 Ev3 Endovascular Inc STENT WITH LAMINATED THIN FILM LINKAGE
US7597704B2 (en) * 2003-04-28 2009-10-06 Atritech, Inc. Left atrial appendage occlusion device with active expansion
EP2191790A3 (en) * 2003-05-19 2012-10-17 SeptRx, Inc. Tissue distention device and related methods for therapeutic intervention
CA2532112C (en) 2003-07-14 2012-09-18 Nmt Medical, Inc. Tubular patent foramen ovale (pfo) closure device with catch system
US8480706B2 (en) 2003-07-14 2013-07-09 W.L. Gore & Associates, Inc. Tubular patent foramen ovale (PFO) closure device with catch system
US9861346B2 (en) 2003-07-14 2018-01-09 W. L. Gore & Associates, Inc. Patent foramen ovale (PFO) closure device with linearly elongating petals
US20050070953A1 (en) * 2003-09-18 2005-03-31 Riley James W. Medical device with flexible distal end loop and related methods of use
US20050192627A1 (en) * 2003-10-10 2005-09-01 Whisenant Brian K. Patent foramen ovale closure devices, delivery apparatus and related methods and systems
CA2542089A1 (en) * 2003-10-10 2005-04-21 Proximare, Inc. Patent foramen ovale (pfo) closure devices, delivery apparatus and related methods and systems
US7056286B2 (en) * 2003-11-12 2006-06-06 Adrian Ravenscroft Medical device anchor and delivery system
US20050177182A1 (en) 2003-12-04 2005-08-11 Van Der Burg Erik J. System and method for delivering a left atrial appendage containment device
US8080023B2 (en) 2003-12-12 2011-12-20 Vitalitec International, Inc. Device and method for performing multiple anastomoses
US20110208233A1 (en) * 2004-01-22 2011-08-25 Mcguckin Jr James F Device for preventing clot migration from left atrial appendage
US20050234540A1 (en) * 2004-03-12 2005-10-20 Nmt Medical, Inc. Dilatation systems and methods for left atrial appendage
US8398670B2 (en) 2004-03-19 2013-03-19 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US8747453B2 (en) 2008-02-18 2014-06-10 Aga Medical Corporation Stent/stent graft for reinforcement of vascular abnormalities and associated method
US8777974B2 (en) 2004-03-19 2014-07-15 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
US8313505B2 (en) 2004-03-19 2012-11-20 Aga Medical Corporation Device for occluding vascular defects
US9039724B2 (en) 2004-03-19 2015-05-26 Aga Medical Corporation Device for occluding vascular defects
US20050234543A1 (en) * 2004-03-30 2005-10-20 Nmt Medical, Inc. Plug for use in left atrial appendage
US8801746B1 (en) 2004-05-04 2014-08-12 Covidien Lp System and method for delivering a left atrial appendage containment device
CA2563298A1 (en) * 2004-05-07 2005-11-24 Nmt Medical, Inc. Catching mechanisms for tubular septal occluder
IES20040368A2 (en) 2004-05-25 2005-11-30 James E Coleman Surgical stapler
US8267985B2 (en) 2005-05-25 2012-09-18 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US8409219B2 (en) * 2004-06-18 2013-04-02 Medtronic, Inc. Method and system for placement of electrical lead inside heart
US7931578B2 (en) * 2004-06-18 2011-04-26 Ncontact Surgical, Inc. Methods and system for tissue cavity closure
US7704267B2 (en) 2004-08-04 2010-04-27 C. R. Bard, Inc. Non-entangling vena cava filter
US7794472B2 (en) * 2004-08-11 2010-09-14 Boston Scientific Scimed, Inc. Single wire intravascular filter
EP2468348B1 (en) * 2004-09-17 2016-10-26 Codman & Shurtleff, Inc. Thin film metallic devices for plugging aneurysms or vessels
EP1654991A1 (en) * 2004-11-08 2006-05-10 Inderbitzi, Rolf, Dr. med. Screw for vascular occlusion
US7794473B2 (en) 2004-11-12 2010-09-14 C.R. Bard, Inc. Filter delivery system
US9545300B2 (en) 2004-12-22 2017-01-17 W. L. Gore & Associates, Inc. Filament-wound implantable devices
US7674238B2 (en) * 2004-12-23 2010-03-09 Boston Scientific Scimed, Inc. Methods and apparatus for emboli removal
WO2006074159A2 (en) * 2005-01-03 2006-07-13 Tricardia, Llc Diffusion catheter
US20080147111A1 (en) * 2005-01-03 2008-06-19 Eric Johnson Endoluminal Filter With Fixation
WO2006074163A2 (en) * 2005-01-03 2006-07-13 Crux Biomedical, Inc. Retrievable endoluminal filter
US8267954B2 (en) * 2005-02-04 2012-09-18 C. R. Bard, Inc. Vascular filter with sensing capability
US8608797B2 (en) 2005-03-17 2013-12-17 Valtech Cardio Ltd. Mitral valve treatment techniques
US7935075B2 (en) * 2005-04-26 2011-05-03 Cardiac Pacemakers, Inc. Self-deploying vascular occlusion device
US7967838B2 (en) 2005-05-12 2011-06-28 C. R. Bard, Inc. Removable embolus blood clot filter
EP1883371B1 (en) 2005-05-25 2015-10-07 Covidien LP System and method for delivering and deploying and occluding device within a vessel
US8273101B2 (en) 2005-05-25 2012-09-25 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US8926633B2 (en) 2005-06-24 2015-01-06 Abbott Laboratories Apparatus and method for delivering a closure element
US8313497B2 (en) 2005-07-01 2012-11-20 Abbott Laboratories Clip applier and methods of use
US8951285B2 (en) 2005-07-05 2015-02-10 Mitralign, Inc. Tissue anchor, anchoring system and methods of using the same
US8029522B2 (en) * 2005-08-05 2011-10-04 Ethicon Endo-Surgery, Inc. Method and apparatus for sealing a gastric opening
US8062327B2 (en) 2005-08-09 2011-11-22 C. R. Bard, Inc. Embolus blood clot filter and delivery system
US20070060895A1 (en) 2005-08-24 2007-03-15 Sibbitt Wilmer L Jr Vascular closure methods and apparatuses
US9456811B2 (en) 2005-08-24 2016-10-04 Abbott Vascular Inc. Vascular closure methods and apparatuses
US8920442B2 (en) 2005-08-24 2014-12-30 Abbott Vascular Inc. Vascular opening edge eversion methods and apparatuses
WO2007028092A1 (en) 2005-09-01 2007-03-08 Cordis Corporation Patent foramen ovale closure method
US7811251B2 (en) * 2005-10-13 2010-10-12 Tyco Healthcare Group Lp Trocar anchor
US8545530B2 (en) * 2005-10-19 2013-10-01 Pulsar Vascular, Inc. Implantable aneurysm closure systems and methods
CN101466316B (en) 2005-10-20 2012-06-27 阿普特斯内系统公司 Devices systems and methods for prosthesis delivery and implantation including the use of a fastener tool
US20070112372A1 (en) * 2005-11-17 2007-05-17 Stephen Sosnowski Biodegradable vascular filter
JP2009519731A (en) 2005-11-18 2009-05-21 シー・アール・バード・インコーポレイテツド Vena cava filter with filament
US7691151B2 (en) 2006-03-31 2010-04-06 Spiration, Inc. Articulable Anchor
US8808310B2 (en) 2006-04-20 2014-08-19 Integrated Vascular Systems, Inc. Resettable clip applier and reset tools
WO2007133366A2 (en) 2006-05-02 2007-11-22 C. R. Bard, Inc. Vena cava filter formed from a sheet
WO2007131110A2 (en) 2006-05-03 2007-11-15 Raptor Ridge, Llc Systems and methods of tissue closure
CA2655158A1 (en) 2006-06-05 2007-12-13 C.R. Bard Inc. Embolus blood clot filter utilizable with a single delivery system or a single retrieval system in one of a femoral or jugular access
AU2007257785B2 (en) * 2006-06-09 2013-05-02 Cardinal Health 529, Llc Single disc occlusionary patent foramen ovale closure device
JP5269779B2 (en) * 2006-06-21 2013-08-21 クック・バイオテック・インコーポレーテッド Acupuncture grafts and related methods and systems useful for the treatment of gastrointestinal fistulas
US8556930B2 (en) 2006-06-28 2013-10-15 Abbott Laboratories Vessel closure device
CA2594239A1 (en) * 2006-08-02 2008-02-02 Tyco Healthcare Group Lp Stabilization assist device for trocar
DE102006050385A1 (en) * 2006-10-05 2008-04-10 pfm Produkte für die Medizin AG Implantable mechanism for use in human and/or animal body for e.g. closing atrium septum defect, has partial piece that is folded back on another partial piece from primary form into secondary form of carrying structure
EP1982655B2 (en) * 2007-04-16 2022-12-07 Occlutech Holding AG Occluder to seal an atrial appendage and method of manufacture thereof
WO2008063455A1 (en) 2006-11-13 2008-05-29 Hines Richard A Over-the wire exclusion device and system for delivery
US20080161825A1 (en) * 2006-11-20 2008-07-03 Stout Medical Group, L.P. Anatomical measurement tool
US9883943B2 (en) 2006-12-05 2018-02-06 Valtech Cardio, Ltd. Implantation of repair devices in the heart
EP2088965B1 (en) * 2006-12-05 2012-11-28 Valtech Cardio, Ltd. Segmented ring placement
WO2010004546A1 (en) 2008-06-16 2010-01-14 Valtech Cardio, Ltd. Annuloplasty devices and methods of delivery therefor
US11259924B2 (en) 2006-12-05 2022-03-01 Valtech Cardio Ltd. Implantation of repair devices in the heart
US8784469B2 (en) * 2011-06-30 2014-07-22 Ghassan S. Kassab Devices, systems, and methods for inverting and closing the left atrial appendage
US11660190B2 (en) 2007-03-13 2023-05-30 Edwards Lifesciences Corporation Tissue anchors, systems and methods, and devices
US9005242B2 (en) 2007-04-05 2015-04-14 W.L. Gore & Associates, Inc. Septal closure device with centering mechanism
WO2008150346A1 (en) * 2007-05-31 2008-12-11 Rex Medical, L.P. Closure device for left atrial appendage
CA2687777A1 (en) * 2007-05-31 2008-12-18 Rex Medical, L.P. Fallopian tube occlusion device
WO2008151204A1 (en) 2007-06-04 2008-12-11 Sequent Medical Inc. Methods and devices for treatment of vascular defects
US8226681B2 (en) 2007-06-25 2012-07-24 Abbott Laboratories Methods, devices, and apparatus for managing access through tissue
US8034061B2 (en) 2007-07-12 2011-10-11 Aga Medical Corporation Percutaneous catheter directed intravascular occlusion devices
US9744022B2 (en) * 2011-11-09 2017-08-29 BiO2 Medical, Inc. Detachment mechanism for a central venous access filter and method of use
WO2009052437A1 (en) * 2007-10-19 2009-04-23 Coherex Medical, Inc. Medical device for percutaneous paravalvular leak and related systems and methods
CA2707043A1 (en) * 2007-12-11 2009-06-18 Cornell University Method and apparatus for sealing an opening in the side wall of a body lumen
US8893947B2 (en) 2007-12-17 2014-11-25 Abbott Laboratories Clip applier and methods of use
US20090157101A1 (en) 2007-12-17 2009-06-18 Abbott Laboratories Tissue closure system and methods of use
US7841502B2 (en) 2007-12-18 2010-11-30 Abbott Laboratories Modular clip applier
US20090171386A1 (en) 2007-12-28 2009-07-02 Aga Medical Corporation Percutaneous catheter directed intravascular occlusion devices
EP2594230B1 (en) * 2008-02-29 2021-04-28 Edwards Lifesciences Corporation Expandable member for deploying a prosthetic device
US20130165967A1 (en) 2008-03-07 2013-06-27 W.L. Gore & Associates, Inc. Heart occlusion devices
US8382829B1 (en) 2008-03-10 2013-02-26 Mitralign, Inc. Method to reduce mitral regurgitation by cinching the commissure of the mitral valve
US20100256661A1 (en) * 2009-04-06 2010-10-07 Zeev Brandeis Apparatus and method for enabling perforating vein ablation
JP5610542B2 (en) 2008-04-21 2014-10-22 コヴィディエン リミテッド パートナーシップ Blade ball embolization device and delivery system
CA2722672C (en) * 2008-05-02 2019-10-22 Sequent Medical Inc. Filamentary devices for treatment of vascular defects
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US9282965B2 (en) 2008-05-16 2016-03-15 Abbott Laboratories Apparatus and methods for engaging tissue
CN102245129B (en) 2008-07-21 2015-03-18 詹妮弗·K·怀特 Repositionable endoluminal support structure and its applications
CN102137626A (en) * 2008-07-22 2011-07-27 微治疗公司 Vascular remodeling device
JP5967937B2 (en) * 2008-09-04 2016-08-10 コンテゴ エービー Temporary embolic protection device and medical procedure for its delivery
US10695126B2 (en) 2008-10-06 2020-06-30 Santa Anna Tech Llc Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue
CA2740867C (en) 2008-10-16 2018-06-12 Aptus Endosystems, Inc. Devices, systems, and methods for endovascular staple and/or prosthesis delivery and implantation
US8398676B2 (en) 2008-10-30 2013-03-19 Abbott Vascular Inc. Closure device
WO2010069562A1 (en) * 2008-12-17 2010-06-24 Abbott Laboratories Vascular Enterprises Limited Body lumen filters with large surface area anchors
US10517719B2 (en) 2008-12-22 2019-12-31 Valtech Cardio, Ltd. Implantation of repair devices in the heart
WO2010073246A2 (en) 2008-12-22 2010-07-01 Valtech Cardio, Ltd. Adjustable annuloplasty devices and adjustment mechanisms therefor
US8323312B2 (en) 2008-12-22 2012-12-04 Abbott Laboratories Closure device
US8926697B2 (en) 2011-06-23 2015-01-06 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
US8715342B2 (en) 2009-05-07 2014-05-06 Valtech Cardio, Ltd. Annuloplasty ring with intra-ring anchoring
US8940044B2 (en) 2011-06-23 2015-01-27 Valtech Cardio, Ltd. Closure element for use with an annuloplasty structure
US8911494B2 (en) 2009-05-04 2014-12-16 Valtech Cardio, Ltd. Deployment techniques for annuloplasty ring
US8858594B2 (en) 2008-12-22 2014-10-14 Abbott Laboratories Curved closure device
US9011530B2 (en) 2008-12-22 2015-04-21 Valtech Cardio, Ltd. Partially-adjustable annuloplasty structure
US8241351B2 (en) 2008-12-22 2012-08-14 Valtech Cardio, Ltd. Adjustable partial annuloplasty ring and mechanism therefor
WO2010081041A1 (en) 2009-01-08 2010-07-15 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US9173644B2 (en) 2009-01-09 2015-11-03 Abbott Vascular Inc. Closure devices, systems, and methods
US9414820B2 (en) 2009-01-09 2016-08-16 Abbott Vascular Inc. Closure devices, systems, and methods
US20100179589A1 (en) 2009-01-09 2010-07-15 Abbott Vascular Inc. Rapidly eroding anchor
US9486191B2 (en) 2009-01-09 2016-11-08 Abbott Vascular, Inc. Closure devices
US9089311B2 (en) 2009-01-09 2015-07-28 Abbott Vascular Inc. Vessel closure devices and methods
US20100185234A1 (en) 2009-01-16 2010-07-22 Abbott Vascular Inc. Closure devices, systems, and methods
JP5750051B2 (en) 2009-01-22 2015-07-15 コーネル ユニヴァーシティー Method and apparatus for restricting flow through a lumen wall
US8353956B2 (en) 2009-02-17 2013-01-15 Valtech Cardio, Ltd. Actively-engageable movement-restriction mechanism for use with an annuloplasty structure
WO2010118064A1 (en) * 2009-04-06 2010-10-14 O'donnell Michael J System and method for resecting a valve
NZ595417A (en) 2009-04-09 2013-10-25 Cardivascular Systems Tissue closure devices, device and systems for delivery, kits and methods therefor
US9968452B2 (en) 2009-05-04 2018-05-15 Valtech Cardio, Ltd. Annuloplasty ring delivery cathethers
US10631969B2 (en) 2009-06-17 2020-04-28 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US10064628B2 (en) 2009-06-17 2018-09-04 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
CA2958338C (en) 2009-06-17 2019-04-16 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US9636094B2 (en) 2009-06-22 2017-05-02 W. L. Gore & Associates, Inc. Sealing device and delivery system
US20120029556A1 (en) 2009-06-22 2012-02-02 Masters Steven J Sealing device and delivery system
EP3505136A1 (en) * 2009-07-29 2019-07-03 C.R. Bard Inc. Tubular filter
DE102009036818A1 (en) 2009-08-10 2011-02-17 Acoredis Gmbh Left atrial appendage occlusion instrument, has distal retention area possessing circular form of lip and changing strong taper in bar, where bar is movable such that distal retention area is bendable until nearly ninety degrees to cover
US20110054515A1 (en) 2009-08-25 2011-03-03 John Bridgeman Device and method for occluding the left atrial appendage
US20110054492A1 (en) 2009-08-26 2011-03-03 Abbott Laboratories Medical device for repairing a fistula
CA2775575C (en) * 2009-09-29 2018-01-02 Cardiokinetix, Inc. Devices and methods for delivering an endocardial device
US20110082495A1 (en) * 2009-10-02 2011-04-07 Ruiz Carlos E Apparatus And Methods For Excluding The Left Atrial Appendage
US9180007B2 (en) 2009-10-29 2015-11-10 Valtech Cardio, Ltd. Apparatus and method for guide-wire based advancement of an adjustable implant
US9011520B2 (en) 2009-10-29 2015-04-21 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
US10098737B2 (en) 2009-10-29 2018-10-16 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
WO2011056981A2 (en) * 2009-11-04 2011-05-12 Nitinol Devices And Components, Inc. Alternating circumferential bridge stent design and methods for use thereof
AU2010315106A1 (en) 2009-11-05 2012-05-17 Sequent Medical Inc. Multiple layer filamentary devices or treatment of vascular defects
JP5711251B2 (en) 2009-11-09 2015-04-30 コヴィディエン リミテッド パートナーシップ Features of braided ball embolizer
US9539081B2 (en) 2009-12-02 2017-01-10 Surefire Medical, Inc. Method of operating a microvalve protection device
US8696698B2 (en) 2009-12-02 2014-04-15 Surefire Medical, Inc. Microvalve protection device and method of use for protection against embolization agent reflux
US8500775B2 (en) * 2009-12-02 2013-08-06 Surefire Medical, Inc. Protection device and method against embolization agent reflux
WO2011067770A1 (en) 2009-12-02 2011-06-09 Valtech Cardio, Ltd. Delivery tool for implantation of spool assembly coupled to a helical anchor
US8870950B2 (en) 2009-12-08 2014-10-28 Mitral Tech Ltd. Rotation-based anchoring of an implant
WO2011094638A1 (en) * 2010-01-28 2011-08-04 Micro Therapeutics, Inc. Vascular remodeling device
WO2011094634A1 (en) * 2010-01-28 2011-08-04 Micro Therapeutics, Inc. Vascular remodeling device
US8795354B2 (en) 2010-03-05 2014-08-05 Edwards Lifesciences Corporation Low-profile heart valve and delivery system
US20110224785A1 (en) 2010-03-10 2011-09-15 Hacohen Gil Prosthetic mitral valve with tissue anchors
US20110224495A1 (en) * 2010-03-12 2011-09-15 Tyco Healthcare Group Lp Surgical access port
US8303624B2 (en) 2010-03-15 2012-11-06 Abbott Cardiovascular Systems, Inc. Bioabsorbable plug
CA2796267A1 (en) 2010-04-13 2011-10-20 Sentreheart, Inc. Methods and devices for treating atrial fibrillation
WO2011156714A2 (en) 2010-06-10 2011-12-15 Chambers Dr Jeffrey W Systems and methods for preventing formation of blood clots in the left atrium
US8828051B2 (en) 2010-07-02 2014-09-09 Pfm Medical Ag Left atrial appendage occlusion device
US9763657B2 (en) 2010-07-21 2017-09-19 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US11653910B2 (en) 2010-07-21 2023-05-23 Cardiovalve Ltd. Helical anchor implantation
US8758399B2 (en) 2010-08-02 2014-06-24 Abbott Cardiovascular Systems, Inc. Expandable bioabsorbable plug apparatus and method
US8603116B2 (en) 2010-08-04 2013-12-10 Abbott Cardiovascular Systems, Inc. Closure device with long tines
US8998947B2 (en) 2010-09-10 2015-04-07 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
ES2671891T3 (en) 2010-09-10 2018-06-11 Covidien Lp Devices for the treatment of vascular defects
WO2012047308A1 (en) * 2010-10-08 2012-04-12 Nitinol Devices And Components, Inc. Alternating circumferential bridge stent design and methods for use thereof
US9186152B2 (en) 2010-11-12 2015-11-17 W. L. Gore & Associates, Inc. Left atrial appendage occlusive devices
US9770319B2 (en) 2010-12-01 2017-09-26 Surefire Medical, Inc. Closed tip dynamic microvalve protection device
CA2825774C (en) 2011-02-11 2017-02-28 Frank P. Becking Two-stage deployment aneurysm embolization devices
US8617184B2 (en) 2011-02-15 2013-12-31 Abbott Cardiovascular Systems, Inc. Vessel closure system
CA2828960A1 (en) * 2011-03-02 2012-09-07 Joe Michael Eskridge Endovascular closure system
US9149276B2 (en) 2011-03-21 2015-10-06 Abbott Cardiovascular Systems, Inc. Clip and deployment apparatus for tissue closure
WO2012134990A1 (en) 2011-03-25 2012-10-04 Tyco Healthcare Group Lp Vascular remodeling device
EP2693981A4 (en) 2011-04-01 2015-07-01 Univ Cornell Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen
US10500033B2 (en) 2011-05-26 2019-12-10 Keystone Heart Ltd. Embolic filter device and method of use thereof
DE102011102955B4 (en) * 2011-05-31 2018-05-03 Acandis Gmbh & Co. Kg Medical implant for arranging a hollow body, in particular an aneurysm, and method for producing a medical implant
DE102011102933B4 (en) * 2011-05-31 2018-05-03 Acandis Gmbh & Co. Kg Medical implant for placement within a hollow body, in particular an aneurysm
US10245049B2 (en) * 2011-06-08 2019-04-02 Cvdevices, Llc Thrombus removal systems and devices and methods of using the same
US10117765B2 (en) 2011-06-14 2018-11-06 W.L. Gore Associates, Inc Apposition fiber for use in endoluminal deployment of expandable implants
US8764787B2 (en) 2011-06-17 2014-07-01 Aga Medical Corporation Occlusion device and associated deployment method
US8764793B2 (en) * 2011-06-17 2014-07-01 Northwestern University Left atrial appendage occluder
US9918840B2 (en) 2011-06-23 2018-03-20 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
US10792152B2 (en) 2011-06-23 2020-10-06 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
EP2731493B1 (en) 2011-07-11 2015-07-01 The Regents of The University of Michigan Multimodality left atrial appendage occlusion device
EP3417813B1 (en) 2011-08-05 2020-05-13 Cardiovalve Ltd Percutaneous mitral valve replacement
US8852272B2 (en) 2011-08-05 2014-10-07 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
WO2013021374A2 (en) 2011-08-05 2013-02-14 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US20140324164A1 (en) 2011-08-05 2014-10-30 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US9770232B2 (en) 2011-08-12 2017-09-26 W. L. Gore & Associates, Inc. Heart occlusion devices
EP2567663A1 (en) * 2011-09-09 2013-03-13 Occlutech Holding AG A collapsible medical closing device, a method and a medical system for delivering an object
US9089668B2 (en) 2011-09-28 2015-07-28 Surefire Medical, Inc. Flow directional infusion device
WO2013049448A1 (en) 2011-09-29 2013-04-04 Covidien Lp Vascular remodeling device
WO2013055703A1 (en) 2011-10-07 2013-04-18 Cornell University Method and apparatus for restricting flow through an opening in a body lumen while maintaining normal flow
US8858623B2 (en) 2011-11-04 2014-10-14 Valtech Cardio, Ltd. Implant having multiple rotational assemblies
EP3970627B1 (en) 2011-11-08 2023-12-20 Edwards Lifesciences Innovation (Israel) Ltd. Controlled steering functionality for implant-delivery tool
CN103917169B (en) 2011-11-09 2016-11-09 波士顿科学国际有限公司 Plugging device
US9877858B2 (en) 2011-11-14 2018-01-30 W. L. Gore & Associates, Inc. External steerable fiber for use in endoluminal deployment of expandable devices
US9782282B2 (en) 2011-11-14 2017-10-10 W. L. Gore & Associates, Inc. External steerable fiber for use in endoluminal deployment of expandable devices
US8758389B2 (en) 2011-11-18 2014-06-24 Aga Medical Corporation Devices and methods for occluding abnormal openings in a patient's vasculature
US9332976B2 (en) 2011-11-30 2016-05-10 Abbott Cardiovascular Systems, Inc. Tissue closure device
IN2014DN05897A (en) * 2012-01-06 2015-06-05 Inceptus Medical LLC
US10548706B2 (en) 2012-01-13 2020-02-04 Volcano Corporation Retrieval snare device and method
US10426501B2 (en) 2012-01-13 2019-10-01 Crux Biomedical, Inc. Retrieval snare device and method
JP6178339B2 (en) 2012-01-17 2017-08-09 スパイレーション インコーポレイテッド System and method for treating lung and tracheal sputum
US9592058B2 (en) 2012-02-21 2017-03-14 Cardia, Inc. Left atrial appendage occlusion device
US9554804B2 (en) 2012-02-21 2017-01-31 Cardia, Inc. Redeployable left atrial appendage occlusion device
US9089341B2 (en) 2012-02-28 2015-07-28 Surefire Medical, Inc. Renal nerve neuromodulation device
US10213288B2 (en) 2012-03-06 2019-02-26 Crux Biomedical, Inc. Distal protection filter
US9375308B2 (en) 2012-03-13 2016-06-28 W. L. Gore & Associates, Inc. External steerable fiber for use in endoluminal deployment of expandable devices
US9901707B2 (en) * 2012-05-23 2018-02-27 Integra Lifesciences Switzerland Sàrl Catheter curvature braces and methods of using same
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
EP2877104A4 (en) * 2012-07-26 2016-03-30 Univ Louisville Res Found Atrial appendage closure device and related methods
US20140046347A1 (en) * 2012-08-10 2014-02-13 W. L. Gore & Associates, Inc. Devices, systems and methods for engaging tissue
EP2900150B1 (en) 2012-09-29 2018-04-18 Mitralign, Inc. Plication lock delivery system
US20140100596A1 (en) 2012-10-09 2014-04-10 Boston Scientific Scimed, Inc. Centered balloon for the left atrial appendage
EP2908744B1 (en) * 2012-10-22 2018-08-22 The Cleveland Clinic Foundation Apparatus for targeting a body tissue
US9949828B2 (en) 2012-10-23 2018-04-24 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
WO2014064695A2 (en) 2012-10-23 2014-05-01 Valtech Cardio, Ltd. Percutaneous tissue anchor techniques
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
KR20150084959A (en) 2012-11-13 2015-07-22 코비디엔 엘피 Occlusive devices
US20140135817A1 (en) 2012-11-14 2014-05-15 Boston Scientific Scimed, Inc. Left atrial appendage closure implant
US9730793B2 (en) 2012-12-06 2017-08-15 Valtech Cardio, Ltd. Techniques for guide-wire based advancement of a tool
US9364209B2 (en) 2012-12-21 2016-06-14 Abbott Cardiovascular Systems, Inc. Articulating suturing device
CA2892261C (en) 2012-12-31 2017-11-07 Boston Scientific Scimed, Inc. Medical devices having fixation anchor
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
US10828019B2 (en) 2013-01-18 2020-11-10 W.L. Gore & Associates, Inc. Sealing device and delivery system
WO2014115149A2 (en) 2013-01-24 2014-07-31 Mitraltech Ltd. Ventricularly-anchored prosthetic valves
US9724084B2 (en) 2013-02-26 2017-08-08 Mitralign, Inc. Devices and methods for percutaneous tricuspid valve repair
US11399842B2 (en) 2013-03-13 2022-08-02 Conformal Medical, Inc. Devices and methods for excluding the left atrial appendage
US10617425B2 (en) 2014-03-10 2020-04-14 Conformal Medical, Inc. Devices and methods for excluding the left atrial appendage
CN105246540A (en) 2013-03-13 2016-01-13 阿龙·V·卡普兰 Devices and methods for excluding left atrial appendage
US10449333B2 (en) 2013-03-14 2019-10-22 Valtech Cardio, Ltd. Guidewire feeder
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
US8690907B1 (en) 2013-03-15 2014-04-08 Insera Therapeutics, Inc. Vascular treatment methods
CN105142545B (en) 2013-03-15 2018-04-06 柯惠有限合伙公司 Locking device
CN105283214B (en) 2013-03-15 2018-10-16 北京泰德制药股份有限公司 Translate conduit, system and its application method
EP3620203A1 (en) 2013-03-15 2020-03-11 Insera Therapeutics, Inc. Vascular treatment devices
US8715314B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment measurement methods
US8679150B1 (en) 2013-03-15 2014-03-25 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy methods
US10123805B2 (en) * 2013-06-26 2018-11-13 W. L. Gore & Associates, Inc. Space filling devices
US20150018860A1 (en) 2013-07-12 2015-01-15 Inceptus Medical, Llc Methods and apparatus for treating small vessel thromboembolisms
US9078658B2 (en) 2013-08-16 2015-07-14 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9955976B2 (en) 2013-08-16 2018-05-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US10070857B2 (en) 2013-08-31 2018-09-11 Mitralign, Inc. Devices and methods for locating and implanting tissue anchors at mitral valve commissure
GB2523291B (en) * 2013-10-16 2016-02-24 Cook Medical Technologies Llc Vascular occluder with crossing frame elements
WO2015059699A2 (en) 2013-10-23 2015-04-30 Valtech Cardio, Ltd. Anchor magazine
WO2015066549A1 (en) 2013-10-31 2015-05-07 Sentreheart, Inc. Devices and methods for left atrial appendage closure
US10485545B2 (en) 2013-11-19 2019-11-26 Datascope Corp. Fastener applicator with interlock
DE102013019890A1 (en) * 2013-11-28 2015-05-28 Bentley Innomed Gmbh Medical implant
US10350098B2 (en) 2013-12-20 2019-07-16 Volcano Corporation Devices and methods for controlled endoluminal filter deployment
US9610162B2 (en) 2013-12-26 2017-04-04 Valtech Cardio, Ltd. Implantation of flexible implant
US9724101B2 (en) * 2014-01-22 2017-08-08 Bandula Wijay Lumen occluding device, delivery catheter and method
US10258343B2 (en) * 2014-01-27 2019-04-16 Lifetech Scientific (Shenzhen) Co. Ltd. Left atrial appendage occluder
US9968740B2 (en) 2014-03-25 2018-05-15 Surefire Medical, Inc. Closed tip dynamic microvalve protection device
US9889031B1 (en) 2014-03-25 2018-02-13 Surefire Medical, Inc. Method of gastric artery embolization
US11154302B2 (en) 2014-03-31 2021-10-26 DePuy Synthes Products, Inc. Aneurysm occlusion device
US11076860B2 (en) 2014-03-31 2021-08-03 DePuy Synthes Products, Inc. Aneurysm occlusion device
HUE036701T2 (en) 2014-03-31 2018-07-30 Jitmed Sp Z O O Left atrial appendage occlusion device
US9629635B2 (en) 2014-04-14 2017-04-25 Sequent Medical, Inc. Devices for therapeutic vascular procedures
EP3134010B1 (en) * 2014-04-25 2020-04-22 Flow Medtech, LLC Left atrial appendage occlusion device
ES2905419T3 (en) 2014-04-30 2022-04-08 Cerus Endovascular Ltd occlusion device
US9808230B2 (en) 2014-06-06 2017-11-07 W. L. Gore & Associates, Inc. Sealing device and delivery system
US10524910B2 (en) 2014-07-30 2020-01-07 Mitraltech Ltd. 3 Ariel Sharon Avenue Articulatable prosthetic valve
US9381020B2 (en) * 2014-08-24 2016-07-05 Easy Notes Ltd. Pyloric obstruction device
WO2016044740A1 (en) 2014-09-19 2016-03-24 Flow Medtech, Inc. Left atrial appendage occlusion device delivery system
EP3206629B1 (en) 2014-10-14 2021-07-14 Valtech Cardio, Ltd. Apparatus for heart valve leaflet restraining
US9820844B2 (en) 2014-11-07 2017-11-21 Cook Medical Technologies Llc Double conical IVC filter
GB201511595D0 (en) * 2014-12-23 2015-08-19 Whiteley Mark Medical device for treating a vein
CA3162308A1 (en) 2015-02-05 2016-08-11 Cardiovalve Ltd. Prosthetic valve with axially-sliding frames
US9974651B2 (en) 2015-02-05 2018-05-22 Mitral Tech Ltd. Prosthetic valve with axially-sliding frames
US20160256269A1 (en) 2015-03-05 2016-09-08 Mitralign, Inc. Devices for treating paravalvular leakage and methods use thereof
US9375333B1 (en) 2015-03-06 2016-06-28 Covidien Lp Implantable device detachment systems and associated devices and methods
DE102015104785A1 (en) * 2015-03-27 2016-09-29 Pfm Medical Ag Device for closing a cardiac ear
US20160287839A1 (en) 2015-03-31 2016-10-06 Surefire Medical, Inc. Apparatus and Method for Infusing an Immunotherapy Agent to a Solid Tumor for Treatment
US9526891B2 (en) 2015-04-24 2016-12-27 Medtronic, Inc. Intracardiac medical device
CA2982063A1 (en) 2015-04-30 2016-11-03 Valtech Cardio, Ltd. Annuloplasty technologies
CN104970900B (en) * 2015-06-26 2017-10-17 深圳市科奕顿生物医疗科技有限公司 Recyclable thrombus filter
EP3322353B1 (en) * 2015-07-13 2023-01-11 Marvel Medical Technologies LLC Device for left atrial appendage closure
US10548579B2 (en) 2015-07-29 2020-02-04 Cardiac Pacemakers, Inc. Left atrial appendage implant
US20170035433A1 (en) 2015-08-06 2017-02-09 Thomas J. Forbes Left atrial appendage occluder device anchoring system, anchor, and method of attachment
US10898202B2 (en) * 2015-08-25 2021-01-26 University Of Louisville Research Foundation, Inc. Atrial appendage closure device and related methods
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
US10492936B2 (en) 2015-10-30 2019-12-03 Ram Medical Innovations, Llc Apparatus and method for improved access of procedural catheter in tortuous vessels
JP6892188B2 (en) 2015-12-07 2021-06-23 シーラス エンドバスキュラー リミテッド Blocking device
CN105361974B (en) * 2015-12-14 2018-09-21 广东脉搏医疗科技有限公司 A kind of thrombus filter
CN106901792B (en) * 2015-12-29 2019-11-01 深圳市科奕顿生物医疗科技有限公司 Occluder for left auricle
US10751182B2 (en) 2015-12-30 2020-08-25 Edwards Lifesciences Corporation System and method for reshaping right heart
WO2017117370A2 (en) 2015-12-30 2017-07-06 Mitralign, Inc. System and method for reducing tricuspid regurgitation
CN105520765A (en) * 2016-01-29 2016-04-27 上海形状记忆合金材料有限公司 Recessed left aurcle plugging device
CN108697423A (en) 2016-02-16 2018-10-23 伊瑟拉医疗公司 The part flow arrangement of suction unit and anchoring
US10531866B2 (en) 2016-02-16 2020-01-14 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
US10327809B2 (en) 2016-02-29 2019-06-25 Covidien Lp Clip collar advanced fixation
CN109069220B (en) 2016-03-11 2021-05-25 Cerus血管内设备有限公司 Plugging device
US11331140B2 (en) 2016-05-19 2022-05-17 Aqua Heart, Inc. Heated vapor ablation systems and methods for treating cardiac conditions
US10702274B2 (en) 2016-05-26 2020-07-07 Edwards Lifesciences Corporation Method and system for closing left atrial appendage
US10173031B2 (en) 2016-06-20 2019-01-08 Mubin I. Syed Interchangeable flush/selective catheter
GB201611910D0 (en) 2016-07-08 2016-08-24 Valtech Cardio Ltd Adjustable annuloplasty device with alternating peaks and troughs
US10478195B2 (en) 2016-08-04 2019-11-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
USD800908S1 (en) 2016-08-10 2017-10-24 Mitraltech Ltd. Prosthetic valve element
US10856975B2 (en) 2016-08-10 2020-12-08 Cardiovalve Ltd. Prosthetic valve with concentric frames
US10780250B1 (en) 2016-09-19 2020-09-22 Surefire Medical, Inc. System and method for selective pressure-controlled therapeutic delivery
US11400263B1 (en) 2016-09-19 2022-08-02 Trisalus Life Sciences, Inc. System and method for selective pressure-controlled therapeutic delivery
CN106333725A (en) * 2016-09-27 2017-01-18 张雯 Left aurcle plugging device and left aurcle plugging apparatus
CN106344100B (en) * 2016-10-11 2019-04-19 北京工业大学 Occluder for left auricle
US9994980B2 (en) 2016-10-14 2018-06-12 Inceptus Medical, Llc Braiding machine and methods of use
WO2018081466A2 (en) 2016-10-27 2018-05-03 Conformal Medical, Inc. Devices and methods for excluding the left atrial appendage
US11426172B2 (en) 2016-10-27 2022-08-30 Conformal Medical, Inc. Devices and methods for excluding the left atrial appendage
US10583301B2 (en) 2016-11-08 2020-03-10 Cardiac Pacemakers, Inc. Implantable medical device for atrial deployment
CN108272538B (en) * 2016-12-30 2020-06-12 先健科技(深圳)有限公司 Elastic implant for lung volume reduction and lung volume reduction instrument
KR20190115474A (en) 2017-02-23 2019-10-11 디퍼이 신테스 프로덕츠, 인코포레이티드 Aneurysm device and delivery system
EP3554391A4 (en) 2017-02-24 2020-09-16 Inceptus Medical LLC Vascular occlusion devices and methods
US10588636B2 (en) 2017-03-20 2020-03-17 Surefire Medical, Inc. Dynamic reconfigurable microvalve protection device
US10898330B2 (en) 2017-03-28 2021-01-26 Edwards Lifesciences Corporation Positioning, deploying, and retrieving implantable devices
US11045627B2 (en) 2017-04-18 2021-06-29 Edwards Lifesciences Corporation Catheter system with linear actuation control mechanism
WO2018218210A1 (en) * 2017-05-25 2018-11-29 Microvention, Inc. Adhesive occlusion systems
US10441258B2 (en) 2017-06-16 2019-10-15 Cardia, Inc. Uncoupled LAA device
US9848906B1 (en) 2017-06-20 2017-12-26 Joe Michael Eskridge Stent retriever having an expandable fragment guard
JP2020527440A (en) * 2017-07-10 2020-09-10 モーリス ブッフビンダー Left atrial appendage obstruction method and obstruction device
US11793633B2 (en) 2017-08-03 2023-10-24 Cardiovalve Ltd. Prosthetic heart valve
US10537426B2 (en) 2017-08-03 2020-01-21 Cardiovalve Ltd. Prosthetic heart valve
US10888421B2 (en) 2017-09-19 2021-01-12 Cardiovalve Ltd. Prosthetic heart valve with pouch
US11246704B2 (en) 2017-08-03 2022-02-15 Cardiovalve Ltd. Prosthetic heart valve
US10575948B2 (en) 2017-08-03 2020-03-03 Cardiovalve Ltd. Prosthetic heart valve
IL301895B1 (en) 2017-08-21 2024-01-01 Cerus Endovascular Ltd Occlusion device
US10675036B2 (en) 2017-08-22 2020-06-09 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
EP3459469A1 (en) 2017-09-23 2019-03-27 Universität Zürich Medical occluder device
CN107595347B (en) * 2017-09-25 2019-11-26 潘湘斌 A kind of the left atrial appendage occlusion device assembly and its interventional method of repeatable folding and unfolding
US11885051B2 (en) 2017-10-14 2024-01-30 Inceptus Medical, Llc Braiding machine and methods of use
WO2019084358A1 (en) 2017-10-27 2019-05-02 Boston Scientific Scimed, Inc. Occlusive medical device with cushioning member
US10835221B2 (en) 2017-11-02 2020-11-17 Valtech Cardio, Ltd. Implant-cinching devices and systems
CN111970980A (en) 2017-11-17 2020-11-20 叙尔科尔公司 Systems and methods for left atrial appendage closure
US11135062B2 (en) 2017-11-20 2021-10-05 Valtech Cardio Ltd. Cinching of dilated heart muscle
GB201720803D0 (en) 2017-12-13 2018-01-24 Mitraltech Ltd Prosthetic Valve and delivery tool therefor
GB201800399D0 (en) 2018-01-10 2018-02-21 Mitraltech Ltd Temperature-control during crimping of an implant
NL2022427B1 (en) * 2018-01-22 2019-11-07 Jemp Holding Bv Direct capture using large bead chromatography media.
US10905430B2 (en) 2018-01-24 2021-02-02 DePuy Synthes Products, Inc. Aneurysm device and delivery system
CA3086884A1 (en) 2018-01-24 2019-08-01 Valtech Cardio, Ltd. Contraction of an annuloplasty structure
EP4248904A3 (en) 2018-01-26 2023-11-29 Edwards Lifesciences Innovation (Israel) Ltd. Techniques for facilitating heart valve tethering and chord replacement
US11191547B2 (en) 2018-01-26 2021-12-07 Syntheon 2.0, LLC Left atrial appendage clipping device and methods for clipping the LAA
WO2019161072A1 (en) 2018-02-14 2019-08-22 Boston Scientific Scimed, Inc. Occlusive medical device
US10857014B2 (en) 2018-02-18 2020-12-08 Ram Medical Innovations, Llc Modified fixed flat wire bifurcated catheter and its application in lower extremity interventions
WO2019190998A1 (en) 2018-03-26 2019-10-03 Tc1 Llc Methods and systems for irrigating and capturing particulates during heart pump implantation
CN112074240A (en) 2018-03-28 2020-12-11 数据显示器公司 Auricle removing device
US11331103B2 (en) 2018-03-29 2022-05-17 Boston Scientific Scimed, Inc. Occlusive medical device with fixation members
US20190307438A1 (en) * 2018-04-10 2019-10-10 TAVR Solutions, LLC Catheter atrial septal closure device
US11058430B2 (en) 2018-05-25 2021-07-13 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11596412B2 (en) 2018-05-25 2023-03-07 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US10939915B2 (en) 2018-05-31 2021-03-09 DePuy Synthes Products, Inc. Aneurysm device and delivery system
WO2020014321A1 (en) 2018-07-11 2020-01-16 Boston Scientific Scimed, Inc. Motorized telescoping medical device delivery system with mechanical bailout feature
CA3106104A1 (en) 2018-07-12 2020-01-16 Valtech Cardio, Ltd. Annuloplasty systems and locking tools therefor
US11850398B2 (en) 2018-08-01 2023-12-26 Trisalus Life Sciences, Inc. Systems and methods for pressure-facilitated therapeutic agent delivery
US11051825B2 (en) 2018-08-08 2021-07-06 DePuy Synthes Products, Inc. Delivery system for embolic braid
WO2020056058A1 (en) 2018-09-13 2020-03-19 Ozgur Kocaturk Devices and methods for closing openings in tissue structures
US11123077B2 (en) 2018-09-25 2021-09-21 DePuy Synthes Products, Inc. Intrasaccular device positioning and deployment system
US11338117B2 (en) 2018-10-08 2022-05-24 Trisalus Life Sciences, Inc. Implantable dual pathway therapeutic agent delivery port
US11076861B2 (en) 2018-10-12 2021-08-03 DePuy Synthes Products, Inc. Folded aneurysm treatment device and delivery method
CN109350227A (en) * 2018-12-04 2019-02-19 武汉唯柯医疗科技有限公司 Implantable atrial septum ostomy appliance
US20200178981A1 (en) * 2018-12-10 2020-06-11 Boston Scientific Scimed, Inc. Left atrial appendage implant with sealing balloon
US11406392B2 (en) 2018-12-12 2022-08-09 DePuy Synthes Products, Inc. Aneurysm occluding device for use with coagulating agents
CN111388043A (en) 2018-12-17 2020-07-10 柯惠有限合伙公司 Occlusion device
US11272939B2 (en) 2018-12-18 2022-03-15 DePuy Synthes Products, Inc. Intrasaccular flow diverter for treating cerebral aneurysms
DE102019100531B4 (en) 2019-01-10 2021-08-19 Qatna Medical GmbH Occluder delivery system and delivery unit
US20200222172A1 (en) * 2019-01-11 2020-07-16 Varun Shetty Method and system for reducing pulmonary flow
US11134953B2 (en) 2019-02-06 2021-10-05 DePuy Synthes Products, Inc. Adhesive cover occluding device for aneurysm treatment
CN113710171A (en) 2019-02-08 2021-11-26 保形医疗公司 Device and method for removing left atrial appendage
CN113556985A (en) 2019-03-15 2021-10-26 后续医疗股份有限公司 Silk device for treating vascular defects
US11317921B2 (en) 2019-03-15 2022-05-03 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US11291453B2 (en) 2019-03-15 2022-04-05 Sequent Medical, Inc. Filamentary devices having a flexible joint for treatment of vascular defects
JP2022521835A (en) 2019-03-25 2022-04-12 ラミナー インコーポレイテッド Devices and systems for treating the left atrial appendage
US11337706B2 (en) 2019-03-27 2022-05-24 DePuy Synthes Products, Inc. Aneurysm treatment device
CN110522486B (en) * 2019-04-22 2021-04-09 上海佐心医疗科技有限公司 Plugging bracket for left auricle
US10925615B2 (en) 2019-05-03 2021-02-23 Syntheon 2.0, LLC Recapturable left atrial appendage clipping device and methods for recapturing a left atrial appendage clip
US10653425B1 (en) 2019-05-21 2020-05-19 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11607226B2 (en) 2019-05-21 2023-03-21 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device with corrugations
US11602350B2 (en) 2019-12-05 2023-03-14 DePuy Synthes Products, Inc. Intrasaccular inverting braid with highly flexible fill material
US11497504B2 (en) 2019-05-21 2022-11-15 DePuy Synthes Products, Inc. Aneurysm treatment with pushable implanted braid
US11413046B2 (en) 2019-05-21 2022-08-16 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11672542B2 (en) 2019-05-21 2023-06-13 DePuy Synthes Products, Inc. Aneurysm treatment with pushable ball segment
US11278292B2 (en) 2019-05-21 2022-03-22 DePuy Synthes Products, Inc. Inverting braided aneurysm treatment system and method
WO2021058555A1 (en) 2019-09-23 2021-04-01 Biotronik Se & Co. Kg A system for holding an active implant in an atrial appendage of a heart and methods for implanting an active implant
US20220370079A1 (en) 2019-09-26 2022-11-24 Universität Zürich Left atrial appendage occlusion devices
US11419611B2 (en) * 2019-10-24 2022-08-23 Virender K. Sharma Left atrial appendage closure device and method
AU2020375903A1 (en) 2019-10-29 2021-12-23 Edwards Lifesciences Innovation (Israel) Ltd. Annuloplasty and tissue anchor technologies
US11498165B2 (en) 2019-11-04 2022-11-15 Covidien Lp Systems and methods for treating aneurysms
CN114786594A (en) * 2019-12-18 2022-07-22 波士顿科学国际有限公司 Left atrial appendage closure device with anticoagulant covering
US11457926B2 (en) 2019-12-18 2022-10-04 DePuy Synthes Products, Inc. Implant having an intrasaccular section and intravascular section
US11406404B2 (en) 2020-02-20 2022-08-09 Cerus Endovascular Limited Clot removal distal protection methods
EP4161408A1 (en) * 2020-06-04 2023-04-12 Clearstream Technologies Limited Flow restrictor for an embolization device
JP2023545121A (en) * 2020-10-12 2023-10-26 テルモ株式会社 Pulmonary embolus removal system
CN116685288A (en) * 2020-12-18 2023-09-01 波士顿科学医学有限公司 Occlusive medical device with sensing capability
CN117642192A (en) 2021-07-09 2024-03-01 波士顿科学医学有限公司 Direct oral anticoagulant eluting medical device
US20230048873A1 (en) * 2021-08-13 2023-02-16 Boston Scientific Scimed, Inc. Left Atrial Appendage Implant with Distal Engagement Element

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306234A (en) 1993-03-23 1994-04-26 Johnson W Dudley Method for closing an atrial appendage
US5865791A (en) 1995-06-07 1999-02-02 E.P. Technologies Inc. Atrial appendage stasis reduction procedure and devices
WO1999005977A1 (en) * 1997-08-04 1999-02-11 Boston Scientific Corporation Occlusion system for aneurysm repair
WO1999007294A1 (en) * 1997-08-05 1999-02-18 Boston Scientific, Limited Detachable aneurysm neck bridge (ii)
WO1999030640A1 (en) * 1997-12-15 1999-06-24 Boston Scientific Limited Sheet metal aneurysm neck bridge
WO2000027292A1 (en) * 1998-11-06 2000-05-18 Appriva Medical, Inc. Method and device for left atrial appendage occlusion

Family Cites Families (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US178283A (en) 1876-06-06 Improvement in vaginal syringes
US1967318A (en) 1931-10-02 1934-07-24 Monahan William Apparatus for the treatment of the urethra
US2753231A (en) * 1952-06-26 1956-07-03 Daimler Benz Ag Reciprocating internal combustion engine and pistons
US3540431A (en) * 1968-04-04 1970-11-17 Kazi Mobin Uddin Collapsible filter for fluid flowing in closed passageway
US3670725A (en) 1969-06-30 1972-06-20 Medical Specialties Inc Protective pad
US3844302A (en) 1970-09-14 1974-10-29 Telesco Brophey Ltd Collapsible umbrella
US3874388A (en) 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
US4007743A (en) 1975-10-20 1977-02-15 American Hospital Supply Corporation Opening mechanism for umbrella-like intravascular shunt defect closure device
US4603693A (en) 1977-05-26 1986-08-05 United States Surgical Corporation Instrument for circular surgical stapling of hollow body organs and disposable cartridge therefor
US4341218A (en) 1978-05-30 1982-07-27 University Of California Detachable balloon catheter
DK147035C (en) 1980-12-05 1984-09-03 Coloplast As Skin Barrier
US4718830A (en) * 1982-09-30 1988-01-12 White Consolidated Industries, Inc. Bearing construction for refrigeration compresssor
US4585000A (en) 1983-09-28 1986-04-29 Cordis Corporation Expandable device for treating intravascular stenosis
US4665906A (en) 1983-10-14 1987-05-19 Raychem Corporation Medical devices incorporating sim alloy elements
JPS6249841A (en) * 1985-08-30 1987-03-04 オリンパス光学工業株式会社 Thrombosis removing jig
US4710192A (en) 1985-12-30 1987-12-01 Liotta Domingo S Diaphragm and method for occlusion of the descending thoracic aorta
US5091171B2 (en) 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
SU1711906A1 (en) * 1988-01-11 1992-02-15 2-й Московский государственный медицинский институт им.Н.И.Пирогова Intravenous filter and device for its implantation
AU613636B2 (en) 1988-01-12 1991-08-08 Kievsky Nauchno-Issledovatelsky Institut Neirokhirurgii Occluding device
US6120437A (en) 1988-07-22 2000-09-19 Inbae Yoon Methods for creating spaces at obstructed sites endoscopically and methods therefor
US4921484A (en) 1988-07-25 1990-05-01 Cordis Corporation Mesh balloon catheter device
US4917089A (en) 1988-08-29 1990-04-17 Sideris Eleftherios B Buttoned device for the transvenous occlusion of intracardiac defects
FR2641692A1 (en) 1989-01-17 1990-07-20 Nippon Zeon Co Plug for closing an opening for a medical application, and device for the closure plug making use thereof
DE8904371U1 (en) 1989-04-07 1989-06-08 Herzberg, Wolfgang, Dr. Med., 2000 Wedel, De
NL8901350A (en) 1989-05-29 1990-12-17 Wouter Matthijs Muijs Van De M CLOSURE ASSEMBLY.
US5421832A (en) 1989-12-13 1995-06-06 Lefebvre; Jean-Marie Filter-catheter and method of manufacturing same
US5041093A (en) 1990-01-31 1991-08-20 Boston Scientific Corp. Catheter with foraminous anchor
WO1991015155A1 (en) 1990-04-02 1991-10-17 Kanji Inoue Device for closing shunt opening by nonoperative method
US5078736A (en) 1990-05-04 1992-01-07 Interventional Thermodynamics, Inc. Method and apparatus for maintaining patency in the body passages
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
GB9021910D0 (en) 1990-10-09 1990-11-21 Smith & Nephew Wound dressing
US5042707A (en) 1990-10-16 1991-08-27 Taheri Syde A Intravascular stapler, and method of operating same
US5108420A (en) 1991-02-01 1992-04-28 Temple University Aperture occlusion device
SE467948B (en) 1991-06-14 1992-10-12 Ams Medinvent Sa DEVICE FOR TRANSLUMINAL REMOVAL OR IMPLANTATION OF A STENT AND APPARATUS INCLUDING A SOUND DEVICE
US5735290A (en) 1993-02-22 1998-04-07 Heartport, Inc. Methods and systems for performing thoracoscopic coronary bypass and other procedures
CA2078530A1 (en) 1991-09-23 1993-03-24 Jay Erlebacher Percutaneous arterial puncture seal device and insertion tool therefore
US5256146A (en) 1991-10-11 1993-10-26 W. D. Ensminger Vascular catheterization system with catheter anchoring feature
EP0545091B1 (en) 1991-11-05 1999-07-07 The Children's Medical Center Corporation Occluder for repair of cardiac and vascular defects
EP0541063B1 (en) 1991-11-05 1998-09-02 The Children's Medical Center Corporation Improved occluder for repair of cardiac and vascular defects
US5282827A (en) 1991-11-08 1994-02-01 Kensey Nash Corporation Hemostatic puncture closure system and method of use
US5176692A (en) 1991-12-09 1993-01-05 Wilk Peter J Method and surgical instrument for repairing hernia
US5258042A (en) 1991-12-16 1993-11-02 Henry Ford Health System Intravascular hydrogel implant
US5626605A (en) 1991-12-30 1997-05-06 Scimed Life Systems, Inc. Thrombosis filter
ES2133382T3 (en) 1992-01-21 1999-09-16 Univ Minnesota DEVICE FOR THE CLOSURE OF SEPTAL DEFECTS.
FR2689388B1 (en) 1992-04-07 1999-07-16 Celsa Lg PERFECTIONALLY RESORBABLE BLOOD FILTER.
US5707362A (en) 1992-04-15 1998-01-13 Yoon; Inbae Penetrating instrument having an expandable anchoring portion for triggering protrusion of a safety member and/or retraction of a penetrating member
US5637097A (en) 1992-04-15 1997-06-10 Yoon; Inbae Penetrating instrument having an expandable anchoring portion
US5766246A (en) 1992-05-20 1998-06-16 C. R. Bard, Inc. Implantable prosthesis and method and apparatus for loading and delivering an implantable prothesis
US5469867A (en) 1992-09-02 1995-11-28 Landec Corporation Cast-in place thermoplastic channel occluder
US5527338A (en) 1992-09-02 1996-06-18 Board Of Regents, The University Of Texas System Intravascular device
FR2696092B1 (en) 1992-09-28 1994-12-30 Lefebvre Jean Marie Kit for medical use composed of a filter and its device for placement in the vessel.
US5382259A (en) 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5643317A (en) 1992-11-25 1997-07-01 William Cook Europe S.A. Closure prosthesis for transcatheter placement
US5443454A (en) 1992-12-09 1995-08-22 Terumo Kabushiki Kaisha Catheter for embolectomy
US5417699A (en) 1992-12-10 1995-05-23 Perclose Incorporated Device and method for the percutaneous suturing of a vascular puncture site
US5284488A (en) 1992-12-23 1994-02-08 Sideris Eleftherios B Adjustable devices for the occlusion of cardiac defects
US5797960A (en) 1993-02-22 1998-08-25 Stevens; John H. Method and apparatus for thoracoscopic intracardiac procedures
US6161543A (en) 1993-02-22 2000-12-19 Epicor, Inc. Methods of epicardial ablation for creating a lesion around the pulmonary veins
US5353784A (en) 1993-04-02 1994-10-11 The Research Foundation Of Suny Endoscopic device and method of use
JPH07405A (en) * 1993-06-14 1995-01-06 Toshio Saeki Thrombus migration preventing filter
US5527322A (en) 1993-11-08 1996-06-18 Perclose, Inc. Device and method for suturing of internal puncture sites
US5490856A (en) 1993-12-14 1996-02-13 Untied States Surgical Corporation Purse string stapler
US5591196A (en) 1994-02-10 1997-01-07 Endovascular Systems, Inc. Method for deployment of radially expandable stents
US5634942A (en) 1994-04-21 1997-06-03 B. Braun Celsa Assembly comprising a blood filter for temporary or definitive use and a device for implanting it
US5732872A (en) 1994-06-17 1998-03-31 Heartport, Inc. Surgical stapling instrument
US5522836A (en) 1994-06-27 1996-06-04 Target Therapeutics, Inc. Electrolytically severable coil assembly with movable detachment point
US5846261A (en) 1994-07-08 1998-12-08 Aga Medical Corp. Percutaneous catheter directed occlusion devices
US5725552A (en) 1994-07-08 1998-03-10 Aga Medical Corporation Percutaneous catheter directed intravascular occlusion devices
US5433727A (en) 1994-08-16 1995-07-18 Sideris; Eleftherios B. Centering buttoned device for the occlusion of large defects for occluding
US5499571A (en) * 1994-08-29 1996-03-19 Tecumseh Products Company Wrist pin - piston assembly
US5690671A (en) 1994-12-13 1997-11-25 Micro Interventional Systems, Inc. Embolic elements and methods and apparatus for their delivery
US5879366A (en) 1996-12-20 1999-03-09 W.L. Gore & Associates, Inc. Self-expanding defect closure device and method of making and using
US5643292A (en) 1995-01-10 1997-07-01 Applied Medical Resources Corporation Percutaneous suturing device
US5702421A (en) 1995-01-11 1997-12-30 Schneidt; Bernhard Closure device for closing a vascular opening, such as patent ductus arteriosus
US5614204A (en) 1995-01-23 1997-03-25 The Regents Of The University Of California Angiographic vascular occlusion agents and a method for hemostatic occlusion
US5634936A (en) 1995-02-06 1997-06-03 Scimed Life Systems, Inc. Device for closing a septal defect
JPH08257031A (en) * 1995-03-24 1996-10-08 Toshio Saeki Filter
US5849005A (en) 1995-06-07 1998-12-15 Heartport, Inc. Method and apparatus for minimizing the risk of air embolism when performing a procedure in a patient's thoracic cavity
US5645558A (en) 1995-04-20 1997-07-08 Medical University Of South Carolina Anatomically shaped vasoocclusive device and method of making the same
US5681347A (en) 1995-05-23 1997-10-28 Boston Scientific Corporation Vena cava filter delivery system
US5709224A (en) 1995-06-07 1998-01-20 Radiotherapeutics Corporation Method and device for permanent vessel occlusion
US5725568A (en) 1995-06-27 1998-03-10 Scimed Life Systems, Inc. Method and device for recanalizing and grafting arteries
US5749883A (en) 1995-08-30 1998-05-12 Halpern; David Marcos Medical instrument
EP0861049B1 (en) 1995-10-30 2001-04-11 Children's Medical Center Corporation Self-centering umbrella-type septal closure device
US5769816A (en) 1995-11-07 1998-06-23 Embol-X, Inc. Cannula with associated filter
US5989281A (en) 1995-11-07 1999-11-23 Embol-X, Inc. Cannula with associated filter and methods of use during cardiac surgery
EP0950385A3 (en) 1995-12-14 1999-10-27 Prograft Medical, Inc. Stent-graft deployment apparatus and method
US5749894A (en) 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
NL1002423C2 (en) 1996-02-22 1997-08-25 Cordis Europ Temporary filter catheter.
US5885258A (en) 1996-02-23 1999-03-23 Memory Medical Systems, Inc. Medical instrument with slotted memory metal tube
US5733294A (en) 1996-02-28 1998-03-31 B. Braun Medical, Inc. Self expanding cardiovascular occlusion device, method of using and method of making the same
US6139527A (en) 1996-03-05 2000-10-31 Vnus Medical Technologies, Inc. Method and apparatus for treating hemorrhoids
US5853422A (en) 1996-03-22 1998-12-29 Scimed Life Systems, Inc. Apparatus and method for closing a septal defect
US5906207A (en) 1996-04-04 1999-05-25 Merck & Co., Inc. Method for simulating heart failure
AR001590A1 (en) 1996-04-10 1997-11-26 Jorge Alberto Baccaro Abnormal vascular communications occluder device and applicator cartridge of said device
WO1997041778A1 (en) 1996-05-08 1997-11-13 Salviac Limited An occluder device
US6048331A (en) 1996-05-14 2000-04-11 Embol-X, Inc. Cardioplegia occluder
US5830228A (en) 1996-05-29 1998-11-03 Urosurge, Inc. Methods and systems for deployment of a detachable balloon at a target site in vivo
GB9614950D0 (en) 1996-07-16 1996-09-04 Anson Medical Ltd A ductus stent and delivery catheter
US5669933A (en) 1996-07-17 1997-09-23 Nitinol Medical Technologies, Inc. Removable embolus blood clot filter
US5662671A (en) 1996-07-17 1997-09-02 Embol-X, Inc. Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries
US5823198A (en) 1996-07-31 1998-10-20 Micro Therapeutics, Inc. Method and apparatus for intravasculer embolization
US5941249A (en) 1996-09-05 1999-08-24 Maynard; Ronald S. Distributed activator for a two-dimensional shape memory alloy
WO1998023322A1 (en) 1996-11-27 1998-06-04 Boston Scientific Corporation Atraumatic anchoring and disengagement mechanism for permanent implant device
US5876367A (en) 1996-12-05 1999-03-02 Embol-X, Inc. Cerebral protection during carotid endarterectomy and downstream vascular protection during other surgeries
US5776097A (en) 1996-12-19 1998-07-07 University Of California At Los Angeles Method and device for treating intracranial vascular aneurysms
US5951589A (en) 1997-02-11 1999-09-14 Biointerventional Corporation Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method
US5782860A (en) 1997-02-11 1998-07-21 Biointerventional Corporation Closure device for percutaneous occlusion of puncture sites and tracts in the human body and method
US5851232A (en) 1997-03-15 1998-12-22 Lois; William A. Venous stent
US5800454A (en) * 1997-03-17 1998-09-01 Sarcos, Inc. Catheter deliverable coiled wire thromboginic apparatus and method
US5836913A (en) 1997-05-02 1998-11-17 Innerdyne, Inc. Device and method for accessing a body cavity
US5868708A (en) 1997-05-07 1999-02-09 Applied Medical Resources Corporation Balloon catheter apparatus and method
US5855597A (en) 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US5911734A (en) 1997-05-08 1999-06-15 Embol-X, Inc. Percutaneous catheter and guidewire having filter and medical device deployment capabilities
US5846260A (en) 1997-05-08 1998-12-08 Embol-X, Inc. Cannula with a modular filter for filtering embolic material
US5957940A (en) 1997-06-30 1999-09-28 Eva Corporation Fasteners for use in the surgical repair of aneurysms
US5928260A (en) 1997-07-10 1999-07-27 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
US5928192A (en) 1997-07-24 1999-07-27 Embol-X, Inc. Arterial aspiration
JP4127960B2 (en) 1997-08-05 2008-07-30 ボストン サイエンティフィック リミテッド Detachable aneurysm neck bridge
DE29714242U1 (en) 1997-08-08 1998-12-10 Applied Biometrics Closure device for closing a physical anomaly such as vascular opening or opening in a septum
US5976174A (en) 1997-12-15 1999-11-02 Ruiz; Carlos E. Medical hole closure device and methods of use
US6089835A (en) * 1997-12-25 2000-07-18 Hitachi Koki Co., Ltd. Portable compressor
US6033116A (en) * 1998-02-20 2000-03-07 Unova Ip Corp Hydrostatic pre-load piston
US6375612B1 (en) * 1998-03-24 2002-04-23 P. Timothy Guichon Method and system for monitoring animals
US6007557A (en) 1998-04-29 1999-12-28 Embol-X, Inc. Adjustable blood filtration system
WO1999059646A1 (en) 1998-05-19 1999-11-25 Schering-Plough Healthcare Products, Inc. Parylene coated devices with adhesive
US5935148A (en) 1998-06-24 1999-08-10 Target Therapeutics, Inc. Detachable, varying flexibility, aneurysm neck bridge
US5954694A (en) 1998-08-07 1999-09-21 Embol-X, Inc. Nested tubing sections and methods for making same
US6033420A (en) 1998-09-02 2000-03-07 Embol-X, Inc. Trocar introducer system and methods of use
US6007523A (en) 1998-09-28 1999-12-28 Embol-X, Inc. Suction support and method of use
JP2000109427A (en) 1998-10-01 2000-04-18 Lion Corp Skin patch
US6051014A (en) 1998-10-13 2000-04-18 Embol-X, Inc. Percutaneous filtration catheter for valve repair surgery and methods of use
US7128073B1 (en) * 1998-11-06 2006-10-31 Ev3 Endovascular, Inc. Method and device for left atrial appendage occlusion
US6068621A (en) 1998-11-20 2000-05-30 Embol X, Inc. Articulating cannula
US6080183A (en) 1998-11-24 2000-06-27 Embol-X, Inc. Sutureless vessel plug and methods of use
US6056720A (en) 1998-11-24 2000-05-02 Embol-X, Inc. Occlusion cannula and methods of use
US6083239A (en) 1998-11-24 2000-07-04 Embol-X, Inc. Compliant framework and methods of use
US6024755A (en) 1998-12-11 2000-02-15 Embol-X, Inc. Suture-free clamp and sealing port and methods of use
US6179859B1 (en) * 1999-07-16 2001-01-30 Baff Llc Emboli filtration system and methods of use
ES2293922T3 (en) 1999-09-20 2008-04-01 Atritech, Inc. APPARATUS TO CLOSE A BODY LUMEN.
US6689150B1 (en) * 1999-10-27 2004-02-10 Atritech, Inc. Filter apparatus for ostium of left atrial appendage
US6551303B1 (en) * 1999-10-27 2003-04-22 Atritech, Inc. Barrier device for ostium of left atrial appendage
US6652555B1 (en) 1999-10-27 2003-11-25 Atritech, Inc. Barrier device for covering the ostium of left atrial appendage
GB0018467D0 (en) 2000-07-27 2000-09-13 Strakan Pharm Ltd Adhesives

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306234A (en) 1993-03-23 1994-04-26 Johnson W Dudley Method for closing an atrial appendage
US5865791A (en) 1995-06-07 1999-02-02 E.P. Technologies Inc. Atrial appendage stasis reduction procedure and devices
WO1999005977A1 (en) * 1997-08-04 1999-02-11 Boston Scientific Corporation Occlusion system for aneurysm repair
WO1999007294A1 (en) * 1997-08-05 1999-02-18 Boston Scientific, Limited Detachable aneurysm neck bridge (ii)
WO1999030640A1 (en) * 1997-12-15 1999-06-24 Boston Scientific Limited Sheet metal aneurysm neck bridge
WO2000027292A1 (en) * 1998-11-06 2000-05-18 Appriva Medical, Inc. Method and device for left atrial appendage occlusion

Cited By (136)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713282B2 (en) 1998-11-06 2010-05-11 Atritech, Inc. Detachable atrial appendage occlusion balloon
US8080032B2 (en) 1998-11-06 2011-12-20 Atritech, Inc. Method and device for left atrial appendage occlusion
US8834519B2 (en) 1998-11-06 2014-09-16 Artritech, Inc. Method and device for left atrial appendage occlusion
US9168043B2 (en) 1998-11-06 2015-10-27 Atritech, Inc. Method for left atrial appendage occlusion
WO2004012629A1 (en) 1999-08-09 2004-02-12 Cardiokinetix, Inc. A device for improving cardiac function
US9872767B2 (en) 1999-08-09 2018-01-23 Edwards Lifesciences Corporation Retrievable cardiac devices
US10307147B2 (en) 1999-08-09 2019-06-04 Edwards Lifesciences Corporation System for improving cardiac function by sealing a partitioning membrane within a ventricle
US10307253B2 (en) 1999-08-09 2019-06-04 Edwards Lifesciences Corporation System for improving cardiac function by sealing a partitioning membrane within a ventricle
US9694121B2 (en) 1999-08-09 2017-07-04 Cardiokinetix, Inc. Systems and methods for improving cardiac function
US8323309B2 (en) 1999-11-08 2012-12-04 Atritech, Inc. Adjustable left atrial appendage implant
US7044134B2 (en) * 1999-11-08 2006-05-16 Ev3 Sunnyvale, Inc Method of implanting a device in the left atrial appendage
US8663273B2 (en) 1999-11-08 2014-03-04 Atritech, Inc. Method of implanting an adjustable occlusion device
US8043329B2 (en) 1999-11-08 2011-10-25 Atritech, Inc. Method of implanting an adjustable occlusion device
US8287563B2 (en) 1999-11-08 2012-10-16 Atritech, Inc. Implant retrieval system
US9943299B2 (en) 1999-11-08 2018-04-17 Atritech, Inc. Method of implanting an adjustable occlusion device
US10064696B2 (en) 2000-08-09 2018-09-04 Edwards Lifesciences Corporation Devices and methods for delivering an endocardial device
US9078660B2 (en) 2000-08-09 2015-07-14 Cardiokinetix, Inc. Devices and methods for delivering an endocardial device
WO2002024106A2 (en) * 2000-09-21 2002-03-28 Atritech, Inc. Apparatus for implanting devices in atrial appendages
WO2002024106A3 (en) * 2000-09-21 2003-02-06 Atritech Inc Apparatus for implanting devices in atrial appendages
WO2002096295A1 (en) * 2001-05-30 2002-12-05 Scimed Life Systems, Inc. Implantable septal defects closure device
US6537300B2 (en) 2001-05-30 2003-03-25 Scimed Life Systems, Inc. Implantable obstruction device for septal defects
US7717937B2 (en) 2001-06-01 2010-05-18 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods and tools, and related methods of use
US9078630B2 (en) 2001-06-01 2015-07-14 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods and tools, and related methods of use
EP1392394A4 (en) * 2001-06-04 2005-05-18 Albert Einstein Healthcare Network Cardiac stimulating apparatus having a blood clot filter and atrial pacer
EP1392394A2 (en) * 2001-06-04 2004-03-03 Albert Einstein Healthcare Network Cardiac stimulating apparatus having a blood clot filter and atrial pacer
WO2003008030A2 (en) * 2001-07-18 2003-01-30 Atritech, Inc. Implantation catheter with tether system
WO2003008030A3 (en) * 2001-07-18 2003-04-03 Atritech Inc Implantation catheter with tether system
EP2078502A3 (en) * 2001-09-11 2009-08-26 Spiration, Inc. Removable lung reduction devices systems, and methods
WO2003032818A2 (en) 2001-10-19 2003-04-24 Ev3 Sunnyvale, Inc. Adjustable left atrial appendage occlusion device
EP1441649A4 (en) * 2001-10-19 2008-02-27 Ev3 Endovascular Inc Adjustable left atrial appendage occlusion device
EP1441649A2 (en) * 2001-10-19 2004-08-04 EV3 Sunnyvale, Inc. Adjustable left atrial appendage occlusion device
US10751158B2 (en) 2002-01-25 2020-08-25 Atritech, Inc. Atrial appendage blood filtration systems
US9883936B2 (en) 2002-01-25 2018-02-06 Boston Scientific Scimed, Inc Atrial appendage blood filtration systems
WO2003063732A2 (en) * 2002-01-25 2003-08-07 Atritech, Inc. Atrial appendage blood filtration systems
WO2003063732A3 (en) * 2002-01-25 2003-11-27 Atritech Inc Atrial appendage blood filtration systems
EP1494632A1 (en) * 2002-03-20 2005-01-12 Spiration, Inc. Removable anchored lung volume reduction devices and methods
EP1494632B1 (en) * 2002-03-20 2019-04-17 Spiration, Inc. Removable anchored lung volume reduction devices
US7691128B2 (en) 2002-05-06 2010-04-06 St. Jude Medical, Cardiology Division, Inc. PFO closure devices and related methods of use
US7976564B2 (en) 2002-05-06 2011-07-12 St. Jude Medical, Cardiology Division, Inc. PFO closure devices and related methods of use
EP1539034A1 (en) * 2002-08-01 2005-06-15 Cardiokinetix, Inc. A device for improving cardiac function
US9592123B2 (en) 2002-08-01 2017-03-14 Cardiokinetix, Inc. Therapeutic methods and devices following myocardial infarction
EP1539034A4 (en) * 2002-08-01 2008-06-25 Cardiokinetix Inc A device for improving cardiac function
AU2017204628B2 (en) * 2002-10-17 2019-07-25 W. L. Gore & Associates, Inc. Embolic filter frame having looped support strut elements
US8372112B2 (en) 2003-04-11 2013-02-12 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods, and related methods of use
US8574264B2 (en) 2003-04-11 2013-11-05 St. Jude Medical, Cardiology Division, Inc. Method for retrieving a closure device
JP4879744B2 (en) * 2003-05-12 2012-02-22 カーディオキネティックス・インコーポレイテッド System to improve heart function
JP2011200659A (en) * 2003-05-12 2011-10-13 Cardiokinetix Inc System for improving cardiac function
WO2004100803A1 (en) * 2003-05-12 2004-11-25 Cardiokinetix, Inc. A system for improving cardiac function
US9622752B2 (en) 2003-08-08 2017-04-18 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
US7735493B2 (en) 2003-08-15 2010-06-15 Atritech, Inc. System and method for delivering a left atrial appendage containment device
US8097015B2 (en) 2003-09-12 2012-01-17 W.L. Gore & Associates, Inc. Device and methods for preventing formation of thrombi in the left atrial appendage
US7806846B2 (en) 2004-03-30 2010-10-05 Nmt Medical, Inc. Restoration of flow in LAA via tubular conduit
US9901350B2 (en) 2005-04-22 2018-02-27 Rex Medical, L.P. Closure device for left atrial appendage
US10932926B2 (en) 2005-05-24 2021-03-02 Inspiremd Ltd. Stent assembly and methods for treatment via body lumens
US8961586B2 (en) 2005-05-24 2015-02-24 Inspiremd Ltd. Bifurcated stent assemblies
US10058440B2 (en) 2005-05-24 2018-08-28 Inspiremd, Ltd. Carotid stent apparatus and methods for treatment via body lumens
US10070977B2 (en) 2005-05-24 2018-09-11 Inspire M.D. Ltd Stent apparatuses for treatment via body lumens and methods of use
US10368942B2 (en) 2005-09-06 2019-08-06 W. L. Gore & Associates, Inc. Devices and methods for treating cardiac tissue
US10143458B2 (en) 2005-09-16 2018-12-04 Atritech, Inc. Intracardiac cage and method of delivering same
US7972359B2 (en) 2005-09-16 2011-07-05 Atritech, Inc. Intracardiac cage and method of delivering same
US9445895B2 (en) 2005-09-16 2016-09-20 Atritech, Inc. Intracardiac cage and method of delivering same
WO2007035497A1 (en) * 2005-09-16 2007-03-29 Ev3 Endovascular, Inc. Intracardiac cage and method of delivering same
US10143456B2 (en) 2005-10-07 2018-12-04 Alex Javois Left atrial appendage occlusion device
EP1981577A2 (en) * 2005-10-07 2008-10-22 Alex Javois Left atrial appendage occlusion device
EP1981577A4 (en) * 2005-10-07 2013-04-17 Alex Javois Left atrial appendage occlusion device
US10499927B2 (en) 2005-10-19 2019-12-10 Pulsar Vascular, Inc. Methods and systems for endovascularly clipping and repairing lumen and tissue defects
US10076335B2 (en) 2005-12-01 2018-09-18 Atritech, Inc. Apparatus for delivering an implant without bias to a left atrial appendage
US10898198B2 (en) 2005-12-01 2021-01-26 Atritech, Inc. Apparatus for delivering an implant without bias to a left atrial appendage
US10137015B2 (en) 2006-10-18 2018-11-27 Inspiremd Ltd. Knitted stent jackets
EP2083902A4 (en) * 2006-10-18 2013-04-10 Inspiremd Ltd Filter assemblies
EP2083902A2 (en) * 2006-10-18 2009-08-05 Inspiremd Ltd. Filter assemblies
US9132261B2 (en) 2006-10-18 2015-09-15 Inspiremd, Ltd. In vivo filter assembly
US10406006B2 (en) 2006-11-22 2019-09-10 Inspiremd, Ltd. Methods of providing optimized drug-eluting stent assemblies
US11051959B2 (en) 2006-11-22 2021-07-06 Inspiremd, Ltd. Intravascular aneurysm treatment device and methods
US9782281B2 (en) 2006-11-22 2017-10-10 Inspiremd, Ltd. Stent-mesh assembly and methods
US10070976B2 (en) 2006-11-22 2018-09-11 Inspiremd Ltd. Optimized stent jacket
US10406008B2 (en) 2006-11-22 2019-09-10 Inspiremd, Ltd. Optimized stent jacket having single fiber mesh
US9526644B2 (en) 2006-11-22 2016-12-27 Inspiremd, Ltd. Optimized drug-eluting stent assembly methods
US9326873B2 (en) 2007-10-12 2016-05-03 Spiration, Inc. Valve loader method, system, and apparatus
US11154303B2 (en) 2007-10-19 2021-10-26 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US8979893B2 (en) 2008-09-05 2015-03-17 Pulsar Vascular, Inc. Systems and methods for supporting or occluding a physiological opening or cavity
US11185333B2 (en) 2008-09-05 2021-11-30 Pulsar Vascular, Inc. Systems and methods for supporting or occluding a physiological opening or cavity
US9615831B2 (en) 2008-09-05 2017-04-11 Pulsar Vascular, Inc. Systems and methods for supporting or occluding a physiological opening or cavity
US10285709B2 (en) 2008-09-05 2019-05-14 Pulsar Vascular, Inc. Systems and methods for supporting or occluding a physiological opening or cavity
EP2163205A1 (en) * 2008-09-11 2010-03-17 Beat Dr. Wicky Device for closing wounds, particularly wounds caused by the insertion of a trocar into the abdominal wall
US11253262B2 (en) 2009-06-17 2022-02-22 Coherex Medical, Inc. Delivery device, system, and method thereof
US11540837B2 (en) 2009-06-17 2023-01-03 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US10335153B2 (en) 2009-09-04 2019-07-02 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening
US9277924B2 (en) 2009-09-04 2016-03-08 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening
US11633189B2 (en) 2009-09-04 2023-04-25 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening
US9364327B2 (en) 2009-10-26 2016-06-14 Cardiokinetix, Inc. Ventricular volume reduction
US9039597B2 (en) 2009-10-26 2015-05-26 Cardiokinetix, Inc. Ventricular volume reduction
US10028835B2 (en) 2009-10-26 2018-07-24 Edwards Lifesciences Corporation Ventricular volume reduction
US10993803B2 (en) 2011-04-01 2021-05-04 W. L. Gore & Associates, Inc. Elastomeric leaflet for prosthetic heart valves
US10624647B2 (en) 2011-06-03 2020-04-21 Pulsar Vascular, Inc. Aneurysm devices with additional anchoring mechanisms and associated systems and methods
US11344311B2 (en) 2011-06-03 2022-05-31 Pulsar Vascular, Inc. Aneurysm devices with additional anchoring mechanisms and associated systems and methods
US10004510B2 (en) 2011-06-03 2018-06-26 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening, including shock absorbing aneurysm devices
US11457925B2 (en) 2011-09-16 2022-10-04 W. L. Gore & Associates, Inc. Occlusive devices
US10426487B2 (en) 2011-10-05 2019-10-01 Pulsar Vascular, Inc. Devices, systems and methods for enclosing an anatomical opening
US9119625B2 (en) 2011-10-05 2015-09-01 Pulsar Vascular, Inc. Devices, systems and methods for enclosing an anatomical opening
US11457923B2 (en) 2011-10-05 2022-10-04 Pulsar Vascular, Inc. Devices, systems and methods for enclosing an anatomical opening
US9636117B2 (en) 2011-10-05 2017-05-02 Pulsar Vascular, Inc. Devices, systems and methods for enclosing an anatomical opening
CN104168843A (en) * 2011-11-01 2014-11-26 科赫里克斯医疗股份有限公司 Medical device for modification of left atrial appendage and related systems and methods
EP3682813A1 (en) * 2011-11-01 2020-07-22 Coherex Medical, Inc. Medical device for modification of left atrial appendage
US9474516B2 (en) 2011-11-08 2016-10-25 Boston Scientific Scimed, Inc. Handle assembly for a left atrial appendage occlusion device
US9259229B2 (en) 2012-05-10 2016-02-16 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening, including coil-tipped aneurysm devices
US11911258B2 (en) 2013-06-26 2024-02-27 W. L. Gore & Associates, Inc. Space filling devices
US11806019B2 (en) 2013-11-14 2023-11-07 Lifetech Scientific (Shenzhen) Co., Ltd Left atrial appendage occluder
EP3072461A4 (en) * 2013-11-14 2017-05-31 Lifetech Scientific (Shenzhen) Co., Ltd. Left atrial appendage occluder
EP4137067A1 (en) * 2013-11-14 2023-02-22 Lifetech Scientific (Shenzhen) Co., Ltd Left atrial appendage occluder
US11832824B2 (en) 2013-12-20 2023-12-05 Terumo Corporation Vascular occlusion
US9730701B2 (en) 2014-01-16 2017-08-15 Boston Scientific Scimed, Inc. Retrieval wire centering device
US10463377B2 (en) 2014-01-16 2019-11-05 Boston Scientific Scimed, Inc. Retrieval wire centering device
US11413047B2 (en) 2014-01-16 2022-08-16 Cardiac Pacemakers, Inc. Occlusive medical implant
US10751183B2 (en) 2014-09-28 2020-08-25 Edwards Lifesciences Corporation Apparatuses for treating cardiac dysfunction
US11129622B2 (en) 2015-05-14 2021-09-28 W. L. Gore & Associates, Inc. Devices and methods for occlusion of an atrial appendage
US10667896B2 (en) 2015-11-13 2020-06-02 Cardiac Pacemakers, Inc. Bioabsorbable left atrial appendage closure with endothelialization promoting surface
US11432809B2 (en) 2017-04-27 2022-09-06 Boston Scientific Scimed, Inc. Occlusive medical device with fabric retention barb
US11173023B2 (en) 2017-10-16 2021-11-16 W. L. Gore & Associates, Inc. Medical devices and anchors therefor
US10952741B2 (en) 2017-12-18 2021-03-23 Boston Scientific Scimed, Inc. Occlusive device with expandable member
US11413048B2 (en) 2018-01-19 2022-08-16 Boston Scientific Scimed, Inc. Occlusive medical device with delivery system
US11331104B2 (en) 2018-05-02 2022-05-17 Boston Scientific Scimed, Inc. Occlusive sealing sensor system
US11241239B2 (en) 2018-05-15 2022-02-08 Boston Scientific Scimed, Inc. Occlusive medical device with charged polymer coating
US11890018B2 (en) 2018-06-08 2024-02-06 Boston Scientific Scimed, Inc. Occlusive device with actuatable fixation members
US11123079B2 (en) 2018-06-08 2021-09-21 Boston Scientific Scimed, Inc. Occlusive device with actuatable fixation members
US11672541B2 (en) 2018-06-08 2023-06-13 Boston Scientific Scimed, Inc. Medical device with occlusive member
US11382635B2 (en) 2018-07-06 2022-07-12 Boston Scientific Scimed, Inc. Occlusive medical device
US11596533B2 (en) 2018-08-21 2023-03-07 Boston Scientific Scimed, Inc. Projecting member with barb for cardiovascular devices
US11564692B2 (en) 2018-11-01 2023-01-31 Terumo Corporation Occlusion systems
US11369355B2 (en) 2019-06-17 2022-06-28 Coherex Medical, Inc. Medical device and system for occluding a tissue opening and method thereof
US11540838B2 (en) 2019-08-30 2023-01-03 Boston Scientific Scimed, Inc. Left atrial appendage implant with sealing disk
US11534175B2 (en) 2020-01-28 2022-12-27 Medtronic, Inc. Modular left atrial appendage closure
WO2021154458A1 (en) * 2020-01-28 2021-08-05 Medtronic, Inc. Modular left atrial appendage closure
US11903589B2 (en) 2020-03-24 2024-02-20 Boston Scientific Scimed, Inc. Medical system for treating a left atrial appendage
US11812969B2 (en) 2020-12-03 2023-11-14 Coherex Medical, Inc. Medical device and system for occluding a tissue opening and method thereof
US11925356B2 (en) 2021-02-11 2024-03-12 Boston Scientific Scimed, Inc. Occlusive device with expandable member

Also Published As

Publication number Publication date
CN1399530A (en) 2003-02-26
AU1232701A (en) 2001-05-08
ES2223602T3 (en) 2005-03-01
US10893926B2 (en) 2021-01-19
EP1523957A2 (en) 2005-04-20
IL149132A (en) 2009-02-11
JP2011005292A (en) 2011-01-13
JP2003529410A (en) 2003-10-07
JP4630513B2 (en) 2011-02-09
JP5710916B2 (en) 2015-04-30
IL149132A0 (en) 2002-11-10
US8685055B2 (en) 2014-04-01
US7727189B2 (en) 2010-06-01
AU779358B2 (en) 2005-01-20
DE60013880T2 (en) 2005-09-29
US20160058539A1 (en) 2016-03-03
US6652556B1 (en) 2003-11-25
CA2388600A1 (en) 2001-05-03
US9132000B2 (en) 2015-09-15
US20040127935A1 (en) 2004-07-01
EP1227770A1 (en) 2002-08-07
US20180338824A1 (en) 2018-11-29
US6689150B1 (en) 2004-02-10
WO2001030266A9 (en) 2002-08-15
EP1523957A3 (en) 2014-08-13
DE60013880D1 (en) 2004-10-21
EP1227770B1 (en) 2004-09-15
US20040122467A1 (en) 2004-06-24
US20140163605A1 (en) 2014-06-12
ATE275886T1 (en) 2004-10-15
CA2388600C (en) 2009-08-04

Similar Documents

Publication Publication Date Title
AU779358B2 (en) Filter apparatus for ostium of left atrial appendage
US6652555B1 (en) Barrier device for covering the ostium of left atrial appendage
AU779124B2 (en) Barrier device for ostium of left atrial appendage

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2002/453/KOL

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 149132

Country of ref document: IL

ENP Entry into the national phase

Ref document number: 2001 532689

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2388600

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 008149097

Country of ref document: CN

Ref document number: 2000973875

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12327/01

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2000973875

Country of ref document: EP

COP Corrected version of pamphlet

Free format text: PAGES 1/38-38/38, DRAWINGS, REPLACED BY NEW PAGES 1/38-38/38; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2000973875

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 12327/01

Country of ref document: AU